data_2mjn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mjn _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.61 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.61 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.428 ' CD1' HG22 ' A' ' 111' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 121.236 0.541 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HB3' ' HZ3' ' A' ' 136' ' ' LYS . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.444 ' HG ' ' CD2' ' A' ' 96' ' ' HIS . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.573 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.439 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.439 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.576 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.414 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 . . . . . 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.4 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.412 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 241' ' ' SER . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.488 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.465 ' HB3' ' CB ' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.419 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.419 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.412 ' HG ' HD21 ' A' ' 214' ' ' LEU . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.465 ' CB ' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.482 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.417 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . 0.615 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.434 -1.25 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.615 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.463 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 115' ' ' PHE . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.442 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' HG21 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 pttt . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.8 m . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.663 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.606 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.71 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.402 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.606 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CG ' ' HA ' ' A' ' 146' ' ' LYS . 18.1 t80 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.523 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' ' HG3' ' A' ' 156' ' ' MET . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 112' ' ' LYS . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.66 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.66 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.446 ' HA ' HG22 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.467 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.479 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.569 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.419 -2.017 0 CA-C-O 120.681 0.277 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 195' ' ' VAL . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 192' ' ' ASP . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.408 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.415 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.42 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.413 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.413 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 223' ' ' PHE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.577 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.577 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.432 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.48 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.458 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 194' ' ' VAL . 5.1 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.579 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.579 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.466 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.433 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.433 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.521 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.534 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.404 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? . . . . . 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CD2' ' HA ' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.534 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.443 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.472 ' O ' HG22 ' A' ' 194' ' ' VAL . 10.9 m . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 76.8 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.452 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.509 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.434 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.434 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.509 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.454 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.44 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.637 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.505 ' HG1' ' HB ' ' A' ' 126' ' ' VAL . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.565 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.505 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.44 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.565 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . 0.528 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.481 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 156' ' ' MET . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.484 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.484 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.417 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.474 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.573 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.422 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.422 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . 0.579 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 138' ' ' TYR . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.591 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.446 HG22 ' CD1' ' A' ' 115' ' ' PHE . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.434 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . 0.4 ' C ' HD13 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.521 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.521 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.591 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.468 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.457 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.699 HD11 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.699 ' SD ' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 224' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 216' ' ' GLU . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . 0.437 HG12 HG23 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 246' ' ' ASN . 0.7 OUTLIER -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.512 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.562 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.563 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.563 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 pttt . . . . . 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . 0.481 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 194' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 77.2 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 219' ' ' MET . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.606 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.497 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.244 0.799 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.443 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.469 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.423 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.561 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.561 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.481 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.421 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt . . . . . 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.419 ' NZ ' HG11 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.472 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.579 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.482 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.511 ' O ' HG22 ' A' ' 194' ' ' VAL . 21.2 t . . . . . 0 C--O 1.204 -1.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 241' ' ' SER . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.467 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.424 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.424 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.424 ' HG ' HD21 ' A' ' 214' ' ' LEU . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.403 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . 0.412 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . . . . . . 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.452 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . 32.8 t80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.407 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.413 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.531 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.476 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ARG . . . . . 0.407 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 194' ' ' VAL . 67.5 m . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.542 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' VAL . . . . . 0.429 ' HB ' HD12 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.429 HD12 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' MET . . . . . 0.542 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLN . . . . . 0.599 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ASP . . . . . 0.505 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' LYS . . . . . 0.505 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' SER . . . . . 0.4 ' HG ' HD22 ' A' ' 214' ' ' LEU . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' SER . . . . . 0.566 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' GLU . . . . . 0.566 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . 0.494 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 252' ' ' ALA . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.425 -1.705 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.658 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' TYR . . . . . 0.658 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.45 124.06 27.72 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.767 0.784 . . . . 0.0 109.304 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -54.26 -23.7 15.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.34 1.056 . . . . 0.0 112.423 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.43 75.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.98 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -100.06 2.28 43.13 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.581 0.705 . . . . 0.0 110.366 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -93.13 135.44 34.32 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -130.7 138.03 49.82 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.543 -171.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.472 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.61 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.61 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.428 HG22 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.428 ' CD1' HG22 ' A' ' 111' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.41 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.508 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG22 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -122.37 164.44 17.97 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.51 136.56 51.59 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.539 0.524 . . . . 0.0 110.134 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 52.6 ttm -63.05 -36.51 83.81 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.487 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.07 -47.97 9.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -95.02 -15.72 23.27 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.975 0.417 . . . . 0.0 112.041 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.17 77.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.517 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.666 ' HA ' ' NZ ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -96.01 138.86 33.02 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 122.311 -0.523 . . . . 0.0 110.353 -178.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t -61.12 145.25 51.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 124.074 0.859 . . . . 0.0 111.626 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HB3' ' HZ3' ' A' ' 136' ' ' LYS . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.444 ' HG ' ' CD2' ' A' ' 96' ' ' HIS . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.508 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.573 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.439 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.576 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.439 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.576 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.414 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 -81.97 130.84 35.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.33 -61.2 1.7 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.275 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 25.4 p -77.87 89.4 4.08 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -79.52 108.37 13.0 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.693 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -72.45 113.62 22.52 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.109 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.69 145.02 17.91 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.887 1.725 . . . . 0.0 111.297 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.98 141.74 19.14 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.596 1.53 . . . . 0.0 110.742 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 123.81 83.88 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.99 -171.58 1.29 Allowed 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 122.933 2.422 . . . . 0.0 112.458 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -146.74 171.93 14.41 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 88.15 1.62 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.8 m -94.56 -20.02 19.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.915 0.864 . . . . 0.0 110.145 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -144.23 144.09 31.35 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.81 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . 0.381 8.3 mm-40 65.75 121.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -163.17 28.84 0.09 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 70.25 77.43 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.18 -170.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 69.5 m -56.66 125.35 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.692 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.468 ' HZ1' ' CD ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -93.08 89.18 6.38 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.586 1.184 . . . . 0.0 112.409 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.98 -174.74 3.82 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.92 85.34 2.68 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.227 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.592 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m -87.87 127.39 35.35 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.489 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.4 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.412 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.412 HD21 ' HG ' ' A' ' 241' ' ' SER . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.488 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.406 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.488 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.465 ' HB3' ' CB ' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.406 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.419 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.419 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.412 ' HG ' HD21 ' A' ' 214' ' ' LEU . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.465 ' CB ' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.482 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.417 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.44 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.44 HG22 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.615 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m -133.92 124.84 27.08 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 38.0 mm -111.04 112.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . 0.265 0.0 OUTLIER 46.28 34.96 2.42 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 126.732 2.013 . . . . 0.0 115.122 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.82 -26.71 11.24 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.483 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -93.98 125.62 38.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.107 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.71 122.54 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.6 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.615 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.412 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.66 14.19 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.604 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.409 -2.507 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.589 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.477 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.04 76.53 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.28 141.68 48.89 Favored 'General case' 0 C--O 1.266 1.925 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.8 -175.17 0.19 Allowed 'General case' 0 C--O 1.239 0.552 0 O-C-N 124.794 1.309 . . . . 0.0 109.084 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -109.16 5.5 23.98 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.419 -1.313 . . . . 0.0 110.18 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.409 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 78.3 m-70 -93.93 126.81 39.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.18 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -112.94 142.2 45.9 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.38 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.403 ' HA ' HG23 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.463 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.582 ' CD ' ' HZ2' ' A' ' 134' ' ' LYS . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.437 HG21 ' CD1' ' A' ' 115' ' ' PHE . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.442 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.488 ' HA ' HG21 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -116.27 149.54 39.05 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.89 123.73 22.69 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.252 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -27.91 69.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.31 -42.91 10.69 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 29.3 p -95.44 -18.58 20.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.582 ' HZ2' ' CD ' ' A' ' 105' ' ' GLU . 31.6 mmmt -103.38 140.0 38.03 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.069 0.461 . . . . 0.0 111.075 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 27.8 m -66.11 138.38 57.7 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.856 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.409 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.439 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.663 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.663 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.444 ' O ' ' HB2' ' A' ' 173' ' ' ARG . 44.3 p-90 -79.98 141.71 35.72 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.36 154.58 27.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.077 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.3 m 68.92 30.7 4.52 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 170' ' ' TRP . 11.0 tpt85 -61.54 136.57 58.07 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 126.506 1.922 . . . . 0.0 111.504 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -99.78 122.94 49.41 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.46 149.8 21.7 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.691 2.261 . . . . 0.0 111.229 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.12 142.21 19.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.61 1.54 . . . . 0.0 110.817 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.86 123.53 89.03 Favored Pre-proline 0 C--O 1.256 1.399 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.8 -57.18 0.71 Allowed 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 123.175 2.583 . . . . 0.0 112.193 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 60.79 -167.06 0.19 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.731 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.8 m -81.09 83.46 6.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -149.07 16.15 0.94 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.27 -63.53 1.32 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.516 -174.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.55 94.54 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.102 2.161 . . . . 0.0 113.1 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 m -80.32 80.65 6.72 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.542 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -171.55 -72.77 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -148.43 163.68 36.41 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -86.74 -17.6 33.19 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.788 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -162.98 159.53 23.58 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.83 107.32 5.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m -77.21 142.18 39.71 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.333 -175.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.525 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.406 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.464 ' HA3' ' OE2' ' A' ' 264' ' ' GLU . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.606 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' MET . . . . . 0.541 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.431 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.449 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.449 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.406 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.71 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.431 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.541 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.402 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.466 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.606 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.16 117.05 16.1 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.66 123.74 67.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' OE2' ' HA3' ' A' ' 213' ' ' GLY . 46.8 mt-10 48.98 36.87 9.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.331 1.052 . . . . 0.0 113.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.04 72.32 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.841 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -95.85 128.04 42.4 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.18 115.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.7 m -105.11 142.42 18.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 -175.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -107.99 -167.19 21.47 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.012 179.02 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -1.192 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.41 93.96 1.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.7 ttm 73.26 -58.96 0.58 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.845 1.258 . . . . 0.0 109.16 -172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.84 150.37 29.25 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -82.83 -37.52 24.3 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.343 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.501 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 95.3 m-70 -145.73 144.95 30.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.417 ' CG ' ' HA ' ' A' ' 146' ' ' LYS . 18.1 t80 -130.62 142.3 50.45 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.479 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.523 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.523 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 116' ' ' ALA . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.444 ' CZ ' ' HG3' ' A' ' 156' ' ' MET . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 112' ' ' LYS . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.66 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.66 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.439 HD13 ' CB ' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.446 ' HA ' HG22 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -110.02 161.15 15.8 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.74 123.92 29.76 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.156 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -26.66 68.55 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.32 -43.44 9.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.42 ' OG1' ' HE2' ' A' ' 134' ' ' LYS . 20.1 p -95.55 -17.09 21.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.18 -5.19 77.98 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.733 -0.27 . . . . 0.0 113.764 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.592 ' O ' ' HE3' ' A' ' 134' ' ' LYS 0.258 0.0 OUTLIER -105.72 160.95 14.82 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.438 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m -55.95 141.76 38.29 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.467 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.444 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.569 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.479 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.408 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.569 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -79.93 131.05 35.75 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.11 27.33 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.406 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 12.9 t -64.33 123.65 19.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.539 -176.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -86.53 91.03 8.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.831 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -112.12 133.35 21.71 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.58 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.8 144.41 19.31 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.438 1.425 . . . . 0.0 111.381 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.53 142.37 18.36 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -94.09 123.98 57.46 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -92.72 25.72 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.744 2.296 . . . . 0.0 112.12 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 103.19 14.23 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 15.5 m -45.32 132.41 7.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.831 1.252 . . . . 0.0 111.865 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 5.1 m -34.05 -79.63 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.628 1.971 . . . . 0.0 115.519 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -109.04 -2.2 18.34 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.678 0.752 . . . . 0.0 110.055 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.438 ' CD ' ' HZ3' ' A' ' 187' ' ' LYS . 5.0 mm-40 -83.39 94.96 8.08 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.6 m -151.29 31.38 0.6 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.372 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -154.72 -172.93 4.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.2 m -68.46 100.83 1.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.328 0.585 . . . . 0.0 110.313 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.438 ' HZ3' ' CD ' ' A' ' 183' ' ' GLU . 48.1 tptt -77.37 -34.28 55.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.93 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.35 178.91 3.1 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 124.328 1.051 . . . . 0.0 108.269 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.77 139.63 49.98 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m -111.66 138.03 48.75 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.747 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.404 ' O ' HG13 ' A' ' 195' ' ' VAL . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.567 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.404 HG13 ' O ' ' A' ' 192' ' ' ASP . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.567 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . 0.422 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.408 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.408 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.427 ' HA ' HG22 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.415 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.555 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.427 HG22 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.406 HG11 HG21 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.42 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.42 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.413 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.413 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . 0.415 HG21 ' CE2' ' A' ' 223' ' ' PHE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.555 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.521 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.489 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m -134.02 122.88 23.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.9 mt -133.07 142.02 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.448 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.0 tt0 56.41 34.09 23.59 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 122.296 1.046 . . . . 0.0 110.346 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.75 -7.59 3.93 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 113.247 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.48 147.99 25.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.152 0.581 . . . . 0.0 109.749 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.2 t -77.21 120.9 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m -98.13 141.05 16.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.424 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -97.85 -156.3 30.0 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 6.1 mtmm . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 124.829 1.252 . . . . 0.0 107.808 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.777 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.637 ' HA ' ' O ' ' A' ' 174' ' ' LYS . . . -77.69 -49.81 13.72 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 171.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 144.69 25.95 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 171.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.06 0.944 . . . . 0.0 111.144 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.96 13.05 13.72 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.768 0.794 . . . . 0.0 110.369 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -94.2 158.69 15.48 Favored 'General case' 0 C--O 1.259 1.601 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.23 138.55 31.33 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.441 ' O ' ' HB1' ' A' ' 171' ' ' ALA . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.458 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.577 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.577 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.402 HD13 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.432 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.48 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -121.39 164.43 17.1 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -77.82 113.8 16.05 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.29 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 24.8 mmt -62.91 -17.87 62.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.52 -48.06 6.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.2 p -95.38 -11.04 28.39 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.191 0.519 . . . . 0.0 112.163 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.54 76.72 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.48 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -105.68 138.92 41.08 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 -176.671 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m -58.27 145.12 38.79 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.499 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.509 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.453 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.453 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.458 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -79.73 152.02 30.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 96' ' ' HIS . . . -160.86 169.55 22.44 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -139.5 -178.3 5.33 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.793 0.724 . . . . 0.0 111.925 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.27 110.05 22.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 173.382 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.637 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 61.9 tttm -111.28 143.27 28.09 Favored Pre-proline 0 C--N 1.278 -2.533 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.839 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.531 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 12.3 Cg_endo -60.48 164.14 13.77 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 121.851 1.701 . . . . 0.0 108.928 167.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.71 141.9 91.71 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.274 1.982 . . . . 0.0 113.395 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.52 124.79 38.07 Favored Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.327 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 118.91 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.943 1.762 . . . . 0.0 109.053 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.32 85.18 7.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.535 0.683 . . . . 0.0 111.548 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.447 ' HA ' ' CE2' ' A' ' 182' ' ' TYR . 28.7 m -88.66 31.72 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.657 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.8 p -81.29 81.54 7.42 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.226 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.447 ' CE2' ' HA ' ' A' ' 180' ' ' SER . 15.5 p90 -164.76 151.74 11.06 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.17 1.388 . . . . 0.0 107.879 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . 0.481 ' CD ' ' H ' ' A' ' 184' ' ' SER . 0.8 OUTLIER 62.6 -159.22 0.32 Allowed 'General case' 0 CA--C 1.567 1.612 0 O-C-N 124.273 0.983 . . . . 0.0 108.717 -178.228 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' SER . . . . . 0.481 ' H ' ' CD ' ' A' ' 183' ' ' GLU . 6.3 m -133.18 5.46 3.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 61.33 57.85 2.29 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.3 m -64.79 106.96 1.31 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.815 -1.539 . . . . 0.0 113.272 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.456 ' HE2' ' HB2' ' A' ' 187' ' ' LYS . 27.8 mtmm -121.19 -52.66 2.06 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 102.691 -3.077 . . . . 0.0 102.691 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.448 ' OE1' ' HE2' ' A' ' 187' ' ' LYS . 0.5 OUTLIER -162.08 162.01 28.51 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 168.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.18 103.61 11.03 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.163 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.496 ' O ' HG22 ' A' ' 194' ' ' VAL . 5.1 m -78.18 146.38 35.05 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.496 HG22 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.451 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.575 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.579 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.579 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.466 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.404 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.451 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.433 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.575 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.433 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.404 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.471 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.453 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m -134.01 117.32 16.55 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.96 119.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.25 37.08 3.7 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.982 1.713 . . . . 0.0 113.281 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.94 -19.28 52.77 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.859 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -93.54 118.86 31.88 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 122.588 -0.36 . . . . 0.0 110.7 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.96 126.75 30.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.38 151.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.521 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.521 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -108.07 -134.29 7.28 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.795 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS 0.383 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.023 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.871 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.23 101.88 13.01 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -104.66 140.44 38.03 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.89 92.48 4.27 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.198 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.61 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 51.0 t30 -80.92 -32.49 34.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.588 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -93.6 137.6 32.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.0 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.518 ' CE1' ' HB ' ' A' ' 172' ' ' THR . 56.6 t80 -130.83 142.46 50.39 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.985 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.534 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.404 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.477 ' CD ' ' HZ1' ' A' ' 112' ' ' LYS . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.416 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.403 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.96 164.71 20.21 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.461 ' HB3' ' OG1' ' A' ' 132' ' ' THR . 8.5 t70 -95.17 136.66 35.23 Favored 'General case' 0 C--N 1.275 -2.65 0 C-N-CA 117.477 -1.689 . . . . 0.0 108.77 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 18.9 mmt -63.86 -36.03 82.58 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.57 29.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.435 0.459 . . . . 0.0 111.829 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.461 ' OG1' ' HB3' ' A' ' 129' ' ' ASP . 72.0 p -94.87 -18.97 20.69 Favored 'General case' 0 C--O 1.249 1.076 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.322 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.09 38.15 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.754 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -107.14 160.41 15.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m -62.68 137.83 58.36 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 124.477 1.111 . . . . 0.0 110.895 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.44 ' HD3' ' HB2' ' A' ' 129' ' ' ASP . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.443 ' CD2' ' HA ' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.61 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.403 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.443 ' HA ' ' CD2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.561 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.561 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.443 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.534 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.443 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -65.25 129.46 39.79 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.84 -43.63 6.35 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.935 0.398 . . . . 0.0 110.182 -179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.518 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 12.7 m -73.85 98.95 3.08 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -129.72 111.65 12.86 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -110.94 118.2 48.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.826 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.6 146.52 49.42 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 121.998 1.799 . . . . 0.0 109.791 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.62 141.33 66.12 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.214 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.12 127.17 31.45 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 93.77 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.075 1.85 . . . . 0.0 109.817 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -82.13 80.91 8.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.098 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.3 m -96.15 102.43 14.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 p -121.53 -48.98 2.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -171.02 34.92 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.98 122.5 13.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.993 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.0 p -74.68 88.6 2.22 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -168.38 98.57 0.42 Allowed 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 170.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.601 ' HB ' ' OG ' ' A' ' 190' ' ' SER . 14.7 m -77.71 130.38 36.72 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.537 ' HA ' ' HZ1' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -93.19 70.69 4.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.609 1.195 . . . . 0.0 111.081 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -151.18 -169.87 3.5 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.36 82.43 8.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.414 -1.314 . . . . 0.0 108.844 174.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.601 ' OG ' ' HB ' ' A' ' 186' ' ' THR . 10.9 m -76.91 130.85 38.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.513 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.472 HG22 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.513 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 76.8 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.403 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.432 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.452 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.452 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.454 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.509 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.404 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.434 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.434 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.509 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.484 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.484 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.454 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.439 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m -132.87 116.95 17.13 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.38 122.27 63.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.72 37.84 5.14 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.396 1.479 . . . . 0.0 113.028 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.29 -12.0 70.72 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.927 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -96.14 122.64 39.21 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.06 120.32 20.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.71 142.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.403 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -123.07 -163.28 11.75 Favored Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 119.046 -0.502 . . . . 0.0 110.7 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.429 ' HA3' ' C ' ' A' ' 94' ' ' HIS . . . . . . . . 0 CA--C 1.492 -1.372 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -101.19 101.27 11.94 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.3 tpt 72.67 -53.48 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.53 -170.33 2.97 Favored 'General case' 0 C--O 1.257 1.489 0 CA-C-O 121.443 0.639 . . . . 0.0 109.677 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -77.84 -18.69 56.02 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 122.068 -0.395 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.429 ' C ' ' HA3' ' A' ' 89' ' ' GLY . 53.0 p-80 -125.52 169.59 12.28 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -115.11 131.79 56.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.44 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.409 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.637 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.505 ' HG1' ' HB ' ' A' ' 126' ' ' VAL . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.637 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.456 HD11 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.425 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.565 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.505 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 1.6 ptpp? -123.55 166.1 16.02 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.0 119.88 29.92 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 123.944 0.897 . . . . 0.0 109.164 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 95.8 mmm -63.19 -17.42 62.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.09 -41.14 11.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 118.114 0.415 . . . . 0.0 111.376 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -95.09 -24.3 16.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 111.464 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.48 11.17 85.14 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.452 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 31.4 mmmt -105.57 169.31 8.54 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-N 116.761 0.28 . . . . 0.0 110.602 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p -69.4 161.47 29.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.44 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.528 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.565 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.418 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . 0.528 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.481 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.437 ' O ' ' HG3' ' A' ' 156' ' ' MET . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . 0.481 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . 0.471 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.409 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -71.09 132.32 44.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.44 83.4 5.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.0 t -72.37 -28.42 63.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 69.9 -53.8 0.62 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.746 1.619 . . . . 0.0 111.98 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.61 140.21 22.36 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.683 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.8 160.6 24.54 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.614 2.209 . . . . 0.0 111.667 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.4 149.4 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.303 2.002 . . . . 0.0 110.573 172.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -101.34 123.47 44.55 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -96.24 109.1 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 122.484 2.122 . . . . 0.0 112.667 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.439 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 9.4 mtpm? -137.36 150.93 48.06 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.729 0.775 . . . . 0.0 112.368 176.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 30.1 t -113.87 -175.44 2.68 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.7 m -130.95 95.09 3.74 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 119.128 0.876 . . . . 0.0 109.506 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -135.27 -13.09 2.09 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.554 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -93.38 -41.08 10.03 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -177.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.9 m -83.82 -20.33 33.4 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.879 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -94.79 143.19 26.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.912 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 30.8 m 42.98 81.22 0.03 OUTLIER 'General case' 0 C--O 1.251 1.178 0 C-N-CA 126.549 1.939 . . . . 0.0 115.313 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -131.65 6.42 4.38 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -174.14 -172.75 0.73 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 74.2 mt -112.34 93.56 4.5 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m -73.48 144.84 46.06 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.573 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.451 ' HB ' HD11 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.484 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . 0.497 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.484 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.417 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.474 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.421 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.421 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.573 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.404 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.422 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.422 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.473 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . 0.579 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.473 HG21 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m -134.12 120.59 20.33 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 69.9 mt -113.37 123.66 69.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 46.28 37.03 3.69 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.895 1.678 . . . . 0.0 113.414 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -16.56 61.02 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.759 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 44.4 m-70 -93.28 119.09 32.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.03 126.76 30.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m -108.42 142.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.579 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.627 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -101.19 44.98 1.46 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.627 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.592 2.357 . . . . 0.0 108.846 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.56 -53.18 60.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -78.33 158.85 28.69 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.917 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.59 171.71 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.111 1.364 . . . . 0.0 111.13 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.2 t30 -82.4 -17.32 45.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.78 141.34 28.56 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.256 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.4 HD13 ' C ' ' A' ' 138' ' ' TYR . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.591 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.414 HD13 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.549 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.549 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.446 HG22 ' CD1' ' A' ' 115' ' ' PHE . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.446 ' CD1' HG22 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.405 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.405 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.434 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -128.41 165.82 19.9 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.482 ' HA ' ' NZ ' ' A' ' 136' ' ' LYS . 29.7 t70 -69.65 131.21 44.26 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.589 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -62.52 -37.41 85.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.3 1.04 . . . . 0.0 113.198 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.51 -42.12 9.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.5 p -94.9 -14.11 24.81 Favored 'General case' 0 C--O 1.259 1.553 0 CA-C-O 121.23 0.538 . . . . 0.0 111.947 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.06 20.75 75.07 Favored Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.768 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.462 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -101.49 131.14 47.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.501 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m -56.18 141.01 42.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.482 ' NZ ' ' HA ' ' A' ' 129' ' ' ASP . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . 0.4 ' C ' HD13 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.521 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.521 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.53 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.53 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . 0.414 ' HA3' HD13 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.591 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.468 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -79.9 131.31 35.82 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.72 81.84 6.94 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.497 0.665 . . . . 0.0 109.339 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -102.88 -51.21 3.33 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.529 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? 75.18 -50.84 0.66 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.933 1.293 . . . . 0.0 111.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -110.47 112.79 56.54 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -60.19 144.85 99.48 Favored 'Trans proline' 0 C--O 1.266 1.916 0 C-N-CA 121.493 1.462 . . . . 0.0 109.911 175.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -58.88 140.75 96.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.621 2.214 . . . . 0.0 113.274 -176.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -103.34 147.38 34.09 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.255 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -53.76 123.65 13.91 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.798 1.665 . . . . 0.0 108.936 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 179' ' ' LYS . 15.0 tptp -84.84 15.87 3.68 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 m -51.47 -47.06 63.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.236 1.017 . . . . 0.0 108.278 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 m -138.84 -67.8 0.45 Allowed 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.51 ' CE1' ' HE2' ' A' ' 187' ' ' LYS . 0.1 OUTLIER 179.37 85.0 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 126.891 2.076 . . . . 0.0 106.887 175.008 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -90.79 88.86 7.24 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 123.448 1.594 . . . . 0.0 114.054 -169.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 65.4 m -153.09 31.0 0.49 Allowed 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -171.96 135.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 112.785 -2.007 . . . . 0.0 106.143 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 m -57.85 109.62 0.76 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.51 ' HE2' ' CE1' ' A' ' 182' ' ' TYR . 3.7 mtmp? -151.19 -60.71 0.18 Allowed 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . 0.618 ' HA ' ' ND2' ' A' ' 259' ' ' ASN . 80.8 mt-30 -99.41 -178.69 3.98 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 159.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.46 116.67 29.13 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m -65.46 142.38 58.18 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.496 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.457 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.699 HD11 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.465 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.699 ' SD ' HD11 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.466 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 224' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 216' ' ' GLU . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . 0.437 HG12 HG23 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.416 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.416 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 246' ' ' ASN . 0.7 OUTLIER -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.512 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.512 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.562 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.562 HG21 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' A' ' 188' ' ' GLN . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -134.38 124.62 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 74.2 mt -134.24 141.73 42.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.505 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 29.9 tt0 55.57 34.15 22.57 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 122.58 1.181 . . . . 0.0 110.081 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.16 -6.61 5.33 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 113.286 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -99.68 145.67 27.36 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.98 0.512 . . . . 0.0 109.838 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.66 123.55 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.72 150.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.45 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -84.8 -41.07 7.84 Favored Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.268 2.076 0 N-CA-C 101.048 -3.686 . . . . 0.0 101.048 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.838 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.02 148.61 42.08 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.2 109.17 3.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.2 -90.06 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.72 -37.67 14.39 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -94.77 163.91 13.16 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.513 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -125.49 127.63 46.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.547 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.563 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.563 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.406 ' HA ' ' CG2' ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.497 ' HB ' ' HG1' ' A' ' 108' ' ' THR . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.489 ' HD2' ' O ' ' A' ' 133' ' ' GLY . 59.4 pttt -120.57 164.63 16.18 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.17 133.21 46.86 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 124.208 1.003 . . . . 0.0 111.916 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 ptp -62.72 -33.73 75.72 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.84 -43.41 9.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 26.6 p -95.3 -18.45 20.79 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . 0.489 ' O ' ' HD2' ' A' ' 128' ' ' LYS . . . 74.17 11.66 81.77 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.255 -0.43 . . . . 0.0 113.083 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.547 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 0.9 OUTLIER -105.96 154.18 20.95 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 122.409 -0.465 . . . . 0.0 110.293 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m -52.36 142.81 16.39 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.419 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.5 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.5 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.518 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . 0.481 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.518 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -65.2 132.25 48.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.442 ' HB3' ' HB2' ' A' ' 98' ' ' PHE . . . -134.55 21.88 3.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.408 0.623 . . . . 0.0 110.15 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 p -72.01 -73.67 0.18 Allowed 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.45 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -112.47 139.08 48.35 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.99 118.47 67.86 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.27 152.03 75.09 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.782 2.988 . . . . 0.0 114.254 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.56 149.08 30.13 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.816 2.344 . . . . 0.0 111.952 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.13 155.92 35.87 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.64 146.9 94.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.516 2.144 . . . . 0.0 110.931 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 185' ' ' ASN . 49.7 mmtm 59.89 3.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.023 1.329 . . . . 0.0 113.593 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 m -102.7 11.77 37.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.659 0.266 . . . . 0.0 111.681 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.2 t -151.49 -58.3 0.16 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.551 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -177.96 147.22 0.45 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.785 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -161.88 164.35 28.69 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.394 1.477 . . . . 0.0 108.264 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.1 m -90.4 -22.93 21.21 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.563 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 24.5 t-20 -75.22 101.87 4.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.451 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.2 p -90.11 161.07 15.96 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.387 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.282 14.5 tppt? -92.9 73.85 4.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 123.146 1.45 . . . . 0.0 111.712 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.77 -169.23 3.33 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 102.757 -3.053 . . . . 0.0 102.757 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.5 mt -82.88 78.57 9.45 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.062 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.445 ' O ' HG21 ' A' ' 194' ' ' VAL . 18.0 m -70.61 135.79 48.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.278 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.445 HG21 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 77.2 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.453 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.443 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 219' ' ' MET . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.425 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.425 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.606 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.497 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.497 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.46 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.46 HG22 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.53 119.18 18.14 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.84 111.15 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.587 0 CA-C-O 121.242 0.544 . . . . 0.0 109.788 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 44.51 36.55 1.73 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.541 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.58 -27.88 7.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.925 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -98.89 124.32 43.73 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.385 -0.479 . . . . 0.0 111.934 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.59 129.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.46 153.07 19.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.429 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -130.93 -172.01 13.03 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.417 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS . 1.5 tpmp? . . . . . 0 N--CA 1.414 -2.251 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.624 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.85 95.64 4.12 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.6 mmm -81.6 86.52 6.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.48 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.15 179.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.19 1.396 . . . . 0.0 112.399 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.415 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.5 t30 -93.32 -13.8 27.7 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -92.64 153.98 18.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 -170.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.443 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 -132.37 140.12 48.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.469 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.423 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . 0.488 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.561 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.561 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.481 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.481 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.579 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.421 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.419 HG11 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -105.82 166.16 10.67 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . 0.531 ' OD2' HG21 ' A' ' 132' ' ' THR . 9.5 t70 -75.52 137.14 40.68 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 123.582 0.551 . . . . 0.0 111.261 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.3 ptp -63.32 -33.2 75.0 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.19 8.35 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . 0.531 HG21 ' OD2' ' A' ' 129' ' ' ASP . 12.2 t -97.71 -10.97 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.927 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.08 19.89 75.93 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.083 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -106.0 145.86 30.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t -56.26 143.02 35.4 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.795 0.685 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.419 ' NZ ' HG11 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.472 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.443 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.579 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.482 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.482 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.469 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -80.7 130.87 35.34 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -107.07 -50.98 2.99 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.355 179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.415 ' HB ' ' CD2' ' A' ' 95' ' ' PHE . 4.0 m -83.28 22.83 0.96 Allowed 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.885 0.85 . . . . 0.0 110.903 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -162.32 118.08 1.94 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.37 144.46 30.55 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -71.64 148.57 53.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.908 1.739 . . . . 0.0 111.351 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -63.62 148.67 92.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.403 2.068 . . . . 0.0 112.081 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.59 124.45 89.28 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.004 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.1 -165.97 0.29 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.079 2.52 . . . . 0.0 111.981 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -133.4 22.39 4.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 46.8 m 63.16 -166.46 0.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.455 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.8 t -100.96 86.83 3.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.106 0.955 . . . . 0.0 112.816 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -176.1 166.93 2.96 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.43 142.4 27.77 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.0 m -83.57 21.09 1.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.229 0.538 . . . . 0.0 111.785 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -149.89 145.79 26.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -79.54 94.27 5.59 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.713 0.768 . . . . 0.0 111.29 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.483 ' HB2' ' HZ1' ' A' ' 187' ' ' LYS . 0.3 OUTLIER -54.49 -41.63 69.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.426 175.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.68 143.97 42.99 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 194' ' ' VAL . 85.1 mt -113.01 136.23 52.91 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.511 ' O ' HG22 ' A' ' 194' ' ' VAL . 21.2 t -111.49 147.41 35.39 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.421 ' O ' HG13 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.466 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . 0.414 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.46 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.424 HD21 ' HG ' ' A' ' 241' ' ' SER . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.467 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.467 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . 0.559 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.424 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.424 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.424 ' HG ' HD21 ' A' ' 214' ' ' LEU . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . 0.559 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.403 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.462 ' H ' ' CD ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.538 ' O ' HG22 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.538 HG22 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m -127.23 117.03 21.51 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.04 141.33 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . 0.452 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.1 tt0 56.21 34.19 23.49 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 122.344 1.069 . . . . 0.0 110.241 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.58 -6.05 5.08 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 113.185 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -100.98 144.0 30.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 123.14 0.576 . . . . 0.0 109.821 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.13 115.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.79 145.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . 0.412 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.414 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . -124.77 -171.03 13.25 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.265 1.891 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.729 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 176' ' ' PRO . . . 64.21 -175.26 0.16 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.81 0.947 . . . . 0.0 110.834 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.2 ttm -163.15 78.35 0.44 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.45 -169.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.149 1.78 . . . . 0.0 115.684 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -109.32 -35.44 6.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -95.03 152.67 18.13 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.306 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.477 ' CE1' ' HB ' ' A' ' 172' ' ' THR . 32.8 t80 -131.97 142.77 49.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.407 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ILE . . . . . 0.445 HD11 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . 0.445 ' CG2' HD11 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.8 ptmm? -132.73 165.36 24.69 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.21 121.6 23.89 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.31 -34.09 76.94 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.94 -45.63 13.92 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.491 0.494 . . . . 0.0 111.973 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -94.85 -16.71 22.7 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.21 88.21 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.815 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 28.7 mtpp -80.57 130.19 34.97 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 122.991 0.517 . . . . 0.0 111.186 -174.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m -61.11 144.74 52.99 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.82 0.448 . . . . 0.0 111.689 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.413 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' LYS . . . . . 0.452 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.531 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.531 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.476 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.5 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . 0.407 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -71.83 128.83 37.01 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.18 -43.56 6.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.101 0.477 . . . . 0.0 109.922 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.477 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 16.8 m -72.08 121.84 19.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -149.01 -46.89 0.14 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.357 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -80.08 110.45 16.27 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.411 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.21 147.96 67.56 Favored 'Trans proline' 0 C--O 1.264 1.799 0 C-N-CA 122.356 2.037 . . . . 0.0 112.441 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PRO . . . . . 0.401 ' HD2' ' O ' ' A' ' 90' ' ' ALA . 37.7 Cg_endo -66.25 156.46 64.85 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.721 2.947 . . . . 0.0 113.467 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.71 152.66 80.61 Favored Pre-proline 0 C--O 1.246 0.902 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PRO . . . . . 0.457 ' C ' ' HD2' ' A' ' 179' ' ' LYS . 57.5 Cg_endo -68.76 -171.32 0.38 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.007 2.471 . . . . 0.0 112.378 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.457 ' HD2' ' C ' ' A' ' 178' ' ' PRO . 2.1 mptp? -125.63 93.93 3.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.955 0.407 . . . . 0.0 111.256 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.5 m -157.98 40.91 0.28 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.4 m -144.59 20.36 1.68 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.46 0.648 . . . . 0.0 109.924 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -125.85 -17.85 5.28 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.284 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.52 112.02 1.82 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.029 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.5 m -89.99 17.93 6.33 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.833 0.825 . . . . 0.0 110.054 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.422 ' C ' ' H ' ' A' ' 187' ' ' LYS . 14.7 m120 -100.52 -156.58 0.56 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 190' ' ' SER . 4.3 m -86.01 25.62 1.11 Allowed 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 122.411 1.101 . . . . 0.0 110.143 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' LYS . . . . . 0.422 ' H ' ' C ' ' A' ' 185' ' ' ASN . 15.9 tptp 68.62 -49.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.462 1.905 . . . . 0.0 113.962 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -100.99 -147.17 0.35 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LEU . . . . . 0.468 HD23 ' HA ' ' A' ' 256' ' ' VAL . 0.0 OUTLIER -63.03 125.65 24.73 Favored 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 171.679 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.572 ' O ' HG21 ' A' ' 194' ' ' VAL . 67.5 m -106.18 139.55 40.52 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -160.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.542 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.572 HG21 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . 0.429 ' HB ' HD12 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.429 HD12 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' MET . . . . . 0.542 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PHE . . . . . 0.542 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLN . . . . . 0.599 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ASP . . . . . 0.505 ' CG ' ' HZ2' ' A' ' 238' ' ' LYS . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' LYS . . . . . 0.505 ' HZ2' ' CG ' ' A' ' 237' ' ' ASP . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . 0.411 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' SER . . . . . 0.4 ' HG ' HD22 ' A' ' 214' ' ' LEU . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PHE . . . . . 0.411 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . 0.599 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' SER . . . . . 0.566 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' GLU . . . . . 0.566 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . 0.494 ' O ' HG21 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 252' ' ' ALA . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m -135.15 130.1 34.87 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.98 111.18 35.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 46.06 37.28 3.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.779 1.632 . . . . 0.0 115.202 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.57 -27.25 8.96 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.517 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -93.36 118.27 31.09 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.015 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.41 124.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.13 139.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.658 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' CYS . . . . . 0.535 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' TYR . . . . . 0.658 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -71.02 -42.75 58.77 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 100.942 -3.725 . . . . 0.0 100.942 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.619 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.619 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.617 ' HA ' HG23 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 108' ' ' THR . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.514 HG12 ' HD3' ' A' ' 136' ' ' LYS . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 121.236 0.541 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HD3' HG12 ' A' ' 127' ' ' VAL . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.448 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.547 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 . . . . . 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 29.1 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 214' ' ' LEU . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 210' ' ' VAL . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.487 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.487 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 246' ' ' ASN . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.479 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASN . . . . . 0.625 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.434 -1.25 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.625 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 102' ' ' LEU . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.529 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 125' ' ' ARG . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 126' ' ' VAL . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.474 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.708 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 111' ' ' ILE . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 44.6 pttt . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 27.8 m . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.67 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 268' ' ' VAL . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.622 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.719 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.543 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.622 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 268' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 210' ' ' VAL . 29.7 m . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.424 ' CG ' ' HA ' ' A' ' 146' ' ' LYS . 18.1 t80 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 153' ' ' ILE . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 167' ' ' ARG . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 125' ' ' ARG . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.667 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' PHE . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.456 HG12 HG13 ' A' ' 97' ' ' VAL . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.537 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 101' ' ' ASP . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.419 -2.017 0 CA-C-O 120.681 0.277 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 256' ' ' VAL . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.644 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 238' ' ' LYS . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 232' ' ' ILE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.571 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 248' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HA ' ' A' ' 125' ' ' ARG . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.587 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.491 HD12 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 111' ' ' ILE . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' A' ' 164' ' ' ARG . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HA ' ' CE3' ' A' ' 160' ' ' TRP . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 194' ' ' VAL . 5.1 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 272' ' ' TRP . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.583 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.583 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.581 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.534 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' TRP . . . . . 0.446 ' HB3' HD21 ' A' ' 202' ' ' ASN . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.414 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.55 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? . . . . . 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 194' ' ' VAL . 10.9 m . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 28.5 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.451 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.518 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 216' ' ' GLU . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.506 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.506 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 166' ' ' ILE . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 164' ' ' ARG . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.645 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 125' ' ' ARG . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 128' ' ' LYS . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG23 ' A' ' 108' ' ' THR . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 1.6 ptpp? . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . 0.539 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 159' ' ' GLN . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 102' ' ' LEU . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.44 ' NE ' ' H ' ' A' ' 168' ' ' THR . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.44 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.401 HG23 ' CD2' ' A' ' 248' ' ' HIS . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.497 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' HIS . . . . . 0.401 ' CD2' HG23 ' A' ' 195' ' ' VAL . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.578 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 102' ' ' LEU . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.604 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.546 HD11 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 126' ' ' VAL . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.487 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' TYR . . . . . 0.412 ' C ' HD12 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 168' ' ' THR . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.604 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 167' ' ' ARG . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 157' ' ' GLY . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 248' ' ' HIS . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 248' ' ' HIS . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.583 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.724 HD12 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.724 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 234' ' ' VAL . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 234' ' ' VAL . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.527 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' HIS . . . . . 0.414 ' CD2' HG23 ' A' ' 195' ' ' VAL . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.527 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.583 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.572 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 126' ' ' VAL . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 121' ' ' ILE . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 115' ' ' PHE . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.427 ' CG2' HD12 ' A' ' 111' ' ' ILE . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 pttt . . . . . 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 28.8 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' A' ' 214' ' ' LEU . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 210' ' ' VAL . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 243' ' ' VAL . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' SER . . . . . 0.614 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 232' ' ' ILE . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.452 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.244 0.799 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 153' ' ' ILE . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.575 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.575 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.504 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.504 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.585 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 124' ' ' ALA . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt . . . . . 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' NZ ' HG12 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.585 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 97' ' ' VAL . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 159' ' ' GLN . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLN . . . . . 0.402 ' HB2' ' CE ' ' A' ' 156' ' ' MET . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.464 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.2 t . . . . . 0 C--O 1.204 -1.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HA ' HG21 ' A' ' 256' ' ' VAL . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 255' ' ' ILE . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 232' ' ' ILE . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 229' ' ' ILE . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 240' ' ' TYR . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 238' ' ' LYS . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 205' ' ' VAL . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 272' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . . . . . . 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . 32.8 t80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 153' ' ' ILE . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.418 HG22 ' HE3' ' A' ' 112' ' ' LYS . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE2' ' H ' ' A' ' 124' ' ' ALA . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 115' ' ' PHE . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 13.8 ptmm? . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.478 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.444 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 190' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 192' ' ' ASP . 67.5 m . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.557 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.566 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' PHE . . . . . 0.541 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLN . . . . . 0.608 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 231' ' ' GLU . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . 0.41 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' GLU . . . . . 0.577 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 252' ' ' ALA . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.425 -1.705 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.668 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' TYR . . . . . 0.668 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.762 ' N ' ' HE2' ' A' ' 94' ' ' HIS . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.45 124.06 27.72 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.767 0.784 . . . . 0.0 109.304 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -54.26 -23.7 15.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.34 1.056 . . . . 0.0 112.423 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.43 75.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.98 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -100.06 2.28 43.13 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.581 0.705 . . . . 0.0 110.366 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.762 ' HE2' ' N ' ' A' ' 89' ' ' GLY . 66.0 m-70 -93.13 135.44 34.32 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -130.7 138.03 49.82 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.543 -171.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.619 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.619 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.617 ' HA ' HG23 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 108' ' ' THR . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.514 HG12 ' HD3' ' A' ' 136' ' ' LYS . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -122.37 164.44 17.97 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.51 136.56 51.59 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.539 0.524 . . . . 0.0 110.134 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 52.6 ttm -63.05 -36.51 83.81 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.487 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.07 -47.97 9.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -95.02 -15.72 23.27 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.975 0.417 . . . . 0.0 112.041 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.17 77.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.517 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.683 ' HA ' ' NZ ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -96.01 138.86 33.02 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 122.311 -0.523 . . . . 0.0 110.353 -178.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t -61.12 145.25 51.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 124.074 0.859 . . . . 0.0 111.626 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HD3' HG12 ' A' ' 127' ' ' VAL . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' HA ' ' CE1' ' A' ' 94' ' ' HIS . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.448 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.547 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 -81.97 130.84 35.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.33 -61.2 1.7 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.275 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.462 HG23 ' HB2' ' A' ' 96' ' ' HIS . 25.4 p -77.87 89.4 4.08 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -79.52 108.37 13.0 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.693 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -72.45 113.62 22.52 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.109 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.69 145.02 17.91 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.887 1.725 . . . . 0.0 111.297 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.98 141.74 19.14 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.596 1.53 . . . . 0.0 110.742 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 123.81 83.88 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.99 -171.58 1.29 Allowed 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 122.933 2.422 . . . . 0.0 112.458 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -146.74 171.93 14.41 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 88.15 1.62 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.8 m -94.56 -20.02 19.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.915 0.864 . . . . 0.0 110.145 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -144.23 144.09 31.35 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.81 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . 0.381 8.3 mm-40 65.75 121.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -163.17 28.84 0.09 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 70.25 77.43 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.18 -170.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 69.5 m -56.66 125.35 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.692 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -93.08 89.18 6.38 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.586 1.184 . . . . 0.0 112.409 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.98 -174.74 3.82 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.92 85.34 2.68 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.227 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m -87.87 127.39 35.35 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' A' ' 187' ' ' LYS . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 29.1 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 214' ' ' LEU . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 210' ' ' VAL . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.487 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.487 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 246' ' ' ASN . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.479 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.625 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m -133.92 124.84 27.08 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 264' ' ' GLU . 38.0 mm -111.04 112.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 263' ' ' ILE 0.265 0.0 OUTLIER 46.28 34.96 2.42 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 126.732 2.013 . . . . 0.0 115.122 179.728 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.82 -26.71 11.24 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.483 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -93.98 125.62 38.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.107 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.71 122.54 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.6 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.625 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.66 14.19 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.63 ' HA ' ' HZ3' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.409 -2.507 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.589 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.477 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.04 76.53 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.28 141.68 48.89 Favored 'General case' 0 C--O 1.266 1.925 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.8 -175.17 0.19 Allowed 'General case' 0 C--O 1.239 0.552 0 O-C-N 124.794 1.309 . . . . 0.0 109.084 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -109.16 5.5 23.98 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.419 -1.313 . . . . 0.0 110.18 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 78.3 m-70 -93.93 126.81 39.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.18 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -112.94 142.2 45.9 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.38 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 102' ' ' LEU . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.529 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 125' ' ' ARG . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 126' ' ' VAL . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.474 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.708 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 111' ' ' ILE . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 44.6 pttt -116.27 149.54 39.05 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.89 123.73 22.69 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.252 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -27.91 69.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.31 -42.91 10.69 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 29.3 p -95.44 -18.58 20.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 31.6 mmmt -103.38 140.0 38.03 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.069 0.461 . . . . 0.0 111.075 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 27.8 m -66.11 138.38 57.7 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.67 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.42 HD21 ' HG2' ' A' ' 173' ' ' ARG . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 173' ' ' ARG . 44.3 p-90 -79.98 141.71 35.72 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.36 154.58 27.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.077 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.3 m 68.92 30.7 4.52 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 170' ' ' TRP . 11.0 tpt85 -61.54 136.57 58.07 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 126.506 1.922 . . . . 0.0 111.504 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -99.78 122.94 49.41 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.46 149.8 21.7 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.691 2.261 . . . . 0.0 111.229 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.12 142.21 19.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.61 1.54 . . . . 0.0 110.817 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.86 123.53 89.03 Favored Pre-proline 0 C--O 1.256 1.399 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.8 -57.18 0.71 Allowed 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 123.175 2.583 . . . . 0.0 112.193 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 60.79 -167.06 0.19 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.731 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.8 m -81.09 83.46 6.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -149.07 16.15 0.94 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.27 -63.53 1.32 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.516 -174.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.55 94.54 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.102 2.161 . . . . 0.0 113.1 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 m -80.32 80.65 6.72 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.542 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -171.55 -72.77 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -148.43 163.68 36.41 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.579 ' HA ' ' HE3' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -86.74 -17.6 33.19 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.788 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -162.98 159.53 23.58 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.83 107.32 5.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m -77.21 142.18 39.71 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.333 -175.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 268' ' ' VAL . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.464 ' HA3' ' OE2' ' A' ' 264' ' ' GLU . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.622 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.719 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.543 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.622 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.16 117.05 16.1 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.66 123.74 67.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' OE2' ' HA3' ' A' ' 213' ' ' GLY . 46.8 mt-10 48.98 36.87 9.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.331 1.052 . . . . 0.0 113.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.04 72.32 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.841 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -95.85 128.04 42.4 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.18 115.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 210' ' ' VAL . 29.7 m -105.11 142.42 18.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -107.99 -167.19 21.47 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.012 179.02 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -1.192 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.41 93.96 1.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.7 ttm 73.26 -58.96 0.58 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.845 1.258 . . . . 0.0 109.16 -172.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.84 150.37 29.25 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -82.83 -37.52 24.3 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.343 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 95.3 m-70 -145.73 144.95 30.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 172' ' ' THR . 18.1 t80 -130.62 142.3 50.45 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 153' ' ' ILE . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 167' ' ' ARG . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 125' ' ' ARG . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.667 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -110.02 161.15 15.8 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.74 123.92 29.76 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.156 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -26.66 68.55 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.32 -43.44 9.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.44 ' OG1' ' HE2' ' A' ' 134' ' ' LYS . 20.1 p -95.55 -17.09 21.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.18 -5.19 77.98 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.733 -0.27 . . . . 0.0 113.764 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.594 ' O ' ' HE3' ' A' ' 134' ' ' LYS 0.258 0.0 OUTLIER -105.72 160.95 14.82 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.438 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m -55.95 141.76 38.29 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' PHE . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.456 HG12 HG13 ' A' ' 97' ' ' VAL . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.537 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 101' ' ' ASP . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -79.93 131.05 35.75 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.11 27.33 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 12.9 t -64.33 123.65 19.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.539 -176.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -86.53 91.03 8.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.831 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -112.12 133.35 21.71 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.58 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.8 144.41 19.31 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.438 1.425 . . . . 0.0 111.381 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.53 142.37 18.36 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -94.09 123.98 57.46 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -92.72 25.72 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.744 2.296 . . . . 0.0 112.12 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 103.19 14.23 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 183' ' ' GLU . 15.5 m -45.32 132.41 7.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.831 1.252 . . . . 0.0 111.865 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 5.1 m -34.05 -79.63 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.628 1.971 . . . . 0.0 115.519 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -109.04 -2.2 18.34 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.678 0.752 . . . . 0.0 110.055 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 180' ' ' SER . 5.0 mm-40 -83.39 94.96 8.08 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.6 m -151.29 31.38 0.6 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.372 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -154.72 -172.93 4.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.2 m -68.46 100.83 1.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.328 0.585 . . . . 0.0 110.313 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -77.37 -34.28 55.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.93 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.35 178.91 3.1 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 124.328 1.051 . . . . 0.0 108.269 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.77 139.63 49.98 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m -111.66 138.03 48.75 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.747 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 256' ' ' VAL . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.644 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 238' ' ' LYS . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 232' ' ' ILE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.571 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 30.5 p30 -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m -134.02 122.88 23.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.9 mt -133.07 142.02 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.0 tt0 56.41 34.09 23.59 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 122.296 1.046 . . . . 0.0 110.346 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.75 -7.59 3.93 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 113.247 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.48 147.99 25.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.152 0.581 . . . . 0.0 109.749 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.2 t -77.21 120.9 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m -98.13 141.05 16.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -97.85 -156.3 30.0 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 6.1 mtmm . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 124.829 1.252 . . . . 0.0 107.808 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.777 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 174' ' ' LYS . . . -77.69 -49.81 13.72 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 171.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 144.69 25.95 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 171.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.06 0.944 . . . . 0.0 111.144 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.96 13.05 13.72 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.768 0.794 . . . . 0.0 110.369 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -94.2 158.69 15.48 Favored 'General case' 0 C--O 1.259 1.601 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.23 138.55 31.33 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HA ' ' A' ' 125' ' ' ARG . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.587 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.491 HD12 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 111' ' ' ILE . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -121.39 164.43 17.1 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.424 ' HB2' ' HE3' ' A' ' 136' ' ' LYS . 15.5 t70 -77.82 113.8 16.05 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.29 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 24.8 mmt -62.91 -17.87 62.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.52 -48.06 6.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.2 p -95.38 -11.04 28.39 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.191 0.519 . . . . 0.0 112.163 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.54 76.72 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -105.68 138.92 41.08 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 -176.671 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m -58.27 145.12 38.79 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' A' ' 164' ' ' ARG . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HA ' ' CE3' ' A' ' 160' ' ' TRP . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -79.73 152.02 30.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -160.86 169.55 22.44 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -139.5 -178.3 5.33 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.793 0.724 . . . . 0.0 111.925 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.27 110.05 22.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 173.382 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 61.9 tttm -111.28 143.27 28.09 Favored Pre-proline 0 C--N 1.278 -2.533 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.839 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 12.3 Cg_endo -60.48 164.14 13.77 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 121.851 1.701 . . . . 0.0 108.928 167.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.71 141.9 91.71 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.274 1.982 . . . . 0.0 113.395 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.52 124.79 38.07 Favored Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.327 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 118.91 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.943 1.762 . . . . 0.0 109.053 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.32 85.18 7.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.535 0.683 . . . . 0.0 111.548 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 182' ' ' TYR . 28.7 m -88.66 31.72 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.657 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.8 p -81.29 81.54 7.42 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.226 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 180' ' ' SER . 15.5 p90 -164.76 151.74 11.06 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.17 1.388 . . . . 0.0 107.879 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 184' ' ' SER . 0.8 OUTLIER 62.6 -159.22 0.32 Allowed 'General case' 0 CA--C 1.567 1.612 0 O-C-N 124.273 0.983 . . . . 0.0 108.717 -178.228 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' SER . . . . . 0.464 ' H ' ' CD ' ' A' ' 183' ' ' GLU . 6.3 m -133.18 5.46 3.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 61.33 57.85 2.29 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.3 m -64.79 106.96 1.31 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.815 -1.539 . . . . 0.0 113.272 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 188' ' ' GLN . 27.8 mtmm -121.19 -52.66 2.06 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 102.691 -3.077 . . . . 0.0 102.691 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.496 ' OE1' ' HE2' ' A' ' 187' ' ' LYS . 0.5 OUTLIER -162.08 162.01 28.51 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 168.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.18 103.61 11.03 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.163 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 194' ' ' VAL . 5.1 m -78.18 146.38 35.05 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 272' ' ' TRP . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.583 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.583 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.581 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m -134.01 117.32 16.55 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.96 119.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.25 37.08 3.7 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.982 1.713 . . . . 0.0 113.281 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.94 -19.28 52.77 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.859 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -93.54 118.86 31.88 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 122.588 -0.36 . . . . 0.0 110.7 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.96 126.75 30.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.38 151.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.534 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' TRP . . . . . 0.446 ' HB3' HD21 ' A' ' 202' ' ' ASN . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -108.07 -134.29 7.28 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.812 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS 0.383 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.023 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.871 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.23 101.88 13.01 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -104.66 140.44 38.03 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.89 92.48 4.27 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.198 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 51.0 t30 -80.92 -32.49 34.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.588 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -93.6 137.6 32.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.0 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' CE1' ' HB ' ' A' ' 172' ' ' THR . 56.6 t80 -130.83 142.46 50.39 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.985 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.414 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.55 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.96 164.71 20.21 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 132' ' ' THR . 8.5 t70 -95.17 136.66 35.23 Favored 'General case' 0 C--N 1.275 -2.65 0 C-N-CA 117.477 -1.689 . . . . 0.0 108.77 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 18.9 mmt -63.86 -36.03 82.58 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.57 29.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.435 0.459 . . . . 0.0 111.829 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 129' ' ' ASP . 72.0 p -94.87 -18.97 20.69 Favored 'General case' 0 C--O 1.249 1.076 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.322 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.09 38.15 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.754 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -107.14 160.41 15.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m -62.68 137.83 58.36 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 124.477 1.111 . . . . 0.0 110.895 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ASP . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -65.25 129.46 39.79 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . . . -99.84 -43.63 6.35 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.935 0.398 . . . . 0.0 110.182 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.526 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 12.7 m -73.85 98.95 3.08 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -129.72 111.65 12.86 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -110.94 118.2 48.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.826 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.6 146.52 49.42 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 121.998 1.799 . . . . 0.0 109.791 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.62 141.33 66.12 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.214 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.12 127.17 31.45 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 93.77 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.075 1.85 . . . . 0.0 109.817 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -82.13 80.91 8.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.098 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.3 m -96.15 102.43 14.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 p -121.53 -48.98 2.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -171.02 34.92 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.98 122.5 13.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.993 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.0 p -74.68 88.6 2.22 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -168.38 98.57 0.42 Allowed 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 170.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.61 ' HB ' ' OG ' ' A' ' 190' ' ' SER . 14.7 m -77.71 130.38 36.72 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.53 ' HA ' ' NZ ' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -93.19 70.69 4.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.609 1.195 . . . . 0.0 111.081 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -151.18 -169.87 3.5 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.36 82.43 8.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.414 -1.314 . . . . 0.0 108.844 174.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.61 ' OG ' ' HB ' ' A' ' 186' ' ' THR . 10.9 m -76.91 130.85 38.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 28.5 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.451 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 19.9 tm0? -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.518 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 216' ' ' GLU . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.506 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.506 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m -132.87 116.95 17.13 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.38 122.27 63.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.72 37.84 5.14 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.396 1.479 . . . . 0.0 113.028 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.29 -12.0 70.72 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.927 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -96.14 122.64 39.21 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.06 120.32 20.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.71 142.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -123.07 -163.28 11.75 Favored Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 119.046 -0.502 . . . . 0.0 110.7 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 94' ' ' HIS . . . . . . . . 0 CA--C 1.492 -1.372 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -101.19 101.27 11.94 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.3 tpt 72.67 -53.48 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.53 -170.33 2.97 Favored 'General case' 0 C--O 1.257 1.489 0 CA-C-O 121.443 0.639 . . . . 0.0 109.677 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -77.84 -18.69 56.02 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 122.068 -0.395 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' C ' ' HA3' ' A' ' 89' ' ' GLY . 53.0 p-80 -125.52 169.59 12.28 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -115.11 131.79 56.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 166' ' ' ILE . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 164' ' ' ARG . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.645 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 125' ' ' ARG . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 128' ' ' LYS . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG23 ' A' ' 108' ' ' THR . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 1.6 ptpp? -123.55 166.1 16.02 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.0 119.88 29.92 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 123.944 0.897 . . . . 0.0 109.164 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 95.8 mmm -63.19 -17.42 62.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.09 -41.14 11.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 118.114 0.415 . . . . 0.0 111.376 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -95.09 -24.3 16.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 111.464 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.48 11.17 85.14 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 31.4 mmmt -105.57 169.31 8.54 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-N 116.761 0.28 . . . . 0.0 110.602 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p -69.4 161.47 29.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . 0.539 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 159' ' ' GLN . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 102' ' ' LEU . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.44 ' NE ' ' H ' ' A' ' 168' ' ' THR . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.44 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -71.09 132.32 44.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.44 83.4 5.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.0 t -72.37 -28.42 63.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 69.9 -53.8 0.62 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.746 1.619 . . . . 0.0 111.98 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.61 140.21 22.36 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.683 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.8 160.6 24.54 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.614 2.209 . . . . 0.0 111.667 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.4 149.4 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.303 2.002 . . . . 0.0 110.573 172.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . . . -101.34 123.47 44.55 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 177' ' ' ALA . 46.7 Cg_endo -96.24 109.1 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 122.484 2.122 . . . . 0.0 112.667 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -137.36 150.93 48.06 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.729 0.775 . . . . 0.0 112.368 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 30.1 t -113.87 -175.44 2.68 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.7 m -130.95 95.09 3.74 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 119.128 0.876 . . . . 0.0 109.506 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -135.27 -13.09 2.09 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.554 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 183' ' ' GLU . 1.4 pm0 -93.38 -41.08 10.03 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.9 m -83.82 -20.33 33.4 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.879 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -94.79 143.19 26.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.912 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 30.8 m 42.98 81.22 0.03 OUTLIER 'General case' 0 C--O 1.251 1.178 0 C-N-CA 126.549 1.939 . . . . 0.0 115.313 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -131.65 6.42 4.38 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -174.14 -172.75 0.73 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 74.2 mt -112.34 93.56 4.5 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m -73.48 144.84 46.06 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.401 HG23 ' CD2' ' A' ' 248' ' ' HIS . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.497 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' HIS . . . . . 0.401 ' CD2' HG23 ' A' ' 195' ' ' VAL . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.578 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m -134.12 120.59 20.33 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 69.9 mt -113.37 123.66 69.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 46.28 37.03 3.69 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.895 1.678 . . . . 0.0 113.414 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -16.56 61.02 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.759 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 210' ' ' VAL . 44.4 m-70 -93.28 119.09 32.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.03 126.76 30.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m -108.42 142.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -101.19 44.98 1.46 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.592 2.357 . . . . 0.0 108.846 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.56 -53.18 60.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -78.33 158.85 28.69 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.917 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.59 171.71 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.111 1.364 . . . . 0.0 111.13 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.2 t30 -82.4 -17.32 45.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.78 141.34 28.56 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.256 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 102' ' ' LEU . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.604 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.546 HD11 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 126' ' ' VAL . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.487 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -128.41 165.82 19.9 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 136' ' ' LYS . 29.7 t70 -69.65 131.21 44.26 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.589 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -62.52 -37.41 85.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.3 1.04 . . . . 0.0 113.198 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.51 -42.12 9.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.5 p -94.9 -14.11 24.81 Favored 'General case' 0 C--O 1.259 1.553 0 CA-C-O 121.23 0.538 . . . . 0.0 111.947 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.06 20.75 75.07 Favored Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.768 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -101.49 131.14 47.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.501 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m -56.18 141.01 42.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 129' ' ' ASP . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' TYR . . . . . 0.412 ' C ' HD12 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 168' ' ' THR . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.604 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 167' ' ' ARG . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 157' ' ' GLY . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -79.9 131.31 35.82 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.72 81.84 6.94 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.497 0.665 . . . . 0.0 109.339 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -102.88 -51.21 3.33 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.529 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? 75.18 -50.84 0.66 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.933 1.293 . . . . 0.0 111.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 175' ' ' PRO . 27.3 tptp -110.47 112.79 56.54 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 13.0 Cg_endo -60.19 144.85 99.48 Favored 'Trans proline' 0 C--O 1.266 1.916 0 C-N-CA 121.493 1.462 . . . . 0.0 109.911 175.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 175' ' ' PRO . 47.0 Cg_exo -58.88 140.75 96.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.621 2.214 . . . . 0.0 113.274 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -103.34 147.38 34.09 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.255 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -53.76 123.65 13.91 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.798 1.665 . . . . 0.0 108.936 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 179' ' ' LYS . 15.0 tptp -84.84 15.87 3.68 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 m -51.47 -47.06 63.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.236 1.017 . . . . 0.0 108.278 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 m -138.84 -67.8 0.45 Allowed 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CE1' ' HE2' ' A' ' 187' ' ' LYS . 0.1 OUTLIER 179.37 85.0 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 126.891 2.076 . . . . 0.0 106.887 175.008 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -90.79 88.86 7.24 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 123.448 1.594 . . . . 0.0 114.054 -169.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 65.4 m -153.09 31.0 0.49 Allowed 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -171.96 135.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 112.785 -2.007 . . . . 0.0 106.143 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 m -57.85 109.62 0.76 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.543 ' HE2' ' CE1' ' A' ' 182' ' ' TYR . 3.7 mtmp? -151.19 -60.71 0.18 Allowed 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLN . . . . . 0.629 ' HA ' ' ND2' ' A' ' 259' ' ' ASN . 80.8 mt-30 -99.41 -178.69 3.98 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 159.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.46 116.67 29.13 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m -65.46 142.38 58.18 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 248' ' ' HIS . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 248' ' ' HIS . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.583 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.724 HD12 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.724 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 81.2 mm-40 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 234' ' ' VAL . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 234' ' ' VAL . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.527 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' HIS . . . . . 0.414 ' CD2' HG23 ' A' ' 195' ' ' VAL . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.527 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.583 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASN . . . . . 0.629 ' ND2' ' HA ' ' A' ' 188' ' ' GLN . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -134.38 124.62 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 74.2 mt -134.24 141.73 42.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 29.9 tt0 55.57 34.15 22.57 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 122.58 1.181 . . . . 0.0 110.081 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.16 -6.61 5.33 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 113.286 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -99.68 145.67 27.36 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.98 0.512 . . . . 0.0 109.838 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.66 123.55 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.72 150.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -84.8 -41.07 7.84 Favored Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.268 2.076 0 N-CA-C 101.048 -3.686 . . . . 0.0 101.048 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.838 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.02 148.61 42.08 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.2 109.17 3.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.2 -90.06 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.72 -37.67 14.39 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -94.77 163.91 13.16 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.513 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -125.49 127.63 46.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.558 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.572 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 126' ' ' VAL . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 121' ' ' ILE . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 115' ' ' PHE . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.427 ' CG2' HD12 ' A' ' 111' ' ' ILE . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 133' ' ' GLY . 59.4 pttt -120.57 164.63 16.18 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.17 133.21 46.86 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 124.208 1.003 . . . . 0.0 111.916 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 ptp -62.72 -33.73 75.72 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.84 -43.41 9.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 26.6 p -95.3 -18.45 20.79 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . 0.498 ' O ' ' HD2' ' A' ' 128' ' ' LYS . . . 74.17 11.66 81.77 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.255 -0.43 . . . . 0.0 113.083 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 0.9 OUTLIER -105.96 154.18 20.95 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 122.409 -0.465 . . . . 0.0 110.293 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m -52.36 142.81 16.39 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -65.2 132.25 48.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . . . -134.55 21.88 3.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.408 0.623 . . . . 0.0 110.15 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 p -72.01 -73.67 0.18 Allowed 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.45 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -112.47 139.08 48.35 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.99 118.47 67.86 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.27 152.03 75.09 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.782 2.988 . . . . 0.0 114.254 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.56 149.08 30.13 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.816 2.344 . . . . 0.0 111.952 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.13 155.92 35.87 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.64 146.9 94.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.516 2.144 . . . . 0.0 110.931 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.572 ' HE3' ' O ' ' A' ' 185' ' ' ASN . 49.7 mmtm 59.89 3.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.023 1.329 . . . . 0.0 113.593 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 m -102.7 11.77 37.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.659 0.266 . . . . 0.0 111.681 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.2 t -151.49 -58.3 0.16 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.551 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -177.96 147.22 0.45 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.785 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -161.88 164.35 28.69 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.394 1.477 . . . . 0.0 108.264 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.1 m -90.4 -22.93 21.21 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.572 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 24.5 t-20 -75.22 101.87 4.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.451 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.2 p -90.11 161.07 15.96 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.387 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.282 14.5 tppt? -92.9 73.85 4.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 123.146 1.45 . . . . 0.0 111.712 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.77 -169.23 3.33 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 102.757 -3.053 . . . . 0.0 102.757 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.5 mt -82.88 78.57 9.45 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.062 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.0 m -70.61 135.79 48.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.278 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 28.8 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' A' ' 214' ' ' LEU . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 210' ' ' VAL . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 30.0 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 243' ' ' VAL . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' SER . . . . . 0.614 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 232' ' ' ILE . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.452 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.53 119.18 18.14 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.84 111.15 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.587 0 CA-C-O 121.242 0.544 . . . . 0.0 109.788 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 44.51 36.55 1.73 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.541 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.58 -27.88 7.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.925 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -98.89 124.32 43.73 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.385 -0.479 . . . . 0.0 111.934 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.59 129.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.46 153.07 19.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -130.93 -172.01 13.03 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS . 1.5 tpmp? . . . . . 0 N--CA 1.414 -2.251 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.624 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.85 95.64 4.12 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.6 mmm -81.6 86.52 6.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.48 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.15 179.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.19 1.396 . . . . 0.0 112.399 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.5 t30 -93.32 -13.8 27.7 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' ' HA ' ' A' ' 144' ' ' PHE . 47.0 m-70 -92.64 153.98 18.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 -170.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 -132.37 140.12 48.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 153' ' ' ILE . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.575 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.575 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.504 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.504 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.585 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 124' ' ' ALA . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -105.82 166.16 10.67 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 132' ' ' THR . 9.5 t70 -75.52 137.14 40.68 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 123.582 0.551 . . . . 0.0 111.261 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.3 ptp -63.32 -33.2 75.0 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.19 8.35 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 129' ' ' ASP . 12.2 t -97.71 -10.97 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.927 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.08 19.89 75.93 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.083 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -106.0 145.86 30.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t -56.26 143.02 35.4 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.795 0.685 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' NZ ' HG12 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HA ' ' ND1' ' A' ' 94' ' ' HIS . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.585 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 34.8 t30 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 97' ' ' VAL . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 159' ' ' GLN . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLN . . . . . 0.402 ' HB2' ' CE ' ' A' ' 156' ' ' MET . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.464 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -80.7 130.87 35.34 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -107.07 -50.98 2.99 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.355 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 95' ' ' PHE . 4.0 m -83.28 22.83 0.96 Allowed 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.885 0.85 . . . . 0.0 110.903 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -162.32 118.08 1.94 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.37 144.46 30.55 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 52.1 Cg_endo -71.64 148.57 53.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.908 1.739 . . . . 0.0 111.351 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 175' ' ' PRO . 39.8 Cg_exo -63.62 148.67 92.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.403 2.068 . . . . 0.0 112.081 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.59 124.45 89.28 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.004 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.1 -165.97 0.29 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.079 2.52 . . . . 0.0 111.981 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -133.4 22.39 4.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 46.8 m 63.16 -166.46 0.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.455 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.8 t -100.96 86.83 3.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.106 0.955 . . . . 0.0 112.816 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -176.1 166.93 2.96 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.43 142.4 27.77 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.0 m -83.57 21.09 1.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.229 0.538 . . . . 0.0 111.785 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -149.89 145.79 26.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -79.54 94.27 5.59 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.713 0.768 . . . . 0.0 111.29 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' LYS . . . . . 0.561 ' HB2' ' HZ3' ' A' ' 187' ' ' LYS . 0.3 OUTLIER -54.49 -41.63 69.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.426 175.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.68 143.97 42.99 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 194' ' ' VAL . 85.1 mt -113.01 136.23 52.91 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.2 t -111.49 147.41 35.39 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HA ' HG21 ' A' ' 256' ' ' VAL . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 255' ' ' ILE . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 232' ' ' ILE . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 229' ' ' ILE . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 240' ' ' TYR . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 238' ' ' LYS . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 205' ' ' VAL . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m -127.23 117.03 21.51 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.04 141.33 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.1 tt0 56.21 34.19 23.49 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 122.344 1.069 . . . . 0.0 110.241 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.58 -6.05 5.08 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 113.185 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -100.98 144.0 30.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 123.14 0.576 . . . . 0.0 109.821 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.13 115.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.79 145.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . -124.77 -171.03 13.25 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' LYS . . . . . 0.429 ' NZ ' ' HB3' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.265 1.891 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.729 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 176' ' ' PRO . . . 64.21 -175.26 0.16 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.81 0.947 . . . . 0.0 110.834 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.2 ttm -163.15 78.35 0.44 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.45 -169.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.149 1.78 . . . . 0.0 115.684 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -109.32 -35.44 6.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.9 p-80 -95.03 152.67 18.13 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.306 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . 32.8 t80 -131.97 142.77 49.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 153' ' ' ILE . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.418 HG22 ' HE3' ' A' ' 112' ' ' LYS . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE2' ' H ' ' A' ' 124' ' ' ALA . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 115' ' ' PHE . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 13.8 ptmm? -132.73 165.36 24.69 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.21 121.6 23.89 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.31 -34.09 76.94 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.94 -45.63 13.92 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.491 0.494 . . . . 0.0 111.973 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -94.85 -16.71 22.7 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.21 88.21 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.815 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 28.7 mtpp -80.57 130.19 34.97 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 122.991 0.517 . . . . 0.0 111.186 -174.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m -61.11 144.74 52.99 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.82 0.448 . . . . 0.0 111.689 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.478 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.444 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -71.83 128.83 37.01 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.18 -43.56 6.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.101 0.477 . . . . 0.0 109.922 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.487 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 16.8 m -72.08 121.84 19.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -149.01 -46.89 0.14 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.357 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -80.08 110.45 16.27 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.411 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.21 147.96 67.56 Favored 'Trans proline' 0 C--O 1.264 1.799 0 C-N-CA 122.356 2.037 . . . . 0.0 112.441 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 90' ' ' ALA . 37.7 Cg_endo -66.25 156.46 64.85 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.721 2.947 . . . . 0.0 113.467 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.71 152.66 80.61 Favored Pre-proline 0 C--O 1.246 0.902 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PRO . . . . . 0.45 ' C ' ' HD2' ' A' ' 179' ' ' LYS . 57.5 Cg_endo -68.76 -171.32 0.38 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.007 2.471 . . . . 0.0 112.378 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 178' ' ' PRO . 2.1 mptp? -125.63 93.93 3.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.955 0.407 . . . . 0.0 111.256 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.5 m -157.98 40.91 0.28 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.4 m -144.59 20.36 1.68 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.46 0.648 . . . . 0.0 109.924 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -125.85 -17.85 5.28 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.284 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.52 112.02 1.82 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.029 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.5 m -89.99 17.93 6.33 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.833 0.825 . . . . 0.0 110.054 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -100.52 -156.58 0.56 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 190' ' ' SER . 4.3 m -86.01 25.62 1.11 Allowed 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 122.411 1.101 . . . . 0.0 110.143 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 68.62 -49.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.462 1.905 . . . . 0.0 113.962 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -100.99 -147.17 0.35 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LEU . . . . . 0.543 HD22 HG13 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -63.03 125.65 24.73 Favored 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 171.679 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 192' ' ' ASP . 67.5 m -106.18 139.55 40.52 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -160.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.557 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.566 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PHE . . . . . 0.541 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLN . . . . . 0.608 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 231' ' ' GLU . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . 0.41 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' GLU . . . . . 0.577 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' VAL . . . . . 0.543 HG13 HD22 ' A' ' 189' ' ' LEU . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m -135.15 130.1 34.87 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.98 111.18 35.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 46.06 37.28 3.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.779 1.632 . . . . 0.0 115.202 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.57 -27.25 8.96 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.517 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -93.36 118.27 31.09 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.015 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.41 124.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.13 139.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.668 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' TYR . . . . . 0.668 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -71.02 -42.75 58.77 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 100.942 -3.725 . . . . 0.0 100.942 179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 . . . . . 0 N--CA 1.426 -1.67 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.619 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.619 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.617 ' HA ' HG23 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 108' ' ' THR . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.514 HG12 ' HD3' ' A' ' 136' ' ' LYS . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt . . . . . 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t . . . . . 0 N--CA 1.44 -0.937 0 CA-C-O 121.236 0.541 . . . . 0.0 111.626 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HD3' HG12 ' A' ' 127' ' ' VAL . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.448 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.547 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 . . . . . 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.501 ' HG2' HE21 ' A' ' 197' ' ' GLN . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.501 HE21 ' HG2' ' A' ' 193' ' ' GLU . 78.4 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 214' ' ' LEU . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 210' ' ' VAL . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.487 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.487 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 246' ' ' ASN . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.479 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . 0.625 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m . . . . . 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.434 -1.25 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.625 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 . . . . . 0 N--CA 1.426 -1.654 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 102' ' ' LEU . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.529 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 125' ' ' ARG . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 126' ' ' VAL . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.474 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.708 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 111' ' ' ILE . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 44.6 pttt . . . . . 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 27.8 m . . . . . 0 N--CA 1.428 -1.534 0 CA-C-O 120.788 0.328 . . . . 0.0 110.856 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.413 ' CD ' HE21 ' A' ' 154' ' ' GLN . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.413 HE21 ' CD ' ' A' ' 150' ' ' GLU . 75.3 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.67 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 44.3 p-90 . . . . . 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m . . . . . 0 N--CA 1.417 -2.111 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 268' ' ' VAL . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.622 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.719 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.543 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.622 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 210' ' ' VAL . 29.7 m . . . . . 0 N--CA 1.433 -1.31 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.424 ' CG ' ' HA ' ' A' ' 146' ' ' LYS . 18.1 t80 . . . . . 0 N--CA 1.439 -0.977 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 153' ' ' ILE . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 167' ' ' ARG . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 125' ' ' ARG . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.667 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt . . . . . 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m . . . . . 0 C--O 1.251 1.178 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' PHE . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.456 HG12 HG13 ' A' ' 97' ' ' VAL . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.537 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 101' ' ' ASP . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 . . . . . 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.419 -2.017 0 CA-C-O 120.681 0.277 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 256' ' ' VAL . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.644 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 238' ' ' LYS . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 232' ' ' ILE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.571 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m . . . . . 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m . . . . . 0 N--CA 1.429 -1.478 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 . . . . . 0 N--CA 1.433 -1.276 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HA ' ' A' ' 125' ' ' ARG . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.587 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.491 HD12 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 111' ' ' ILE . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt . . . . . 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.47 0.57 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' A' ' 164' ' ' ARG . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HA ' ' CE3' ' A' ' 160' ' ' TRP . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 . . . . . 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 194' ' ' VAL . 5.1 m . . . . . 0 N--CA 1.42 -1.928 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 272' ' ' TRP . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.583 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.583 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.581 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m . . . . . 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.439 -0.976 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.534 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . 0.446 ' HB3' HD21 ' A' ' 202' ' ' ASN . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 56.6 t80 . . . . . 0 N--CA 1.428 -1.539 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.414 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.55 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? . . . . . 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 N--CA 1.437 -1.079 0 CA-C-O 120.656 0.265 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 . . . . . 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.455 ' O ' HG23 ' A' ' 194' ' ' VAL . 10.9 m . . . . . 0 N--CA 1.423 -1.792 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 76.8 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.451 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.518 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 216' ' ' GLU . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.506 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.506 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 . . . . . 0 N--CA 1.439 -0.997 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 166' ' ' ILE . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 164' ' ' ARG . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.645 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 125' ' ' ARG . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 128' ' ' LYS . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG23 ' A' ' 108' ' ' THR . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 1.6 ptpp? . . . . . 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 CA--C 1.544 0.715 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . 0.539 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 159' ' ' GLN . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 102' ' ' LEU . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.44 ' NE ' ' H ' ' A' ' 168' ' ' THR . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.44 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 . . . . . 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m . . . . . 0 N--CA 1.435 -1.198 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.401 HG23 ' CD2' ' A' ' 248' ' ' HIS . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.497 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . 0.401 ' CD2' HG23 ' A' ' 195' ' ' VAL . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.578 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m . . . . . 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m . . . . . 0 N--CA 1.436 -1.131 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 . . . . . 0 N--CA 1.436 -1.127 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 102' ' ' LEU . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.604 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.546 HD11 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 126' ' ' VAL . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.487 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt . . . . . 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . 0.412 ' C ' HD12 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 168' ' ' THR . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.604 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 167' ' ' ARG . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 157' ' ' GLY . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 . . . . . 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m . . . . . 0 N--CA 1.441 -0.919 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 248' ' ' HIS . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 248' ' ' HIS . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.583 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.724 HD12 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.724 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 234' ' ' VAL . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 234' ' ' VAL . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 246' ' ' ASN . 0.7 OUTLIER -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.527 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . 0.414 ' CD2' HG23 ' A' ' 195' ' ' VAL . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.527 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.583 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m . . . . . 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.433 -1.304 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 . . . . . 0 N--CA 1.434 -1.236 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.572 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 126' ' ' VAL . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 121' ' ' ILE . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 115' ' ' PHE . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.427 ' CG2' HD12 ' A' ' 111' ' ' ILE . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 59.4 pttt . . . . . 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 . . . . . 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.0 m . . . . . 0 N--CA 1.429 -1.486 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 77.2 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' A' ' 214' ' ' LEU . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 210' ' ' VAL . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 243' ' ' VAL . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . 0.614 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 232' ' ' ILE . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.452 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m . . . . . 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m . . . . . 0 C--O 1.244 0.799 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 153' ' ' ILE . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.481 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.575 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.575 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.504 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.504 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.585 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 124' ' ' ALA . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt . . . . . 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t . . . . . 0 N--CA 1.445 -0.693 0 CA-C-O 121.162 0.506 . . . . 0.0 111.221 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.434 ' NZ ' HG12 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.585 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 97' ' ' VAL . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 159' ' ' GLN . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . 0.402 ' HB2' ' CE ' ' A' ' 156' ' ' MET . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.464 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 . . . . . 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.2 t . . . . . 0 C--O 1.204 -1.29 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HA ' HG21 ' A' ' 256' ' ' VAL . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 255' ' ' ILE . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 232' ' ' ILE . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 229' ' ' ILE . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 240' ' ' TYR . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 238' ' ' LYS . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 205' ' ' VAL . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m . . . . . 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . . . . . . 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . 32.8 t80 . . . . . 0 C--O 1.245 0.868 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 153' ' ' ILE . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.418 HG22 ' HE3' ' A' ' 112' ' ' LYS . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE2' ' H ' ' A' ' 124' ' ' ALA . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 115' ' ' PHE . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.466 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 13.8 ptmm? . . . . . 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.873 0.368 . . . . 0.0 111.689 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.478 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.444 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 . . . . . 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 192' ' ' ASP . 67.5 m . . . . . 0 N--CA 1.408 -2.526 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.557 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.566 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' PHE . . . . . 0.541 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLN . . . . . 0.608 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 231' ' ' GLU . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . 0.41 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' GLU . . . . . 0.577 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 252' ' ' ALA . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m . . . . . 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m . . . . . 0 N--CA 1.425 -1.705 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.668 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' TYR . . . . . 0.668 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . . . . . . 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.762 ' N ' ' HE2' ' A' ' 94' ' ' HIS . . . . . . . . 0 CA--C 1.487 -1.698 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -78.45 124.06 27.72 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 117.767 0.784 . . . . 0.0 109.304 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -54.26 -23.7 15.94 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.34 1.056 . . . . 0.0 112.423 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -64.11 -33.43 75.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.98 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -100.06 2.28 43.13 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 121.581 0.705 . . . . 0.0 110.366 -176.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.762 ' HE2' ' N ' ' A' ' 89' ' ' GLY . 66.0 m-70 -93.13 135.44 34.32 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 177.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -130.7 138.03 49.82 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-N 115.573 -0.74 . . . . 0.0 109.543 -171.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.462 ' HA ' ' O ' ' A' ' 141' ' ' VAL . 35.9 m80 -108.31 125.91 52.24 Favored 'General case' 0 C--O 1.248 1.02 0 C-N-CA 123.16 0.584 . . . . 0.0 110.218 175.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 89.2 t -107.08 138.52 32.56 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -96.38 124.81 40.51 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.97 141.44 24.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -144.78 176.58 23.8 Favored Glycine 0 N--CA 1.429 -1.822 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 58.94 24.83 13.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.931 0.893 . . . . 0.0 113.005 177.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.9 mt -64.54 131.26 46.55 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 115.244 -0.889 . . . . 0.0 110.441 178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 12.7 m -67.81 139.88 93.74 Favored Pre-proline 0 N--CA 1.423 -1.79 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -51.39 -30.08 33.12 Favored 'Trans proline' 0 CA--C 1.544 1.025 0 C-N-CA 122.889 2.392 . . . . 0.0 114.2 -177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 105' ' ' GLU . 1.6 mp0 -66.35 -23.0 66.27 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 122.138 -0.351 . . . . 0.0 110.18 -178.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 49.7 mm -73.28 148.09 9.13 Favored 'Isoleucine or valine' 0 C--O 1.249 1.064 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.133 -175.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -138.66 171.49 14.28 Favored 'General case' 0 N--CA 1.419 -2.012 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -178.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.619 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 98.2 m -55.52 -43.03 75.36 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.782 0.801 . . . . 0.0 111.413 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.619 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.0 mp0 -62.83 -34.95 78.39 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 114.267 -1.333 . . . . 0.0 110.478 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -68.05 -47.6 67.91 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.92 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.441 HG23 ' CD1' ' A' ' 115' ' ' PHE . 13.3 mt -60.1 -40.45 83.38 Favored 'Isoleucine or valine' 0 C--O 1.241 0.648 0 C-N-CA 121.176 -0.21 . . . . 0.0 110.869 178.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -55.03 -49.15 72.29 Favored 'General case' 0 C--O 1.219 -0.516 0 O-C-N 123.693 0.621 . . . . 0.0 110.024 179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.63 -46.5 63.21 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.52 179.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -62.11 -43.23 99.29 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -175.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.511 ' HB2' HD11 ' A' ' 121' ' ' ILE . 13.7 m-85 -86.49 -19.11 30.03 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -176.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.404 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -51.34 -45.71 89.78 Favored Pre-proline 0 CA--C 1.565 1.542 0 N-CA-C 115.488 1.662 . . . . 0.0 115.488 -177.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.404 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 29.0 Cg_endo -64.08 -24.52 66.43 Favored 'Trans proline' 0 C--N 1.376 2.01 0 C-N-CA 121.636 1.557 . . . . 0.0 113.362 179.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 -93.97 -43.33 8.59 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.666 -0.414 . . . . 0.0 109.987 -176.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 148' ' ' ASP . . . -138.36 140.25 10.96 Favored Glycine 0 N--CA 1.417 -2.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.771 -177.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.504 ' HG2' ' OD2' ' A' ' 148' ' ' ASP . 24.3 mmt-85 -80.55 120.89 25.1 Favored 'General case' 0 N--CA 1.434 -1.272 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.7 mt -102.41 134.21 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.496 0 CA-C-N 114.631 -1.168 . . . . 0.0 109.768 -170.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.7 m -87.15 -37.91 16.9 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -164.84 153.61 12.52 Favored 'General case' 0 C--O 1.22 -0.455 0 CA-C-N 114.535 -1.212 . . . . 0.0 109.475 178.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -145.94 141.67 27.98 Favored 'General case' 0 CA--C 1.476 -1.866 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -177.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.617 ' HA ' HG23 ' A' ' 108' ' ' THR . 6.7 ptp85 -144.98 131.58 19.88 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.612 0.72 . . . . 0.0 111.774 -174.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.496 HG23 ' HA ' ' A' ' 108' ' ' THR . 74.7 t -108.85 135.31 48.09 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.066 0 N-CA-C 106.925 -1.509 . . . . 0.0 106.925 176.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.514 HG12 ' HD3' ' A' ' 136' ' ' LYS . 31.0 t -86.13 105.06 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.406 -2.644 0 N-CA-C 104.7 -2.333 . . . . 0.0 104.7 173.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.9 pttt -122.37 164.44 17.97 Favored 'General case' 0 C--N 1.285 -2.197 0 CA-C-N 114.706 -1.133 . . . . 0.0 108.224 -174.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -69.51 136.56 51.59 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 123.539 0.524 . . . . 0.0 110.134 176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 52.6 ttm -63.05 -36.51 83.81 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-N 115.256 -0.883 . . . . 0.0 112.487 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -85.07 -47.97 9.66 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 -172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 61.2 p -95.02 -15.72 23.27 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 120.975 0.417 . . . . 0.0 112.041 -176.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.6 20.17 77.0 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.704 -0.76 . . . . 0.0 111.517 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.683 ' HA ' ' NZ ' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -96.01 138.86 33.02 Favored 'General case' 0 C--N 1.309 -1.16 0 O-C-N 122.311 -0.523 . . . . 0.0 110.353 -178.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.2 t -61.12 145.25 51.66 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 124.074 0.859 . . . . 0.0 111.626 -176.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.514 ' HD3' HG12 ' A' ' 127' ' ' VAL . 8.4 mtpm? -92.69 5.88 49.47 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.264 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.54 5.97 53.45 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.398 -0.819 . . . . 0.0 114.713 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -154.36 167.92 28.37 Favored 'General case' 0 C--O 1.245 0.826 0 CA-C-N 118.026 0.913 . . . . 0.0 112.087 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . 177.26 -172.98 45.85 Favored Glycine 0 N--CA 1.442 -0.937 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.626 -178.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -144.98 150.08 36.31 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 123.868 0.867 . . . . 0.0 109.454 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 96' ' ' HIS . 46.9 t -130.63 136.78 57.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.005 0 N-CA-C 109.884 -0.414 . . . . 0.0 109.884 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 18.2 m -103.32 116.04 31.7 Favored 'General case' 0 N--CA 1.435 -1.192 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -97.8 155.45 17.03 Favored 'General case' 0 C--N 1.296 -1.727 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.405 ' HA ' ' CE1' ' A' ' 94' ' ' HIS . 78.2 t80 -81.22 -26.64 35.74 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 123.873 0.733 . . . . 0.0 111.072 -177.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -138.86 146.6 41.39 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.81 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 13.7 tmtt? -59.53 -42.08 91.46 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 75.0 t-105 -64.2 -36.36 83.82 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.935 0.398 . . . . 0.0 110.694 -177.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.504 ' OD2' ' HG2' ' A' ' 120' ' ' ARG . 2.2 m-20 -60.64 -43.8 97.12 Favored 'General case' 0 CA--C 1.495 -1.153 0 CA-C-N 115.414 -0.812 . . . . 0.0 111.182 -179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.58 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.01 -45.96 72.58 Favored 'General case' 0 N--CA 1.434 -1.231 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.696 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -63.74 -44.2 94.23 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.588 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -62.07 -45.36 93.87 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.042 177.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.87 -40.3 92.42 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.695 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.58 HG13 ' O ' ' A' ' 149' ' ' ALA . 88.1 mt -58.95 -45.53 91.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -66.66 -50.68 62.12 Favored 'General case' 0 C--N 1.323 -0.578 0 O-C-N 123.805 0.69 . . . . 0.0 112.226 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -67.27 -32.19 73.02 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 121.194 0.521 . . . . 0.0 111.939 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.448 ' CE ' ' HB3' ' A' ' 159' ' ' GLN . 76.2 mmm -100.72 15.55 27.89 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.351 178.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.68 74.37 0.45 Allowed Glycine 0 C--O 1.226 -0.351 0 O-C-N 123.982 0.801 . . . . 0.0 111.9 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.547 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 80.65 48.93 5.98 Favored Glycine 0 N--CA 1.422 -2.29 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.448 ' HB3' ' CE ' ' A' ' 156' ' ' MET . 6.7 tp-100 -98.66 149.96 22.26 Favored 'General case' 0 N--CA 1.419 -1.983 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -71.85 90.05 1.09 Allowed 'General case' 0 C--N 1.31 -1.112 0 O-C-N 123.72 0.638 . . . . 0.0 111.844 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 36.0 tp -111.96 109.23 18.89 Favored 'General case' 0 N--CA 1.433 -1.32 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 173.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 92.73 -151.65 20.65 Favored Glycine 0 N--CA 1.43 -1.764 0 N-CA-C 108.657 -1.777 . . . . 0.0 108.657 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -81.88 0.88 87.87 Favored Glycine 0 C--N 1.304 -1.235 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.831 178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 14.6 ttp180 -150.79 161.48 42.57 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-N 117.764 0.782 . . . . 0.0 110.677 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.4 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 49.7 mt-30 -68.71 137.03 53.77 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 174.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.547 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 32.7 pt -101.0 173.48 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 O-C-N 123.266 0.354 . . . . 0.0 110.262 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -114.43 148.78 37.23 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.4 p -134.76 150.19 50.53 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -161.62 147.56 13.85 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.429 ' HB3' ' CD1' ' A' ' 153' ' ' ILE . 4.8 p90 -81.97 130.84 35.19 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -91.33 -61.2 1.7 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.275 -177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.462 HG23 ' HB2' ' A' ' 96' ' ' HIS . 25.4 p -77.87 89.4 4.08 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -79.52 108.37 13.0 Favored 'General case' 0 N--CA 1.415 -2.204 0 CA-C-N 114.537 -1.21 . . . . 0.0 108.693 -176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -72.45 113.62 22.52 Favored Pre-proline 0 C--N 1.317 -0.836 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.109 -177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -79.69 145.02 17.91 Favored 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 121.887 1.725 . . . . 0.0 111.297 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -77.98 141.74 19.14 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.596 1.53 . . . . 0.0 110.742 176.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 123.81 83.88 Favored Pre-proline 0 C--O 1.251 1.15 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.99 -171.58 1.29 Allowed 'Trans proline' 0 C--O 1.25 1.094 0 C-N-CA 122.933 2.422 . . . . 0.0 112.458 -177.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -146.74 171.93 14.41 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 177.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 m -73.5 88.15 1.62 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.8 m -94.56 -20.02 19.99 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 121.915 0.864 . . . . 0.0 110.145 -179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 50.6 m-85 -144.23 144.09 31.35 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.81 -178.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . 0.381 8.3 mm-40 65.75 121.64 0.02 OUTLIER 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 117.761 2.504 . . . . 0.0 117.761 178.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 53.9 m -163.17 28.84 0.09 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 176.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 70.25 77.43 0.2 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 114.017 -1.447 . . . . 0.0 110.18 -170.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 69.5 m -56.66 125.35 21.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 114.279 -1.328 . . . . 0.0 110.692 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.521 ' HZ1' ' CD ' ' A' ' 193' ' ' GLU . 0.0 OUTLIER -93.08 89.18 6.38 Favored 'General case' 0 N--CA 1.421 -1.889 0 CA-C-O 122.586 1.184 . . . . 0.0 112.409 -179.359 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -136.98 -174.74 3.82 Favored 'General case' 0 C--N 1.281 -2.41 0 N-CA-C 105.058 -2.201 . . . . 0.0 105.058 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.1 mt -101.92 85.34 2.68 Favored 'General case' 0 N--CA 1.419 -2.022 0 C-N-CA 119.439 -0.904 . . . . 0.0 110.227 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.573 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.6 m -87.87 127.39 35.35 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 176.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -57.05 -40.92 77.72 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.193 0.521 . . . . 0.0 110.405 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 3.9 p-10 -59.0 -47.78 83.96 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 124.956 1.302 . . . . 0.0 110.992 177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.521 ' CD ' ' HZ1' ' A' ' 187' ' ' LYS . 45.1 tt0 -68.05 -42.98 79.67 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 120.511 0.196 . . . . 0.0 110.479 178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 190' ' ' SER . 57.9 t -63.73 -43.91 98.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 -178.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 7.9 p -66.13 -28.1 42.74 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.959 0 CA-C-O 121.175 0.512 . . . . 0.0 110.786 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 30.8 m-80 -83.91 -2.41 56.44 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-O 120.975 0.417 . . . . 0.0 112.082 179.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.501 HE21 ' HG2' ' A' ' 193' ' ' GLU . 78.4 mt-30 -85.0 -3.63 58.85 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.862 0.363 . . . . 0.0 111.885 -179.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.6 t -147.45 160.46 42.55 Favored 'General case' 0 N--CA 1.426 -1.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.103 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.6 m -73.16 139.05 78.9 Favored Pre-proline 0 N--CA 1.426 -1.632 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -58.27 -12.34 12.98 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 123.93 3.086 . . . . 0.0 115.184 -175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 9.7 m -86.35 -14.83 42.34 Favored 'General case' 0 C--N 1.308 -1.23 0 CA-C-O 121.062 0.458 . . . . 0.0 110.836 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -79.26 123.02 27.04 Favored 'General case' 0 C--O 1.221 -0.446 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 82.1 m -119.71 21.88 11.83 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 120.816 0.341 . . . . 0.0 111.337 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 10.7 m -106.98 129.91 54.71 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 120.284 -0.567 . . . . 0.0 112.302 -175.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 95.4 t -104.83 132.73 50.85 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.106 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -94.88 113.08 24.76 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 107.726 -1.212 . . . . 0.0 107.726 177.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.433 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 53.9 t -103.12 122.84 45.52 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.73 151.94 20.55 Favored Glycine 0 C--N 1.301 -1.387 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.738 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 116.35 -15.96 15.02 Favored Glycine 0 N--CA 1.443 -0.885 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.15 177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.426 ' HB ' HD13 ' A' ' 214' ' ' LEU . 3.2 t -89.63 91.43 3.64 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.868 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 -177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 2.7 p -85.98 -23.06 27.02 Favored 'General case' 0 C--N 1.287 -2.148 0 CA-C-O 121.501 0.667 . . . . 0.0 111.857 178.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 33.6 t -124.82 154.37 41.09 Favored 'General case' 0 C--N 1.296 -1.736 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.187 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.37 5.29 7.99 Favored Glycine 0 N--CA 1.469 0.876 0 CA-C-N 115.291 -0.868 . . . . 0.0 114.599 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.426 HD13 ' HB ' ' A' ' 210' ' ' VAL . 32.1 tp -70.57 101.5 2.03 Favored 'General case' 0 N--CA 1.434 -1.273 0 CA-C-O 121.795 0.807 . . . . 0.0 112.069 -174.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.3 p -122.61 166.99 13.96 Favored 'General case' 0 N--CA 1.418 -2.048 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.205 177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -66.22 -38.9 89.02 Favored 'General case' 0 N--CA 1.431 -1.384 0 CA-C-O 121.349 0.595 . . . . 0.0 111.123 178.089 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -65.46 -41.53 93.31 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.956 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.2 tp -60.69 -45.54 93.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 123.054 0.221 . . . . 0.0 110.605 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.487 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 32.3 mmt -69.37 -45.29 69.67 Favored 'General case' 0 C--N 1.321 -0.648 0 C-N-CA 120.392 -0.523 . . . . 0.0 110.069 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.435 ' HB2' HG13 ' A' ' 232' ' ' ILE . 36.7 ttp-105 -55.87 -52.62 63.43 Favored 'General case' 0 C--O 1.216 -0.676 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.41 -178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -62.75 -32.93 74.16 Favored 'General case' 0 C--N 1.318 -0.799 0 O-C-N 123.436 0.46 . . . . 0.0 112.192 -177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 46.0 m -74.7 -49.51 20.96 Favored 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 121.178 0.513 . . . . 0.0 111.033 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.487 ' HD1' ' O ' ' A' ' 219' ' ' MET . 84.9 m-85 -69.54 -33.65 73.09 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 114.698 1.37 . . . . 0.0 114.698 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.0 m -47.69 -49.69 55.23 Favored Pre-proline 0 CA--C 1.569 1.702 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -64.07 -13.79 39.69 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 121.546 1.497 . . . . 0.0 113.359 177.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -96.82 -33.31 11.7 Favored 'General case' 0 N--CA 1.442 -0.825 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.505 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.463 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.39 172.06 42.8 Favored Glycine 0 N--CA 1.44 -1.09 0 C-N-CA 119.667 -1.254 . . . . 0.0 113.182 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 246' ' ' ASN . 52.2 tt0 -79.7 130.18 35.13 Favored 'General case' 0 C--O 1.242 0.684 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 mm -93.37 135.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.077 -175.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.479 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 74.6 mtp -110.06 -36.66 5.8 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.144 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 16.8 tt0 -150.44 146.55 26.73 Favored 'General case' 0 C--O 1.243 0.723 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.435 HG13 ' HB2' ' A' ' 220' ' ' ARG . 28.4 mm -128.43 113.26 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 N-CA-C 106.585 -1.635 . . . . 0.0 106.585 173.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -117.52 121.53 41.24 Favored 'General case' 0 C--N 1.287 -2.128 0 N-CA-C 106.837 -1.542 . . . . 0.0 106.837 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.95 151.46 30.58 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 120.787 0.327 . . . . 0.0 111.666 -172.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -144.51 85.58 8.53 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -64.46 -28.08 62.35 Favored 'Trans proline' 0 N--CA 1.479 0.637 0 C-N-CA 122.617 2.211 . . . . 0.0 112.253 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -71.92 -29.13 63.99 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.046 -176.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 46.7 mttp -104.93 -9.36 18.0 Favored 'General case' 0 N--CA 1.442 -0.84 0 CA-C-O 121.349 0.595 . . . . 0.0 109.77 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.82 37.72 43.97 Favored Glycine 0 C--O 1.244 0.753 0 CA-C-N 115.203 -0.908 . . . . 0.0 114.991 175.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -153.16 165.56 35.28 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.799 0.8 . . . . 0.0 111.066 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 36.8 m -147.14 160.5 42.35 Favored 'General case' 0 C--N 1.306 -1.3 0 C-N-CA 123.509 0.724 . . . . 0.0 110.808 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -115.91 120.45 39.22 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 173.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.8 t -107.32 119.47 56.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.029 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.485 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 15.9 tpp180 -99.03 123.06 43.06 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -176.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -102.94 163.54 12.15 Favored 'General case' 0 C--N 1.29 -1.991 0 CA-C-O 121.098 0.475 . . . . 0.0 111.09 179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.479 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 6.8 t30 -75.84 -31.86 59.54 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 114.44 -1.254 . . . . 0.0 110.559 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 87.0 p -141.96 165.12 28.32 Favored 'General case' 0 N--CA 1.418 -2.057 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.252 -178.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -73.54 -36.36 65.65 Favored 'General case' 0 C--N 1.315 -0.905 0 C-N-CA 123.553 0.741 . . . . 0.0 110.598 -173.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -59.92 -47.02 87.5 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.463 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 49.1 m -58.99 -40.94 86.38 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.641 179.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.64 69.52 Favored 'General case' 0 N--CA 1.44 -0.943 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.407 -177.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.457 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.73 -40.13 88.23 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.18 -0.304 . . . . 0.0 110.18 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-160 -60.05 -43.04 95.65 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.697 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.81 91.17 Favored 'General case' 0 C--O 1.213 -0.835 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.766 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 89.4 mt -61.14 -48.55 88.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.956 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.332 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 252' ' ' ALA . 71.8 t -58.14 -33.77 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-O 121.19 0.519 . . . . 0.0 111.64 -179.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.5 m -88.22 -48.37 7.74 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-N 116.135 -0.484 . . . . 0.0 112.156 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.1 t -77.83 -27.85 15.32 Favored 'Isoleucine or valine' 0 C--O 1.246 0.874 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 -174.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.625 ' OD1' ' HD3' ' A' ' 269' ' ' LYS . 47.8 t30 -69.16 105.89 2.64 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 122.198 0.999 . . . . 0.0 112.381 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.75 13.25 26.2 Favored Glycine 0 C--N 1.297 -1.584 0 CA-C-N 113.976 -1.465 . . . . 0.0 112.208 178.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 41.5 p -92.86 -170.65 2.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 119.732 -0.787 . . . . 0.0 109.934 176.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.6 m -133.92 124.84 27.08 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.685 -0.634 . . . . 0.0 110.699 -177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . 0.406 HG22 ' HG3' ' A' ' 264' ' ' GLU . 38.0 mm -111.04 112.93 42.72 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.406 ' HG3' HG22 ' A' ' 263' ' ' ILE 0.265 0.0 OUTLIER 46.28 34.96 2.42 Favored 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 126.732 2.013 . . . . 0.0 115.122 179.728 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 111.82 -26.71 11.24 Favored Glycine 0 N--CA 1.442 -0.917 0 C-N-CA 120.348 -0.93 . . . . 0.0 112.483 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -93.98 125.62 38.72 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-O 121.214 0.531 . . . . 0.0 111.107 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -72.71 122.54 25.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.882 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 29.1 m -98.6 155.14 3.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 122.779 1.276 . . . . 0.0 112.923 -173.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.625 ' HD3' ' OD1' ' A' ' 259' ' ' ASN . 0.3 OUTLIER -131.66 129.37 40.7 Favored 'General case' 0 C--N 1.276 -2.627 0 CA-C-N 114.137 -1.392 . . . . 0.0 107.764 -176.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.433 ' SG ' ' HA ' ' A' ' 207' ' ' CYS . 95.0 m -134.16 141.27 47.02 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.094 -0.642 . . . . 0.0 112.345 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -149.21 -165.52 2.3 Favored 'General case' 0 C--N 1.314 -0.956 0 N-CA-C 106.967 -1.494 . . . . 0.0 106.967 177.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 100.0 m95 -77.89 142.12 38.65 Favored 'General case' 0 C--N 1.3 -1.547 0 CA-C-O 120.861 0.363 . . . . 0.0 111.288 179.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -118.88 -168.66 14.19 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.63 ' HA ' ' HZ3' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.409 -2.507 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.589 -179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.49 -1.477 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -68.78 -43.04 76.53 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 66.0 mtt -72.28 141.68 48.89 Favored 'General case' 0 C--O 1.266 1.925 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 173.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 67.8 -175.17 0.19 Allowed 'General case' 0 C--O 1.239 0.552 0 O-C-N 124.794 1.309 . . . . 0.0 109.084 -173.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -109.16 5.5 23.98 Favored 'General case' 0 C--N 1.307 -1.255 0 C-N-CA 118.419 -1.313 . . . . 0.0 110.18 178.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.432 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 78.3 m-70 -93.93 126.81 39.34 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 115.016 -0.993 . . . . 0.0 109.18 -174.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -112.94 142.2 45.9 Favored 'General case' 0 C--N 1.297 -1.702 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.38 -177.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -107.07 118.59 37.12 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 124.096 0.958 . . . . 0.0 111.884 -175.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 61.0 t -109.27 139.22 33.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 CA-C-N 115.082 -0.963 . . . . 0.0 108.504 179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -95.81 125.57 40.47 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.461 HG12 HD21 ' A' ' 102' ' ' LEU . 41.3 t -110.16 133.98 53.79 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.214 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -149.92 -178.31 24.74 Favored Glycine 0 N--CA 1.424 -2.113 0 C-N-CA 120.337 -0.935 . . . . 0.0 110.816 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.6 t0 62.22 35.55 15.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 122.621 1.2 . . . . 0.0 109.029 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' ILE . 98.4 mt -74.61 178.64 5.22 Favored 'General case' 0 C--O 1.243 0.757 0 CA-C-N 114.288 -1.324 . . . . 0.0 112.32 -178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.529 ' HB2' HG12 ' A' ' 106' ' ' ILE . 17.0 m -98.64 151.11 37.3 Favored Pre-proline 0 N--CA 1.428 -1.556 0 N-CA-C 105.575 -2.009 . . . . 0.0 105.575 171.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -58.75 -18.05 39.19 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 123.002 2.468 . . . . 0.0 113.699 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.407 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 20.0 mm-40 -91.28 -8.56 47.97 Favored 'General case' 0 N--CA 1.448 -0.545 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.386 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.529 HG12 ' HB2' ' A' ' 103' ' ' SER . 43.8 mm -81.06 92.69 2.07 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.784 0 CA-C-O 121.892 0.853 . . . . 0.0 109.817 -176.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.6 t -86.79 172.4 10.16 Favored 'General case' 0 C--N 1.278 -2.5 0 CA-C-N 114.429 -1.26 . . . . 0.0 110.341 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.708 HG23 ' HA ' ' A' ' 125' ' ' ARG . 54.5 m -55.53 -43.1 75.43 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 123.862 0.865 . . . . 0.0 110.844 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.573 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.08 -34.99 77.32 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 114.284 -1.326 . . . . 0.0 110.567 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -69.82 -48.01 60.61 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.306 -177.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.477 HD12 HG22 ' A' ' 126' ' ' VAL . 12.7 mt -59.49 -40.39 81.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.471 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -55.82 -49.97 71.79 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.385 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.74 -44.92 65.81 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.258 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.9 -44.58 92.54 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.474 ' CB ' HD11 ' A' ' 121' ' ' ILE . 25.6 m-85 -83.53 -18.71 37.47 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 113.193 0.812 . . . . 0.0 113.193 -176.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -49.32 -48.36 74.62 Favored Pre-proline 0 CA--C 1.568 1.661 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -64.55 -31.38 60.47 Favored 'Trans proline' 0 C--N 1.374 1.88 0 C-N-CA 121.493 1.462 . . . . 0.0 112.752 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -82.49 -41.57 19.56 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.361 -174.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.01 149.51 21.52 Favored Glycine 0 N--CA 1.44 -1.035 0 N-CA-C 111.314 -0.714 . . . . 0.0 111.314 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.92 120.45 24.16 Favored 'General case' 0 N--CA 1.418 -2.039 0 C-N-CA 124.089 0.956 . . . . 0.0 109.223 -178.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.474 HD11 ' CB ' ' A' ' 115' ' ' PHE . 70.0 mt -106.08 132.89 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.432 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.054 -171.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.1 m -89.18 -38.26 14.41 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 173.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -164.65 155.9 15.21 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 114.316 -1.311 . . . . 0.0 109.278 177.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.43 141.84 21.61 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 105.868 -1.901 . . . . 0.0 105.868 -177.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.708 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.3 ptp180 -152.37 140.31 20.12 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 123.707 0.63 . . . . 0.0 111.558 -177.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.477 HG22 HD12 ' A' ' 111' ' ' ILE . 93.4 t -112.97 137.88 44.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 61.8 t -80.27 104.95 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.387 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 176.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 135' ' ' SER . 44.6 pttt -116.27 149.54 39.05 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.139 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -70.89 123.73 22.69 Favored 'General case' 0 C--N 1.285 -2.221 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.252 -177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -62.53 -27.91 69.49 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -178.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -90.31 -42.91 10.69 Favored 'General case' 0 C--N 1.308 -1.233 0 N-CA-C 112.179 0.437 . . . . 0.0 112.179 -175.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 29.3 p -95.44 -18.58 20.57 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -177.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.76 12.4 84.53 Favored Glycine 0 N--CA 1.446 -0.694 0 N-CA-C 111.844 -0.502 . . . . 0.0 111.844 -179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.407 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 31.6 mmmt -103.38 140.0 38.03 Favored 'General case' 0 CA--C 1.496 -1.101 0 CA-C-O 121.069 0.461 . . . . 0.0 111.075 -176.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 128' ' ' LYS . 27.8 m -66.11 138.38 57.7 Favored 'General case' 0 C--N 1.288 -2.083 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.856 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -86.21 3.56 42.51 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.288 0.566 . . . . 0.0 111.135 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 100.68 5.4 53.89 Favored Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 115.32 0.888 . . . . 0.0 115.32 171.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -151.99 164.25 37.59 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 118.07 0.935 . . . . 0.0 111.673 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.58 -167.04 32.76 Favored Glycine 0 N--CA 1.43 -1.721 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.76 -178.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -143.56 150.03 38.28 Favored 'General case' 0 C--N 1.311 -1.101 0 C-N-CA 123.547 0.739 . . . . 0.0 109.488 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 46.6 t -130.59 133.6 63.31 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 175.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.2 m -108.16 117.0 33.0 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 94' ' ' HIS . 86.1 m-85 -91.82 158.7 16.18 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.077 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -74.09 -28.76 61.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.901 0.751 . . . . 0.0 111.228 -177.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -135.03 142.25 46.34 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.603 -179.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -54.03 -53.03 58.62 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 113.111 0.782 . . . . 0.0 113.111 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 25.2 t90 -71.0 -20.91 62.36 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.178 0.513 . . . . 0.0 111.631 -178.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -71.21 -31.82 68.06 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 -176.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.49 -43.2 81.51 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 114.045 -1.434 . . . . 0.0 110.476 174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.413 ' CD ' HE21 ' A' ' 154' ' ' GLN . 0.6 OUTLIER -62.18 -46.2 89.98 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -179.415 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -61.69 -35.08 76.97 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.536 178.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -66.9 -41.67 86.75 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 122.103 -0.373 . . . . 0.0 110.789 176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 149' ' ' ALA . 73.2 mt -59.05 -40.16 80.1 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.958 0 C-N-CA 122.55 0.34 . . . . 0.0 110.21 176.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.413 HE21 ' CD ' ' A' ' 150' ' ' GLU . 75.3 mt-30 -55.82 -47.79 76.59 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 121.451 0.643 . . . . 0.0 111.804 177.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -82.41 -32.16 29.23 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.492 -0.776 . . . . 0.0 111.984 -174.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 81.1 mmm -103.6 17.03 24.99 Favored 'General case' 0 C--N 1.3 -1.55 0 CA-C-N 115.682 -0.69 . . . . 0.0 112.674 -176.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.23 43.75 0.87 Allowed Glycine 0 CA--C 1.53 0.988 0 CA-C-O 121.312 0.396 . . . . 0.0 113.514 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.67 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 117.0 70.73 0.43 Allowed Glycine 0 N--CA 1.412 -2.94 0 N-CA-C 112.055 -0.418 . . . . 0.0 112.055 -179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -114.67 150.68 34.81 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -78.2 90.35 4.3 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.519 0.676 . . . . 0.0 110.058 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 39.5 tp -107.18 112.81 25.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.371 -0.831 . . . . 0.0 109.311 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 95.89 -92.55 1.44 Allowed Glycine 0 N--CA 1.431 -1.636 0 N-CA-C 110.684 -0.966 . . . . 0.0 110.684 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -147.64 12.74 1.34 Allowed Glycine 0 N--CA 1.442 -0.964 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 40.2 mtp-105 -145.81 162.39 37.78 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 -179.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 58.4 tt0 -87.24 123.53 32.35 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.102 -1.814 . . . . 0.0 106.102 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.67 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 27.4 pt -94.21 173.31 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 C-N-CA 120.597 -0.441 . . . . 0.0 110.606 -175.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 2.6 tpp180 -130.48 149.87 51.95 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-O 120.895 0.378 . . . . 0.0 110.003 -177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 3.2 p -130.09 150.34 51.4 Favored 'General case' 0 C--N 1.301 -1.503 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.165 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.42 HD21 ' HG2' ' A' ' 173' ' ' ARG . 41.8 t30 -158.9 149.5 19.83 Favored 'General case' 0 C--O 1.212 -0.921 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.453 ' O ' ' HB2' ' A' ' 173' ' ' ARG . 44.3 p-90 -79.98 141.71 35.72 Favored 'General case' 0 C--N 1.3 -1.559 0 C-N-CA 119.671 -0.811 . . . . 0.0 111.9 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.36 154.58 27.65 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.077 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 11.3 m 68.92 30.7 4.52 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 107.556 -1.275 . . . . 0.0 107.556 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 170' ' ' TRP . 11.0 tpt85 -61.54 136.57 58.07 Favored 'General case' 0 C--O 1.222 -0.365 0 C-N-CA 126.506 1.922 . . . . 0.0 111.504 -179.267 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -99.78 122.94 49.41 Favored Pre-proline 0 C--O 1.249 1.049 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -79.46 149.8 21.7 Favored 'Trans proline' 0 N--CA 1.453 -0.858 0 C-N-CA 122.691 2.261 . . . . 0.0 111.229 175.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.12 142.21 19.2 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.61 1.54 . . . . 0.0 110.817 176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -74.86 123.53 89.03 Favored Pre-proline 0 C--O 1.256 1.399 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -60.8 -57.18 0.71 Allowed 'Trans proline' 0 CA--C 1.494 -1.477 0 C-N-CA 123.175 2.583 . . . . 0.0 112.193 -179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 19.5 mtmm 60.79 -167.06 0.19 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 113.142 -1.845 . . . . 0.0 108.731 -178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.8 m -81.09 83.46 6.75 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 171.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 9.4 m -149.07 16.15 0.94 Allowed 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -108.27 -63.53 1.32 Allowed 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.516 -174.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 52.55 94.54 0.02 OUTLIER 'General case' 0 C--N 1.282 -2.345 0 C-N-CA 127.102 2.161 . . . . 0.0 113.1 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.7 m -80.32 80.65 6.72 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 114.913 -1.039 . . . . 0.0 111.542 -177.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.3 t30 -171.55 -72.77 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 176.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -148.43 163.68 36.41 Favored 'General case' 0 N--CA 1.424 -1.739 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.579 ' HA ' ' HE3' ' A' ' 187' ' ' LYS . 0.0 OUTLIER -86.74 -17.6 33.19 Favored 'General case' 0 C--N 1.311 -1.065 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.788 -178.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -162.98 159.53 23.58 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 65.3 mt -73.83 107.32 5.99 Favored 'General case' 0 N--CA 1.435 -1.202 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.473 ' O ' HG23 ' A' ' 194' ' ' VAL . 19.7 m -77.21 142.18 39.71 Favored 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.333 -175.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -49.71 -43.41 47.56 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.772 0.286 . . . . 0.0 111.772 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -62.01 -48.44 80.31 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.514 0.673 . . . . 0.0 110.128 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.533 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 48.7 tt0 -59.68 -41.47 90.74 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.439 -1.255 . . . . 0.0 109.883 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 190' ' ' SER . 60.5 t -71.74 -50.29 39.81 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.226 178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 6.4 p -63.97 -31.19 52.25 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.266 0.555 . . . . 0.0 111.398 -172.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -78.41 -2.14 36.92 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.504 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.533 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 79.1 mt-30 -87.05 -5.56 59.01 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 38.1 m -150.94 164.39 36.46 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 121.724 -0.61 . . . . 0.0 111.665 178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 5.0 p -74.4 145.69 82.95 Favored Pre-proline 0 N--CA 1.419 -1.999 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 177.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.76 -12.51 14.9 Favored 'Trans proline' 0 N--CA 1.486 1.088 0 C-N-CA 123.28 2.653 . . . . 0.0 114.229 -177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 10.7 m -88.68 -14.99 36.01 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-O 121.164 0.507 . . . . 0.0 110.275 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -78.74 121.73 25.12 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 176.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 244' ' ' ARG . 76.7 m -119.67 11.89 12.1 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.854 -178.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.7 m -92.54 126.57 37.68 Favored 'General case' 0 N--CA 1.435 -1.193 0 C-N-CA 120.362 -0.535 . . . . 0.0 111.83 -175.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 72.3 t -103.11 137.09 32.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 124.477 1.111 . . . . 0.0 108.346 175.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -109.35 111.56 23.19 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.719 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.9 p -104.79 126.51 51.94 Favored 'General case' 0 C--N 1.286 -2.191 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 175.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -123.51 148.99 16.84 Favored Glycine 0 N--CA 1.43 -1.717 0 C-N-CA 120.09 -1.052 . . . . 0.0 111.19 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 115.5 -8.52 20.04 Favored Glycine 0 N--CA 1.438 -1.224 0 N-CA-C 111.842 -0.503 . . . . 0.0 111.842 178.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.484 HG22 HG11 ' A' ' 268' ' ' VAL . 3.2 t -92.57 86.6 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 119.874 -0.73 . . . . 0.0 109.291 -177.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 6.9 p -85.35 -21.89 28.69 Favored 'General case' 0 C--N 1.282 -2.357 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.694 -178.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.2 t -124.69 154.57 40.6 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.142 -175.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.464 ' HA3' ' OE2' ' A' ' 264' ' ' GLU . . . 60.91 4.81 4.73 Favored Glycine 0 C--N 1.344 1.015 0 O-C-N 125.126 1.516 . . . . 0.0 114.861 176.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 32.8 tp -65.86 93.45 0.19 Allowed 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.206 1.003 . . . . 0.0 111.698 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 12.8 p -121.58 174.19 6.95 Favored 'General case' 0 N--CA 1.412 -2.361 0 CA-C-N 113.761 -1.563 . . . . 0.0 107.83 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.507 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -68.69 -39.78 80.39 Favored 'General case' 0 N--CA 1.422 -1.87 0 C-N-CA 120.223 -0.591 . . . . 0.0 111.108 178.307 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 51.9 tp60 -62.18 -46.99 86.49 Favored 'General case' 0 N--CA 1.431 -1.42 0 C-N-CA 123.853 0.861 . . . . 0.0 111.952 176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 34.6 tp -56.27 -45.5 80.1 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.438 -178.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.9 mmt -71.38 -45.86 61.79 Favored 'General case' 0 CA--C 1.506 -0.731 0 C-N-CA 119.942 -0.703 . . . . 0.0 110.667 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -58.27 -42.54 86.72 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.547 -179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -68.24 -38.83 82.23 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 122.808 0.443 . . . . 0.0 110.973 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 61.7 m -68.83 -49.6 57.07 Favored 'General case' 0 CA--C 1.545 0.785 0 CA-C-O 121.122 0.487 . . . . 0.0 110.492 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -68.42 -32.83 73.14 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 -177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -46.83 -48.32 51.21 Favored Pre-proline 0 CA--C 1.568 1.664 0 N-CA-C 115.118 1.525 . . . . 0.0 115.118 -174.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -64.28 -17.42 59.64 Favored 'Trans proline' 0 C--N 1.371 1.743 0 C-N-CA 121.575 1.516 . . . . 0.0 113.35 176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.01 -27.83 14.44 Favored 'General case' 0 C--O 1.252 1.187 0 CA-C-O 120.766 0.317 . . . . 0.0 110.47 -178.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.622 ' HA3' ' OG ' ' A' ' 250' ' ' SER . . . 177.35 175.43 44.6 Favored Glycine 0 N--CA 1.431 -1.689 0 C-N-CA 120.007 -1.092 . . . . 0.0 113.791 176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 19.0 mp0 -83.73 128.58 34.64 Favored 'General case' 0 N--CA 1.44 -0.955 0 CA-C-O 120.858 0.361 . . . . 0.0 110.498 -178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.5 mp -89.02 134.93 27.09 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.494 178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . 0.543 ' SD ' ' HA ' ' A' ' 246' ' ' ASN . 73.9 mtp -113.67 -26.41 8.25 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.138 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.533 ' HB3' ' HB2' ' A' ' 244' ' ' ARG . 29.5 tt0 -145.57 146.31 31.34 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 109.853 -0.425 . . . . 0.0 109.853 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.507 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -133.2 119.75 37.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 O-C-N 123.679 0.612 . . . . 0.0 110.275 178.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.492 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 47.0 mtm180 -123.5 118.62 27.8 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 171.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 14.6 m -124.89 143.74 37.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 C-N-CA 120.848 -0.341 . . . . 0.0 111.167 -176.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -142.06 88.15 9.39 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -68.2 -15.45 42.72 Favored 'Trans proline' 0 N--CA 1.483 0.857 0 C-N-CA 122.802 2.335 . . . . 0.0 112.414 -178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.464 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.3 t70 -65.74 -37.61 86.86 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.302 -178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.464 ' HG2' ' OD2' ' A' ' 237' ' ' ASP . 37.9 mmtm -112.17 -4.14 14.48 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.981 -0.554 . . . . 0.0 112.462 175.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.72 46.53 17.86 Favored Glycine 0 N--CA 1.439 -1.137 0 CA-C-N 115.527 -0.76 . . . . 0.0 114.301 177.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 46.0 p90 -146.0 160.51 41.77 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 117.267 0.533 . . . . 0.0 110.78 178.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.719 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 43.6 t -146.39 151.42 37.43 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.163 -0.471 . . . . 0.0 109.992 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.492 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 90.6 m-85 -114.94 118.71 34.24 Favored 'General case' 0 N--CA 1.437 -1.098 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 174.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 67.9 t -119.91 126.29 75.15 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.058 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.533 ' HB2' ' HB3' ' A' ' 231' ' ' GLU . 90.4 mtt180 -101.29 136.29 41.38 Favored 'General case' 0 C--N 1.31 -1.141 0 C-N-CA 120.261 -0.576 . . . . 0.0 110.344 177.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -103.46 169.17 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.054 -177.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.543 ' HA ' ' SD ' ' A' ' 230' ' ' MET . 5.1 t30 -66.82 -37.47 84.58 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.33 178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 77.4 p -142.35 164.77 29.24 Favored 'General case' 0 N--CA 1.412 -2.328 0 C-N-CA 120.026 -0.67 . . . . 0.0 111.499 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -75.76 -36.01 59.97 Favored 'General case' 0 C--N 1.318 -0.783 0 C-N-CA 123.219 0.607 . . . . 0.0 110.659 -172.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.564 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.12 -46.63 89.82 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.622 ' OG ' ' HA3' ' A' ' 227' ' ' GLY . 34.9 t -63.15 -37.66 88.08 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.488 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.14 -41.92 73.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.501 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.43 -40.61 93.51 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 116.23 -0.441 . . . . 0.0 109.88 177.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -58.41 -44.41 89.0 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.769 177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.46 -47.1 86.78 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.162 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -59.12 -50.51 79.48 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.553 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.6 t -55.8 -44.31 77.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 O-C-N 123.839 0.712 . . . . 0.0 111.631 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 22.7 t -83.14 -36.16 25.0 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.3 t -77.49 -18.24 14.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 120.99 0.424 . . . . 0.0 110.992 -179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -62.86 99.59 0.16 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.302 0.572 . . . . 0.0 111.131 178.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.68 15.73 21.81 Favored Glycine 0 C--N 1.299 -1.478 0 CA-C-N 115.124 -0.943 . . . . 0.0 112.385 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 33.4 p -87.77 179.63 6.45 Favored 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 119.755 -0.778 . . . . 0.0 110.104 177.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.16 117.05 16.1 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.427 -0.796 . . . . 0.0 111.449 -176.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 56.4 mt -111.66 123.74 67.76 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.464 ' OE2' ' HA3' ' A' ' 213' ' ' GLY . 46.8 mt-10 48.98 36.87 9.15 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 124.331 1.052 . . . . 0.0 113.306 -177.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 90.25 -11.04 72.32 Favored Glycine 0 C--O 1.224 -0.503 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.841 177.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -95.85 128.04 42.4 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.6 t -75.18 115.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.061 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . 0.484 HG11 HG22 ' A' ' 210' ' ' VAL . 29.7 m -105.11 142.42 18.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.839 0.828 . . . . 0.0 111.547 -175.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 34.1 ttpt -130.6 149.02 52.45 Favored 'General case' 0 C--N 1.293 -1.858 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.259 -179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 96.1 m -116.38 155.59 28.22 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 113.779 1.029 . . . . 0.0 113.779 177.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -144.72 -174.92 4.47 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -82.14 138.77 34.67 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 120.619 -0.433 . . . . 0.0 110.695 174.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -107.99 -167.19 21.47 Favored Glycine 0 N--CA 1.429 -1.786 0 N-CA-C 109.761 -1.336 . . . . 0.0 109.761 177.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm . . . . . 0 C--N 1.305 -1.331 0 CA-C-O 118.251 -0.881 . . . . 0.0 109.012 179.02 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.213 -1.192 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -160.41 93.96 1.05 Allowed 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 176.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 54.7 ttm 73.26 -58.96 0.58 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.845 1.258 . . . . 0.0 109.16 -172.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -110.84 150.37 29.25 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 105.937 -1.875 . . . . 0.0 105.937 173.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -82.83 -37.52 24.3 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 118.161 -1.416 . . . . 0.0 110.343 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HA ' ' O ' ' A' ' 143' ' ' PHE . 95.3 m-70 -145.73 144.95 30.66 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 178.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.441 ' CZ ' ' HA ' ' A' ' 172' ' ' THR . 18.1 t80 -130.62 142.3 50.45 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 70.1 m-70 -105.52 139.13 40.6 Favored 'General case' 0 C--N 1.305 -1.354 0 CA-C-O 121.3 0.571 . . . . 0.0 112.498 -169.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.456 HG13 HG12 ' A' ' 153' ' ' ILE . 93.6 t -126.07 136.43 60.84 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.149 0 C-N-CA 124.77 1.228 . . . . 0.0 108.106 175.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -108.18 126.09 52.38 Favored 'General case' 0 C--N 1.309 -1.153 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.5 t -110.67 144.77 18.03 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.983 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 -178.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -147.97 177.94 25.9 Favored Glycine 0 CA--C 1.475 -2.41 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.409 ' HB3' ' HB2' ' A' ' 167' ' ' ARG . 51.1 t0 56.23 50.69 12.94 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.4 mt -86.04 135.69 33.54 Favored 'General case' 0 CA--C 1.482 -1.647 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.252 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.488 ' OG ' ' HB3' ' A' ' 164' ' ' ARG . 10.4 m -74.87 155.51 86.76 Favored Pre-proline 0 N--CA 1.418 -2.058 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 176.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -55.62 -27.74 62.0 Favored 'Trans proline' 0 CA--C 1.536 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 114.63 -176.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 11.4 pm0 -84.66 -16.43 41.94 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 34.6 mm -83.22 84.19 1.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.577 0 CA-C-O 122.025 0.917 . . . . 0.0 110.286 -176.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.1 t -86.01 172.95 10.26 Favored 'General case' 0 C--N 1.279 -2.472 0 CA-C-N 114.218 -1.355 . . . . 0.0 110.086 -179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.683 HG23 ' HA ' ' A' ' 125' ' ' ARG . 94.0 m -54.29 -40.86 68.29 Favored 'General case' 0 C--O 1.242 0.679 0 C-N-CA 123.852 0.861 . . . . 0.0 110.182 179.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.535 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 3.1 mp0 -64.15 -35.5 80.98 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-N 114.42 -1.264 . . . . 0.0 110.812 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -70.2 -48.0 59.05 Favored 'General case' 0 CA--C 1.504 -0.798 0 O-C-N 123.116 0.26 . . . . 0.0 110.592 -177.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 30.9 mt -60.07 -43.43 92.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.745 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -56.96 -49.79 74.6 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.487 178.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.93 73.23 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.96 -41.66 74.22 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.519 ' HB2' HD11 ' A' ' 121' ' ' ILE . 6.9 m-85 -84.71 -20.92 30.39 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 112.008 0.373 . . . . 0.0 112.008 -176.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -55.35 -48.06 97.15 Favored Pre-proline 0 N--CA 1.489 1.485 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 -176.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -64.81 -16.26 54.45 Favored 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.631 1.554 . . . . 0.0 112.955 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -99.33 -42.74 6.86 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.352 -177.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.667 ' HA2' ' NH2' ' A' ' 120' ' ' ARG . . . -141.21 163.15 26.77 Favored Glycine 0 N--CA 1.44 -1.038 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.946 -176.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' NH2' ' HA2' ' A' ' 119' ' ' GLY . 0.0 OUTLIER -91.74 120.68 32.69 Favored 'General case' 0 N--CA 1.435 -1.21 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 -177.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 115' ' ' PHE . 70.1 mt -110.79 132.55 58.93 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.08 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -173.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.9 m -85.85 -38.96 17.55 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 174.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -165.27 156.67 14.58 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.743 -1.117 . . . . 0.0 110.266 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.53 141.8 21.49 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 105.477 -2.045 . . . . 0.0 105.477 -178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.683 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.0 ptp180 -152.51 142.86 22.56 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 123.35 0.406 . . . . 0.0 112.003 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 55.9 t -116.46 138.05 48.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 CA-C-N 114.895 -1.048 . . . . 0.0 109.326 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.09 105.91 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 38.1 pttt -110.02 161.15 15.8 Favored 'General case' 0 C--N 1.285 -2.21 0 CA-C-O 121.635 0.731 . . . . 0.0 111.504 177.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -82.74 123.92 29.76 Favored 'General case' 0 C--N 1.274 -2.687 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.156 -175.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -62.32 -26.66 68.55 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.32 -43.44 9.26 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 -176.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.44 ' OG1' ' HE2' ' A' ' 134' ' ' LYS . 20.1 p -95.55 -17.09 21.69 Favored 'General case' 0 C--N 1.308 -1.218 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -177.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 83.18 -5.19 77.98 Favored Glycine 0 CA--C 1.518 0.234 0 C-N-CA 121.733 -0.27 . . . . 0.0 113.764 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.594 ' O ' ' HE3' ' A' ' 134' ' ' LYS 0.258 0.0 OUTLIER -105.72 160.95 14.82 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -176.438 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.9 m -55.95 141.76 38.29 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 114.344 1.239 . . . . 0.0 114.344 -175.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -89.74 -19.81 24.32 Favored 'General case' 0 C--O 1.215 -0.757 0 CA-C-N 115.095 -0.957 . . . . 0.0 110.387 174.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 126.91 -0.98 7.28 Favored Glycine 0 CA--C 1.522 0.484 0 C-N-CA 119.213 -1.47 . . . . 0.0 114.866 176.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -112.39 146.13 38.88 Favored 'General case' 0 CA--C 1.468 -2.199 0 CA-C-N 117.801 0.8 . . . . 0.0 112.407 -177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -143.81 154.91 25.9 Favored Glycine 0 C--N 1.294 -1.763 0 O-C-N 124.435 1.084 . . . . 0.0 110.942 176.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -149.01 139.33 22.37 Favored 'General case' 0 C--N 1.292 -1.928 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 29.5 t -138.24 138.07 43.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' PHE . 49.1 m -119.66 121.12 38.56 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 174.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.524 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 26.8 m-85 -95.29 171.37 8.76 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.721 -177.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 71.7 t80 -84.06 -18.92 35.38 Favored 'General case' 0 C--O 1.253 1.282 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.895 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -140.52 150.05 43.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.892 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.522 ' HG3' ' N ' ' A' ' 147' ' ' TRP . 6.6 ptmm? -61.78 -53.69 52.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -177.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . 0.522 ' N ' ' HG3' ' A' ' 146' ' ' LYS . 38.3 p90 -72.31 -24.45 61.32 Favored 'General case' 0 C--O 1.211 -0.969 0 C-N-CA 120.562 -0.455 . . . . 0.0 112.015 -175.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 43.3 t0 -63.64 -44.93 92.42 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 178.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -70.0 -46.07 65.94 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.623 177.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -65.08 -39.59 93.43 Favored 'General case' 0 C--N 1.306 -1.308 0 CA-C-N 114.814 -1.085 . . . . 0.0 110.531 -173.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -71.06 -34.3 71.07 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 121.278 0.561 . . . . 0.0 110.137 176.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.29 -39.68 87.78 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.209 176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.456 HG12 HG13 ' A' ' 97' ' ' VAL . 60.0 mt -58.79 -40.38 79.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 -65.9 -50.88 62.9 Favored 'General case' 0 C--O 1.222 -0.358 0 O-C-N 123.795 0.685 . . . . 0.0 110.634 -177.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -62.27 -44.84 95.63 Favored 'General case' 0 C--O 1.219 -0.53 0 CA-C-O 121.481 0.658 . . . . 0.0 111.298 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.448 ' HG3' ' CZ ' ' A' ' 115' ' ' PHE . 80.2 mmm -89.15 16.23 7.57 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -175.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -70.76 54.77 0.97 Allowed Glycine 0 CA--C 1.527 0.836 0 O-C-N 123.597 0.561 . . . . 0.0 113.047 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.537 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 103.48 50.98 1.0 Allowed Glycine 0 N--CA 1.413 -2.852 0 N-CA-C 111.822 -0.511 . . . . 0.0 111.822 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -105.4 143.56 33.4 Favored 'General case' 0 N--CA 1.418 -2.053 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 73.9 m95 -73.04 92.2 1.65 Allowed 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.442 -176.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 35.3 tp -102.42 140.33 36.84 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 177.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 69.51 -104.84 1.37 Allowed Glycine 0 N--CA 1.443 -0.878 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 -176.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -125.85 4.41 7.97 Favored Glycine 0 N--CA 1.427 -1.928 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.773 177.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.488 ' HB3' ' OG ' ' A' ' 103' ' ' SER . 16.6 ttp85 -157.57 158.35 35.44 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 117.964 0.882 . . . . 0.0 111.9 -178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 164' ' ' ARG . 34.3 tt0 -68.64 126.31 29.3 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 124.358 1.063 . . . . 0.0 111.089 178.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.537 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 2.6 pp -107.87 173.57 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 C-N-CA 123.899 0.88 . . . . 0.0 109.048 178.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.409 ' HB2' ' HB3' ' A' ' 101' ' ' ASP . 5.4 tpp180 -123.49 149.64 44.9 Favored 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 120.206 -0.598 . . . . 0.0 110.29 -176.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 7.1 p -116.21 150.38 37.59 Favored 'General case' 0 C--N 1.292 -1.898 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -133.96 153.41 51.79 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 65.3 m95 -79.93 131.05 35.75 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.718 -177.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -130.11 27.33 5.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 173.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.441 ' HA ' ' CZ ' ' A' ' 95' ' ' PHE . 12.9 t -64.33 123.65 19.71 Favored 'General case' 0 N--CA 1.427 -1.58 0 CA-C-N 112.664 -2.062 . . . . 0.0 110.539 -176.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -86.53 91.03 8.43 Favored 'General case' 0 N--CA 1.433 -1.287 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.831 -177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -112.12 133.35 21.71 Favored Pre-proline 0 C--N 1.291 -1.945 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.58 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.8 144.41 19.31 Favored 'Trans proline' 0 N--CA 1.45 -1.041 0 C-N-CA 121.438 1.425 . . . . 0.0 111.381 177.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.53 142.37 18.36 Favored 'Trans proline' 0 N--CA 1.451 -1.024 0 C-N-CA 122.148 1.899 . . . . 0.0 111.602 177.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -94.09 123.98 57.46 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -92.72 25.72 0.42 Allowed 'Trans proline' 0 CA--C 1.532 0.422 0 C-N-CA 122.744 2.296 . . . . 0.0 112.12 -179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.17 103.19 14.23 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 183' ' ' GLU . 15.5 m -45.32 132.41 7.68 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 124.831 1.252 . . . . 0.0 111.865 179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 5.1 m -34.05 -79.63 0.01 OUTLIER 'General case' 0 C--O 1.239 0.529 0 C-N-CA 126.628 1.971 . . . . 0.0 115.519 -172.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 11.9 p90 -109.04 -2.2 18.34 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-O 121.678 0.752 . . . . 0.0 110.055 -177.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 180' ' ' SER . 5.0 mm-40 -83.39 94.96 8.08 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 -177.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 48.6 m -151.29 31.38 0.6 Allowed 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.372 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -154.72 -172.93 4.37 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 28.2 m -68.46 100.83 1.14 Allowed 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 121.328 0.585 . . . . 0.0 110.313 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 48.1 tptt -77.37 -34.28 55.07 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.93 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -171.35 178.91 3.1 Favored 'General case' 0 CA--C 1.503 -0.853 0 C-N-CA 124.328 1.051 . . . . 0.0 108.269 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 94.9 mt -115.77 139.63 49.98 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 41.2 m -111.66 138.03 48.75 Favored 'General case' 0 C--N 1.289 -2.053 0 C-N-CA 120.46 -0.496 . . . . 0.0 110.747 -173.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -49.7 -39.35 36.54 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.377 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -59.8 -50.6 73.16 Favored 'General case' 0 C--O 1.215 -0.746 0 O-C-N 123.766 0.666 . . . . 0.0 111.202 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.574 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 2.8 pp20? -69.5 -36.4 76.43 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.723 -176.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.462 HG21 HG22 ' A' ' 256' ' ' VAL . 87.3 t -63.48 -45.22 98.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.216 177.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.3 p -69.73 -27.74 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.899 0 CA-C-O 121.494 0.664 . . . . 0.0 109.616 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -82.87 -1.43 52.02 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 123.791 0.836 . . . . 0.0 111.72 178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 72.9 mt-30 -80.83 -12.74 59.38 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 112.066 0.395 . . . . 0.0 112.066 -179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 66.7 m -152.8 165.74 34.42 Favored 'General case' 0 C--N 1.31 -1.115 0 O-C-N 121.977 -0.452 . . . . 0.0 110.902 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.1 m -71.59 143.13 87.03 Favored Pre-proline 0 N--CA 1.429 -1.498 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.476 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 14.2 Cg_endo -56.7 -12.44 8.85 Favored 'Trans proline' 0 N--CA 1.489 1.248 0 C-N-CA 123.947 3.098 . . . . 0.0 114.614 -177.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 8.7 m -80.79 -15.28 56.83 Favored 'General case' 0 N--CA 1.437 -1.123 0 O-C-N 122.155 -0.341 . . . . 0.0 110.869 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -78.11 124.08 27.63 Favored 'General case' 0 CA--C 1.509 -0.61 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 2.1 p -118.93 8.02 11.59 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 112.245 0.461 . . . . 0.0 112.245 -177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.6 m -106.3 133.29 51.22 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.252 -0.579 . . . . 0.0 112.332 -175.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.9 t -104.74 137.24 34.81 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 C-N-CA 124.475 1.11 . . . . 0.0 108.853 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -102.16 122.16 43.61 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 176.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 54.0 t -111.12 131.49 55.04 Favored 'General case' 0 C--N 1.288 -2.103 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 178.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -139.04 148.72 20.21 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.911 -1.138 . . . . 0.0 111.604 177.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.79 10.55 4.34 Favored Glycine 0 C--O 1.216 -0.991 0 C-N-CA 121.154 -0.546 . . . . 0.0 113.237 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.468 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.8 t -124.51 106.68 17.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 64.8 p -85.88 -34.11 21.07 Favored 'General case' 0 C--N 1.289 -2.023 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -176.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 17.5 m -132.17 140.47 48.75 Favored 'General case' 0 C--N 1.3 -1.559 0 CA-C-O 121.643 0.735 . . . . 0.0 112.158 -169.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.0 8.63 86.9 Favored Glycine 0 C--O 1.239 0.425 0 C-N-CA 120.645 -0.788 . . . . 0.0 111.859 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.468 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.7 tp -69.73 94.39 0.8 Allowed 'General case' 0 N--CA 1.431 -1.42 0 CA-C-O 121.565 0.698 . . . . 0.0 109.532 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 19.4 p -105.96 168.48 9.09 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.92 -1.037 . . . . 0.0 109.326 -179.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.644 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -69.45 -35.96 76.15 Favored 'General case' 0 N--CA 1.42 -1.962 0 CA-C-O 121.133 0.492 . . . . 0.0 110.984 178.04 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -64.37 -44.92 89.9 Favored 'General case' 0 N--CA 1.421 -1.92 0 C-N-CA 124.03 0.932 . . . . 0.0 110.802 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.6 tp -56.95 -45.55 82.73 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.497 0.498 . . . . 0.0 111.267 -179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 30.6 mmt -72.47 -40.96 66.57 Favored 'General case' 0 CA--C 1.508 -0.658 0 C-N-CA 120.195 -0.602 . . . . 0.0 110.347 -178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.9 ttm105 -56.16 -51.48 67.83 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.199 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -58.54 -42.23 87.34 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 123.605 0.762 . . . . 0.0 111.216 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 48.2 m -66.57 -49.82 65.15 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.29 -178.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.425 ' CE2' HG21 ' A' ' 243' ' ' VAL 0.26 73.6 m-85 -69.08 -32.52 72.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 -177.308 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.2 m -46.31 -48.57 45.03 Favored Pre-proline 0 CA--C 1.57 1.728 0 N-CA-C 115.821 1.785 . . . . 0.0 115.821 -175.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.22 -17.53 60.06 Favored 'Trans proline' 0 C--N 1.37 1.67 0 CA-C-N 121.058 1.414 . . . . 0.0 113.261 176.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.3 m-85 -97.34 -32.04 12.09 Favored 'General case' 0 C--O 1.248 1.02 0 CA-C-N 116.707 -0.224 . . . . 0.0 111.328 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -170.59 177.25 43.82 Favored Glycine 0 N--CA 1.435 -1.401 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.161 179.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -93.22 123.86 36.79 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.258 -0.275 . . . . 0.0 110.258 -177.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 3.1 mp -90.15 135.33 26.64 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.0 -178.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 75.0 mtp -100.12 -39.44 8.09 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.231 0.538 . . . . 0.0 109.919 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.571 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 8.3 pt-20 -150.74 156.77 41.96 Favored 'General case' 0 C--O 1.243 0.74 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.486 -176.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.644 HG21 ' HA ' ' A' ' 216' ' ' GLU . 27.4 mm -132.12 117.29 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.936 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 38.8 mtm180 -109.11 123.51 49.31 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.435 HG13 HG22 ' A' ' 232' ' ' ILE . 15.3 m -124.93 144.03 36.39 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-O 120.989 0.423 . . . . 0.0 111.181 -177.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -138.19 85.38 18.78 Favored Pre-proline 0 C--N 1.308 -1.22 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.59 -19.56 60.24 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.616 2.211 . . . . 0.0 111.576 -179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.413 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.7 t70 -62.82 -36.8 84.39 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.146 -179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 238' ' ' LYS . 36.5 mmtm -111.9 -1.84 15.37 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.885 -0.598 . . . . 0.0 112.441 176.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.76 47.58 Favored Glycine 0 C--O 1.247 0.91 0 CA-C-N 115.479 -0.782 . . . . 0.0 114.629 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.412 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 34.2 p90 -141.95 166.13 25.57 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.682 0.741 . . . . 0.0 111.51 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 44.9 t -146.16 150.83 36.61 Favored 'General case' 0 N--CA 1.43 -1.454 0 C-N-CA 123.415 0.686 . . . . 0.0 110.132 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.412 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -115.03 118.57 33.79 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.438 HG13 HD13 ' A' ' 232' ' ' ILE . 91.5 t -114.21 116.36 52.35 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 -179.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.571 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 43.8 ttm180 -101.91 131.33 48.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.222 -0.591 . . . . 0.0 110.858 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -103.7 164.88 11.39 Favored 'General case' 0 C--N 1.311 -1.077 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.383 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -93.53 -2.54 54.2 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.353 0.596 . . . . 0.0 111.153 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 3.2 p -138.31 138.93 38.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.665 -179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 74.3 t60 -75.93 -36.34 59.42 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.418 0.628 . . . . 0.0 109.34 -175.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.609 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.7 mp0 -59.45 -47.97 83.45 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.692 -1.14 . . . . 0.0 108.884 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 14.0 m -66.47 -33.54 75.91 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.124 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.97 -42.06 73.65 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.156 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.517 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.16 -41.64 94.49 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 177.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.8 t-160 -58.35 -44.9 88.98 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.827 177.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.26 -44.62 92.4 Favored 'General case' 0 C--O 1.21 -1.015 0 O-C-N 123.629 0.581 . . . . 0.0 110.589 -179.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.1 mt -61.62 -48.07 90.43 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.598 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 252' ' ' ALA . 84.2 t -56.99 -41.81 77.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.621 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 11.6 p -85.81 -37.94 18.7 Favored 'General case' 0 N--CA 1.426 -1.627 0 N-CA-C 113.026 0.75 . . . . 0.0 113.026 -174.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 88.2 t -77.14 -19.29 14.38 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 CA-C-O 120.805 0.336 . . . . 0.0 111.293 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -65.2 101.92 0.59 Allowed 'General case' 0 CA--C 1.493 -1.237 0 CA-C-O 121.809 0.814 . . . . 0.0 113.074 178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.02 15.03 23.14 Favored Glycine 0 N--CA 1.428 -1.874 0 CA-C-N 114.18 -1.373 . . . . 0.0 112.054 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -88.62 -177.78 5.65 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.999 176.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.7 m -134.02 122.88 23.65 Favored 'General case' 0 N--CA 1.43 -1.45 0 O-C-N 121.407 -0.808 . . . . 0.0 111.642 -175.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 84.9 mt -133.07 142.02 43.25 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.001 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 176.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.0 tt0 56.41 34.09 23.59 Favored 'General case' 0 CA--C 1.561 1.378 0 CA-C-O 122.296 1.046 . . . . 0.0 110.346 -178.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.75 -7.59 3.93 Favored Glycine 0 CA--C 1.54 1.621 0 O-C-N 121.338 -0.851 . . . . 0.0 113.247 -178.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.48 147.99 25.27 Favored 'General case' 0 N--CA 1.431 -1.387 0 C-N-CA 123.152 0.581 . . . . 0.0 109.749 -178.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.2 t -77.21 120.9 28.53 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 177.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.0 m -98.13 141.05 16.77 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 CA-C-O 122.27 1.033 . . . . 0.0 110.943 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 13.2 ttpp -130.14 130.81 45.24 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.061 -1.427 . . . . 0.0 110.578 -173.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 89.7 m -116.84 152.35 34.63 Favored 'General case' 0 C--N 1.291 -1.957 0 N-CA-C 113.307 0.855 . . . . 0.0 113.307 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -151.77 -172.87 4.34 Favored 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 174.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.8 m95 -75.66 131.19 39.76 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 122.145 0.974 . . . . 0.0 112.443 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -97.85 -156.3 30.0 Favored Glycine 0 N--CA 1.42 -2.407 0 CA-C-N 114.552 -1.204 . . . . 0.0 110.517 -178.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 6.1 mtmm . . . . . 0 C--N 1.3 -1.573 0 C-N-CA 124.829 1.252 . . . . 0.0 107.808 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.777 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 174' ' ' LYS . . . -77.69 -49.81 13.72 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 105.801 -1.926 . . . . 0.0 105.801 171.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.11 144.69 25.95 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 171.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 68.56 139.65 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.06 0.944 . . . . 0.0 111.144 -176.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -88.96 13.05 13.72 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-O 121.768 0.794 . . . . 0.0 110.369 -175.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 27.7 m-70 -94.2 158.69 15.48 Favored 'General case' 0 C--O 1.259 1.601 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -89.23 138.55 31.33 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 -176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.468 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 6.4 m-70 -119.79 138.62 53.24 Favored 'General case' 0 C--N 1.302 -1.458 0 C-N-CA 120.373 -0.531 . . . . 0.0 110.204 -177.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.0 137.65 50.21 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.985 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 176.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -96.1 125.29 40.53 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 25.8 t -107.94 134.14 50.66 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.182 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.4 173.73 22.9 Favored Glycine 0 N--CA 1.419 -2.443 0 C-N-CA 119.984 -1.103 . . . . 0.0 111.322 -175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.468 ' OD2' ' HB3' ' A' ' 167' ' ' ARG . 26.0 m-20 63.34 25.67 14.73 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 122.357 1.075 . . . . 0.0 108.845 179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 68.8 mt -65.45 125.12 24.16 Favored 'General case' 0 CA--C 1.478 -1.806 0 CA-C-N 114.127 -1.397 . . . . 0.0 111.089 -178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 22.0 m -75.88 141.61 71.94 Favored Pre-proline 0 N--CA 1.401 -2.895 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.325 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -58.68 -18.56 41.33 Favored 'Trans proline' 0 N--CA 1.486 1.055 0 C-N-CA 122.787 2.324 . . . . 0.0 111.1 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -66.57 -21.6 66.15 Favored 'General case' 0 C--N 1.3 -1.568 0 C-N-CA 126.887 2.075 . . . . 0.0 109.846 178.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 43.3 mm -96.97 156.63 3.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 124.532 1.133 . . . . 0.0 108.455 -178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -138.54 172.18 13.27 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 176.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.59 HG23 ' HA ' ' A' ' 125' ' ' ARG . 89.6 m -58.16 -41.13 83.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.674 0.75 . . . . 0.0 111.247 -179.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.587 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.4 mp0 -62.48 -35.17 78.49 Favored 'General case' 0 C--N 1.303 -1.445 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.434 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -67.14 -47.37 71.3 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.104 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.491 HD12 ' CG2' ' A' ' 126' ' ' VAL . 20.4 mt -58.74 -44.37 89.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.15 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -54.43 -48.98 71.05 Favored 'General case' 0 C--O 1.223 -0.3 0 O-C-N 123.602 0.563 . . . . 0.0 110.784 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.83 -44.64 66.09 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 112.438 0.532 . . . . 0.0 112.438 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.97 -41.45 86.82 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.515 ' HB2' HD11 ' A' ' 121' ' ' ILE . 10.6 m-85 -83.76 -20.2 33.78 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 -176.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.83 -46.56 92.04 Favored Pre-proline 0 CA--C 1.568 1.669 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -177.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -64.06 -30.15 65.93 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 121.497 1.464 . . . . 0.0 112.498 178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -81.74 -42.27 20.06 Favored 'General case' 0 C--O 1.248 0.996 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.415 -176.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.22 141.88 9.17 Favored Glycine 0 N--CA 1.425 -2.078 0 O-C-N 123.641 0.588 . . . . 0.0 111.753 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.55 120.71 17.53 Favored 'General case' 0 N--CA 1.428 -1.574 0 CA-C-O 121.766 0.793 . . . . 0.0 110.156 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.515 HD11 ' HB2' ' A' ' 115' ' ' PHE . 67.8 mt -99.99 132.29 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.407 0 CA-C-N 114.382 -1.281 . . . . 0.0 109.033 -173.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.2 m -85.91 -38.73 17.71 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 106.977 -1.49 . . . . 0.0 106.977 174.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -165.46 159.94 17.39 Favored 'General case' 0 C--O 1.22 -0.454 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.133 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.16 141.47 21.49 Favored 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.59 ' HA ' HG23 ' A' ' 108' ' ' THR . 18.7 ptp180 -153.37 140.41 19.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 123.663 0.602 . . . . 0.0 111.315 -176.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.491 ' CG2' HD12 ' A' ' 111' ' ' ILE . 60.5 t -121.39 144.96 28.77 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -79.63 105.34 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.365 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 170.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -121.39 164.43 17.1 Favored 'General case' 0 N--CA 1.41 -2.462 0 CA-C-N 115.039 -0.982 . . . . 0.0 109.212 -176.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.424 ' HB2' ' HE3' ' A' ' 136' ' ' LYS . 15.5 t70 -77.82 113.8 16.05 Favored 'General case' 0 C--N 1.276 -2.612 0 CA-C-N 114.958 -1.019 . . . . 0.0 108.29 -179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 24.8 mmt -62.91 -17.87 62.29 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.52 -48.06 6.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.011 0.434 . . . . 0.0 111.391 -177.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 39.2 p -95.38 -11.04 28.39 Favored 'General case' 0 C--O 1.256 1.411 0 CA-C-O 121.191 0.519 . . . . 0.0 112.163 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.24 20.54 76.72 Favored Glycine 0 C--O 1.224 -0.48 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.537 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -105.68 138.92 41.08 Favored 'General case' 0 C--O 1.21 -1.003 0 N-CA-C 109.994 -0.372 . . . . 0.0 109.994 -176.671 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.2 m -58.27 145.12 38.79 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.8 mmpt? -89.93 -8.71 51.14 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.976 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 133.87 -15.51 4.58 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 119.347 -1.406 . . . . 0.0 114.88 176.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -153.91 160.57 42.19 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 118.361 1.08 . . . . 0.0 112.19 -176.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -163.75 -175.9 35.13 Favored Glycine 0 N--CA 1.434 -1.46 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.56 -178.277 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -141.63 145.93 35.59 Favored 'General case' 0 C--N 1.311 -1.108 0 C-N-CA 123.55 0.74 . . . . 0.0 109.294 -177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 36.2 t -125.2 137.11 58.69 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.16 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 27.1 t -108.67 117.14 33.41 Favored 'General case' 0 N--CA 1.422 -1.841 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -108.24 156.02 19.82 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 84.9 t80 -83.74 -34.8 24.77 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-O 120.965 0.412 . . . . 0.0 111.292 -177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -127.36 154.34 45.1 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.863 -176.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -56.8 -52.16 66.13 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -176.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 71.3 t-105 -60.3 -35.04 74.67 Favored 'General case' 0 C--O 1.215 -0.753 0 O-C-N 123.498 0.499 . . . . 0.0 111.75 -175.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -62.84 -45.05 94.41 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.284 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.506 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -70.13 -46.74 64.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.096 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -61.98 -46.05 90.96 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.435 -1.257 . . . . 0.0 110.994 -176.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 155' ' ' GLN . 54.1 t30 -61.8 -45.23 94.76 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.834 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.506 HG13 ' O ' ' A' ' 149' ' ' ALA . 71.3 mt -60.51 -45.41 97.05 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 15.0 mm100 -66.29 -49.26 67.68 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.751 -0.659 . . . . 0.0 112.698 -179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 151' ' ' ASN . 77.3 mm-40 -67.29 -39.27 85.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.34 0.591 . . . . 0.0 111.443 -176.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 73.5 mmm -94.68 15.87 17.09 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.224 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.61 62.86 1.52 Allowed Glycine 0 CA--C 1.522 0.517 0 O-C-N 123.686 0.616 . . . . 0.0 112.686 179.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 96.84 49.75 1.89 Allowed Glycine 0 N--CA 1.431 -1.634 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -107.68 145.9 32.78 Favored 'General case' 0 N--CA 1.417 -2.092 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.407 ' CE3' ' HA ' ' A' ' 164' ' ' ARG . 70.0 m95 -69.85 94.13 0.81 Allowed 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.642 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 42.2 tp -109.48 134.28 52.06 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 77.03 -104.51 1.92 Allowed Glycine 0 N--CA 1.432 -1.592 0 N-CA-C 109.026 -1.63 . . . . 0.0 109.026 -173.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -127.19 -0.22 6.95 Favored Glycine 0 N--CA 1.433 -1.556 0 C-N-CA 119.753 -1.213 . . . . 0.0 112.385 177.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.407 ' HA ' ' CE3' ' A' ' 160' ' ' TRP . 5.9 ptp180 -156.18 -175.8 5.62 Favored 'General case' 0 C--O 1.216 -0.667 0 C-N-CA 120.252 -0.579 . . . . 0.0 111.877 -178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -85.24 142.4 29.43 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 36.3 pt -123.56 167.58 17.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 173.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.468 ' HB3' ' OD2' ' A' ' 101' ' ' ASP . 1.2 tmm_? -129.99 148.51 51.86 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.581 0.705 . . . . 0.0 111.568 -178.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 2.6 p -105.37 150.76 24.94 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.752 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -131.56 149.07 52.64 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 75.1 m95 -79.73 152.02 30.09 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-O 121.022 0.439 . . . . 0.0 111.684 -178.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -160.86 169.55 22.44 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 176.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -139.5 -178.3 5.33 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 118.793 0.724 . . . . 0.0 111.925 -176.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.27 110.05 22.7 Favored 'General case' 0 N--CA 1.437 -1.121 0 N-CA-C 105.307 -2.108 . . . . 0.0 105.307 173.382 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 90' ' ' ALA . 61.9 tttm -111.28 143.27 28.09 Favored Pre-proline 0 C--N 1.278 -2.533 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.839 -173.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.536 ' O ' ' HG2' ' A' ' 174' ' ' LYS . 12.3 Cg_endo -60.48 164.14 13.77 Favored 'Trans proline' 0 CA--C 1.56 1.797 0 C-N-CA 121.851 1.701 . . . . 0.0 108.928 167.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -56.71 141.9 91.71 Favored 'Trans proline' 0 C--O 1.24 0.587 0 C-N-CA 122.274 1.982 . . . . 0.0 113.395 -173.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.52 124.79 38.07 Favored Pre-proline 0 C--N 1.304 -1.377 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.327 -179.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_exo -67.42 118.91 5.94 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.943 1.762 . . . . 0.0 109.053 173.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -84.32 85.18 7.41 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.535 0.683 . . . . 0.0 111.548 -177.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.476 ' HA ' ' CE2' ' A' ' 182' ' ' TYR . 28.7 m -88.66 31.72 0.83 Allowed 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.937 -1.029 . . . . 0.0 109.657 176.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 17.8 p -81.29 81.54 7.42 Favored 'General case' 0 N--CA 1.424 -1.773 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.226 -178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.476 ' CE2' ' HA ' ' A' ' 180' ' ' SER . 15.5 p90 -164.76 151.74 11.06 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 125.17 1.388 . . . . 0.0 107.879 179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 184' ' ' SER . 0.8 OUTLIER 62.6 -159.22 0.32 Allowed 'General case' 0 CA--C 1.567 1.612 0 O-C-N 124.273 0.983 . . . . 0.0 108.717 -178.228 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . 0.464 ' H ' ' CD ' ' A' ' 183' ' ' GLU . 6.3 m -133.18 5.46 3.82 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 178.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 61.33 57.85 2.29 Favored 'General case' 0 C--O 1.242 0.677 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 -172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 47.3 m -64.79 106.96 1.31 Allowed 'General case' 0 N--CA 1.438 -1.067 0 CA-C-N 113.815 -1.539 . . . . 0.0 113.272 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.496 ' HE2' ' OE1' ' A' ' 188' ' ' GLN . 27.8 mtmm -121.19 -52.66 2.06 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 102.691 -3.077 . . . . 0.0 102.691 171.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.496 ' OE1' ' HE2' ' A' ' 187' ' ' LYS . 0.5 OUTLIER -162.08 162.01 28.51 Favored 'General case' 0 N--CA 1.408 -2.555 0 N-CA-C 100.903 -3.74 . . . . 0.0 100.903 168.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 62.4 mt -115.18 103.61 11.03 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.26 -0.976 . . . . 0.0 110.163 176.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.484 ' O ' HG23 ' A' ' 194' ' ' VAL . 5.1 m -78.18 146.38 35.05 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 177.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 78.9 t80 -51.15 -42.25 60.66 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 122.805 0.442 . . . . 0.0 110.426 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.15 -49.57 71.48 Favored 'General case' 0 C--N 1.311 -1.069 0 C-N-CA 125.4 1.48 . . . . 0.0 110.246 178.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 45.5 mt-10 -63.25 -42.74 99.21 Favored 'General case' 0 C--O 1.218 -0.587 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.23 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 190' ' ' SER . 50.9 t -71.05 -49.6 48.07 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.936 -175.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 9.8 p -63.69 -30.16 49.18 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 CA-C-O 121.389 0.614 . . . . 0.0 111.343 -173.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -79.7 -2.39 42.72 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.27 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 78.3 mt-30 -87.48 -3.96 59.0 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 35.6 m -151.8 163.28 39.51 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.358 0.599 . . . . 0.0 112.355 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 8.2 m -75.44 146.0 80.29 Favored Pre-proline 0 N--CA 1.421 -1.923 0 N-CA-C 107.019 -1.474 . . . . 0.0 107.019 173.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -54.7 -17.1 12.45 Favored 'Trans proline' 0 N--CA 1.486 1.072 0 C-N-CA 123.675 2.917 . . . . 0.0 114.637 -176.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 4.7 p -80.12 -16.12 55.64 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 122.078 -0.389 . . . . 0.0 111.643 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . 0.446 HD21 ' HB3' ' A' ' 272' ' ' TRP . 33.0 t30 -79.49 121.23 24.95 Favored 'General case' 0 CA--C 1.506 -0.723 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 172.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.0 m -122.12 11.9 10.26 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 120.698 0.285 . . . . 0.0 110.585 178.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 28.2 m -99.92 132.83 45.03 Favored 'General case' 0 N--CA 1.435 -1.204 0 CA-C-O 121.287 0.565 . . . . 0.0 111.855 -174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 83.0 t -103.8 137.22 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.511 0 C-N-CA 124.56 1.144 . . . . 0.0 107.983 175.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -105.72 111.47 24.16 Favored 'General case' 0 C--N 1.286 -2.17 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 178.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.581 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 5.5 p -112.23 118.29 34.89 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 110.119 -0.326 . . . . 0.0 110.119 178.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -120.34 149.62 17.61 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.974 -178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 139.1 -31.91 2.32 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.382 -0.437 . . . . 0.0 112.6 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 17.2 t -90.17 97.75 7.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-O 120.846 0.355 . . . . 0.0 110.432 -176.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 25.2 p -85.8 -18.82 31.87 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-O 121.457 0.646 . . . . 0.0 112.106 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 29.5 t -139.36 147.01 40.94 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 120.182 -0.607 . . . . 0.0 110.221 -178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 77.41 5.5 85.76 Favored Glycine 0 C--N 1.316 -0.566 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.531 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 45.4 tp -76.55 94.64 3.76 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-O 121.42 0.629 . . . . 0.0 110.53 -177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.583 ' HB ' ' OE1' ' A' ' 217' ' ' GLN . 34.7 p -104.63 159.95 15.35 Favored 'General case' 0 N--CA 1.416 -2.136 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 177.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.461 ' O ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -71.36 -26.78 62.95 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-O 121.688 0.756 . . . . 0.0 109.703 179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.583 ' OE1' ' HB ' ' A' ' 215' ' ' THR . 22.5 mp0 -65.23 -47.85 75.38 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 114.931 -1.031 . . . . 0.0 109.626 177.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 50.1 tp -56.51 -43.27 79.61 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.478 0.711 . . . . 0.0 111.667 -178.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.2 mmt -68.35 -42.98 78.43 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.843 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 44.7 ttm105 -62.2 -40.46 96.14 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -57.95 -40.31 80.23 Favored 'General case' 0 C--N 1.314 -0.961 0 C-N-CA 124.53 1.132 . . . . 0.0 111.152 178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 24.2 m -81.08 -49.31 11.03 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.813 -176.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.277 93.7 m-85 -69.1 -32.9 72.64 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -174.896 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 56.3 m -47.81 -49.84 55.62 Favored Pre-proline 0 CA--C 1.567 1.615 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -64.09 -13.54 38.26 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 121.463 1.442 . . . . 0.0 113.403 175.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -92.19 -34.87 14.13 Favored 'General case' 0 C--O 1.241 0.643 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -175.17 179.73 46.25 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 119.662 -1.256 . . . . 0.0 113.098 177.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -82.78 125.43 31.28 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 64.2 mt -99.25 136.2 31.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.333 0 C-N-CA 123.443 0.697 . . . . 0.0 112.141 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 78.5 mtp -106.35 -38.75 6.12 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.88 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.431 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 3.7 tp10 -141.04 144.19 34.84 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.318 -174.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.461 HG21 ' O ' ' A' ' 216' ' ' GLU . 20.0 mm -136.26 112.91 13.18 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 N-CA-C 106.619 -1.622 . . . . 0.0 106.619 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 8.8 tpp180 -127.73 128.7 45.84 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 28.8 m -124.37 149.0 28.48 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 CA-C-O 120.75 0.31 . . . . 0.0 111.363 -172.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -141.18 85.11 12.27 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 176.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.84 -27.87 67.51 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 122.546 2.164 . . . . 0.0 112.07 -178.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -69.63 -27.23 64.89 Favored 'General case' 0 C--N 1.313 -0.988 0 CA-C-N 115.437 -0.802 . . . . 0.0 110.593 -176.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 47.7 mttp -105.83 -8.06 17.94 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 121.553 0.692 . . . . 0.0 109.163 178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.98 35.1 51.01 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.8 -1.091 . . . . 0.0 115.652 175.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 23.4 p90 -151.15 166.87 29.49 Favored 'General case' 0 C--O 1.241 0.654 0 CA-C-N 118.156 0.978 . . . . 0.0 111.29 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.581 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 40.4 t -141.4 152.8 44.63 Favored 'General case' 0 N--CA 1.426 -1.67 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.897 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 66.0 m-85 -109.17 118.75 37.55 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 173.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.8 t -117.54 113.09 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.447 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 15.0 ttm-85 -102.3 135.4 43.96 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.836 -0.746 . . . . 0.0 111.114 177.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -102.18 169.37 8.77 Favored 'General case' 0 N--CA 1.422 -1.872 0 CA-C-N 114.615 -1.175 . . . . 0.0 110.996 -178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -73.04 -27.67 61.88 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.344 -1.298 . . . . 0.0 110.348 179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . . . . . . . . . 90.0 p -142.47 164.98 28.65 Favored 'General case' 0 N--CA 1.417 -2.123 0 C-N-CA 119.452 -0.899 . . . . 0.0 111.557 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -74.33 -36.6 63.68 Favored 'General case' 0 C--N 1.317 -0.808 0 C-N-CA 123.394 0.677 . . . . 0.0 110.291 -174.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.553 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.24 -46.69 88.92 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 50.3 m -59.15 -40.84 86.81 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 114.412 -1.267 . . . . 0.0 110.7 179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.9 -42.28 70.15 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.885 -178.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.06 -41.47 95.1 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.113 178.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -59.59 -42.62 92.95 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.727 177.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.41 -45.34 91.79 Favored 'General case' 0 C--O 1.211 -0.961 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.103 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 92.1 mt -61.41 -47.75 92.02 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.481 178.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 252' ' ' ALA . 90.6 t -55.64 -40.77 61.61 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.496 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 28.1 t -85.42 -36.18 20.82 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -174.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 96.4 t -77.18 -17.67 14.45 Favored 'Isoleucine or valine' 0 C--O 1.241 0.623 0 CA-C-O 120.762 0.315 . . . . 0.0 110.994 -179.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -52.12 99.4 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 87.88 24.16 36.21 Favored Glycine 0 C--N 1.305 -1.159 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.858 174.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 37.4 p -92.5 179.04 5.63 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.197 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 30.4 m -134.01 117.32 16.55 Favored 'General case' 0 N--CA 1.42 -1.933 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 57.0 mt -106.96 119.74 57.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.25 37.08 3.7 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 125.982 1.713 . . . . 0.0 113.281 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 100.94 -19.28 52.77 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.859 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -93.54 118.86 31.88 Favored 'General case' 0 C--N 1.308 -1.206 0 O-C-N 122.588 -0.36 . . . . 0.0 110.7 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.96 126.75 30.73 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.4 m -120.38 151.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 CA-C-O 122.045 0.926 . . . . 0.0 113.277 -174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.534 ' HE2' ' O ' ' A' ' 270' ' ' CYS . 17.6 tptm -125.93 145.4 50.29 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 174.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.534 ' O ' ' HE2' ' A' ' 269' ' ' LYS . 4.1 p -113.91 142.79 45.69 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 123.502 0.721 . . . . 0.0 110.654 -176.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -142.04 178.75 7.32 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 177.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . 0.446 ' HB3' HD21 ' A' ' 202' ' ' ASN . 92.1 m95 -81.84 147.42 29.36 Favored 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 120.7 0.286 . . . . 0.0 110.341 172.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -108.07 -134.29 7.28 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.812 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS 0.383 0.0 OUTLIER . . . . . 0 CA--C 1.485 -1.533 0 N-CA-C 116.269 1.952 . . . . 0.0 116.269 -179.023 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.484 -1.871 0 N-CA-C 108.394 -1.882 . . . . 0.0 108.394 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.23 101.88 13.01 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 175.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 3.7 mpp? -104.66 140.44 38.03 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -77.89 92.48 4.27 Favored 'General case' 0 C--N 1.31 -1.135 0 CA-C-O 121.078 0.466 . . . . 0.0 110.198 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 51.0 t30 -80.92 -32.49 34.62 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.588 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 45.1 m-70 -93.6 137.6 32.7 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 114.935 -1.029 . . . . 0.0 109.0 -175.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.526 ' CE1' ' HB ' ' A' ' 172' ' ' THR . 56.6 t80 -130.83 142.46 50.39 Favored 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.985 -172.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 80.0 m80 -103.21 131.45 50.24 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-O 120.915 0.388 . . . . 0.0 110.323 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 90.5 t -110.79 138.11 40.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.441 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 68.7 t80 -96.38 126.56 41.67 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 -179.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.7 124.81 60.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -121.26 151.0 17.08 Favored Glycine 0 N--CA 1.422 -2.255 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.606 -177.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.549 ' OD1' ' HD3' ' A' ' 164' ' ' ARG . 33.7 t70 66.8 66.5 0.44 Allowed 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 125.805 1.642 . . . . 0.0 111.054 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.4 mt -94.9 132.39 39.78 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 113.918 -1.492 . . . . 0.0 110.172 178.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.414 ' HB2' ' CG1' ' A' ' 106' ' ' ILE . 3.0 m -64.99 139.33 97.77 Favored Pre-proline 0 C--N 1.285 -2.198 0 CA-C-N 114.539 -1.209 . . . . 0.0 108.796 177.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -64.76 -22.8 63.51 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 C-N-CA 122.566 2.177 . . . . 0.0 113.817 -175.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -90.97 -11.03 40.2 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.781 0.324 . . . . 0.0 111.283 -179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.414 ' CG1' ' HB2' ' A' ' 103' ' ' SER . 22.9 mm -85.06 124.66 40.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.693 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 6.2 p -101.97 173.38 6.42 Favored 'General case' 0 N--CA 1.414 -2.236 0 N-CA-C 114.326 1.232 . . . . 0.0 114.326 -177.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.1 m -55.74 -38.41 69.76 Favored 'General case' 0 N--CA 1.412 -2.363 0 CA-C-N 114.095 -1.412 . . . . 0.0 112.123 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -68.92 -34.21 75.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.811 -177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -61.05 -43.62 98.61 Favored 'General case' 0 CA--C 1.504 -0.811 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . . . . . . . . . 31.2 mt -60.24 -44.46 95.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.805 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -58.33 -45.87 87.29 Favored 'General case' 0 C--O 1.219 -0.523 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.698 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.07 -40.72 74.86 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.105 -0.498 . . . . 0.0 112.032 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -67.65 -42.18 82.63 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.159 0.429 . . . . 0.0 112.159 -177.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.55 ' HB2' HD11 ' A' ' 121' ' ' ILE . 53.3 m-85 -84.55 -19.74 32.67 Favored 'General case' 0 C--N 1.31 -1.109 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -176.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -51.41 -45.82 90.12 Favored Pre-proline 0 CA--C 1.566 1.583 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -64.74 -26.77 60.3 Favored 'Trans proline' 0 C--N 1.376 2.002 0 C-N-CA 121.73 1.62 . . . . 0.0 112.44 177.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -93.38 -39.05 11.14 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -173.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -149.7 154.46 25.74 Favored Glycine 0 N--CA 1.441 -1.018 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.216 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.421 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -80.48 121.47 25.8 Favored 'General case' 0 N--CA 1.416 -2.134 0 C-N-CA 124.308 1.043 . . . . 0.0 108.738 -179.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.55 HD11 ' HB2' ' A' ' 115' ' ' PHE . 71.0 mt -102.07 130.23 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.079 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.0 -174.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.1 m -93.38 -31.64 14.56 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 174.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -164.5 144.16 7.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.141 179.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -133.15 141.13 47.97 Favored 'General case' 0 C--N 1.288 -2.098 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 175.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 10.5 ttm180 -151.47 145.97 25.58 Favored 'General case' 0 N--CA 1.401 -2.877 0 C-N-CA 119.324 -0.95 . . . . 0.0 111.377 -172.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 99.6 t -121.88 142.22 39.12 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.977 0 CA-C-N 114.91 -1.041 . . . . 0.0 108.969 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -90.75 118.16 35.46 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.01 0 N-CA-C 107.072 -1.455 . . . . 0.0 107.072 173.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.5 ptmm? -125.96 164.71 20.21 Favored 'General case' 0 C--N 1.284 -2.241 0 N-CA-C 105.811 -1.922 . . . . 0.0 105.811 -174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 132' ' ' THR . 8.5 t70 -95.17 136.66 35.23 Favored 'General case' 0 C--N 1.275 -2.65 0 C-N-CA 117.477 -1.689 . . . . 0.0 108.77 175.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 18.9 mmt -63.86 -36.03 82.58 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.16 -32.57 29.95 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.435 0.459 . . . . 0.0 111.829 -175.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.502 ' OG1' ' HB3' ' A' ' 129' ' ' ASP . 72.0 p -94.87 -18.97 20.69 Favored 'General case' 0 C--O 1.249 1.076 0 C-N-CA 119.309 -0.956 . . . . 0.0 111.322 -178.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 76.18 -6.09 38.15 Favored Glycine 0 C--O 1.215 -1.04 0 CA-C-N 116.285 -0.416 . . . . 0.0 113.754 175.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 5.3 ptpp? -107.14 160.41 15.6 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.3 m -62.68 137.83 58.36 Favored 'General case' 0 C--N 1.309 -1.175 0 O-C-N 124.477 1.111 . . . . 0.0 110.895 179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.482 ' HD3' ' HB2' ' A' ' 129' ' ' ASP . 51.0 mtmt -93.03 6.68 47.08 Favored 'General case' 0 CA--C 1.514 -0.442 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 104.34 4.52 43.78 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 119.697 -1.239 . . . . 0.0 115.457 171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -153.97 164.61 38.14 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 118.657 1.228 . . . . 0.0 110.993 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -176.87 -162.77 27.98 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 -178.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -155.03 159.37 40.25 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 117.335 0.568 . . . . 0.0 110.484 -179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 47.8 t -131.58 135.77 58.5 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.296 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 t -100.49 119.71 38.91 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.478 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 42.5 m-85 -102.43 161.2 13.9 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 120.716 0.293 . . . . 0.0 111.564 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -71.09 -35.35 71.79 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.913 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.617 ' HA ' ' O ' ' A' ' 93' ' ' ASN . 18.8 t-20 -139.04 146.96 41.44 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 112.473 0.546 . . . . 0.0 112.473 -178.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -54.82 -49.61 70.59 Favored 'General case' 0 C--N 1.348 0.543 0 C-N-CA 123.33 0.652 . . . . 0.0 112.351 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 89.4 t90 -71.0 -34.57 71.49 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 -177.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.421 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 30.5 t70 -66.16 -39.72 89.99 Favored 'General case' 0 C--N 1.315 -0.901 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.478 ' HB2' ' HB2' ' A' ' 143' ' ' PHE . . . -63.31 -45.66 90.31 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 114.522 -1.217 . . . . 0.0 110.6 174.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.567 ' O ' ' HG2' ' A' ' 154' ' ' GLN . 28.9 tt0 -68.02 -35.81 78.9 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.553 -175.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -62.03 -40.78 96.89 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 123.323 0.649 . . . . 0.0 109.854 175.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.86 -40.21 94.78 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.597 176.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 149' ' ' ALA . 67.8 mt -58.76 -40.26 79.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 123.313 0.383 . . . . 0.0 110.436 178.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 150' ' ' GLU . 73.8 mm-40 -58.56 -47.66 83.49 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.365 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 23.7 tp60 -86.56 -36.71 18.75 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 112.59 0.589 . . . . 0.0 112.59 -177.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 74.8 mmm -96.81 16.18 19.95 Favored 'General case' 0 C--N 1.313 -1.022 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.33 40.38 2.17 Favored Glycine 0 C--N 1.299 -1.479 0 C-N-CA 121.346 -0.454 . . . . 0.0 112.899 178.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 138.21 68.11 0.05 OUTLIER Glycine 0 N--CA 1.42 -2.398 0 C-N-CA 120.082 -1.056 . . . . 0.0 114.345 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 47.6 tp60 -123.51 137.58 54.75 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 177.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 89.7 m95 -70.96 96.38 1.29 Allowed 'General case' 0 N--CA 1.432 -1.353 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.838 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 22.1 tp -111.64 108.7 18.26 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 83.03 -141.71 20.99 Favored Glycine 0 C--N 1.299 -1.523 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -87.28 0.68 85.8 Favored Glycine 0 C--N 1.308 -1.009 0 N-CA-C 114.684 0.633 . . . . 0.0 114.684 -179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.549 ' HD3' ' OD1' ' A' ' 101' ' ' ASP . 70.2 mtt180 -133.22 171.63 13.75 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 117.902 0.851 . . . . 0.0 111.469 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -103.47 108.71 20.08 Favored 'General case' 0 N--CA 1.43 -1.446 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 21.0 pt -83.95 136.75 22.17 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.803 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -174.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 39.3 mtm180 -128.83 149.48 50.73 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.481 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -127.27 156.37 42.02 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 120.544 0.211 . . . . 0.0 111.455 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -156.62 163.04 39.79 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 177.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 16.8 m-90 -65.25 129.46 39.79 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -178.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.441 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . . . -99.84 -43.63 6.35 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 120.935 0.398 . . . . 0.0 110.182 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.526 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 12.7 m -73.85 98.95 3.08 Favored 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 176.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -129.72 111.65 12.86 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.121 -172.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 13.4 mmmm -110.94 118.2 48.67 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.826 -179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -71.6 146.52 49.42 Favored 'Trans proline' 0 C--O 1.254 1.277 0 C-N-CA 121.998 1.799 . . . . 0.0 109.791 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -65.62 141.33 66.12 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.29 1.993 . . . . 0.0 112.214 178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.12 127.17 31.45 Favored Pre-proline 0 C--N 1.296 -1.723 0 CA-C-N 115.139 -0.937 . . . . 0.0 110.23 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -70.06 93.77 0.55 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.075 1.85 . . . . 0.0 109.817 174.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 12.7 ttpp -82.13 80.91 8.24 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.098 -175.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 20.3 m -96.15 102.43 14.22 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.0 p -121.53 -48.98 2.15 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 -173.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -171.02 34.92 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 -174.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -58.98 122.5 13.86 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.676 -1.147 . . . . 0.0 109.993 -173.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 22.0 p -74.68 88.6 2.22 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -173.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -168.38 98.57 0.42 Allowed 'General case' 0 CA--C 1.499 -0.983 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.032 170.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.61 ' HB ' ' OG ' ' A' ' 190' ' ' SER . 14.7 m -77.71 130.38 36.72 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 177.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.53 ' HA ' ' NZ ' ' A' ' 187' ' ' LYS . 0.1 OUTLIER -93.19 70.69 4.48 Favored 'General case' 0 N--CA 1.43 -1.463 0 CA-C-O 122.609 1.195 . . . . 0.0 111.081 -178.882 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 27.8 mt-30 -151.18 -169.87 3.5 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 102.645 -3.094 . . . . 0.0 102.645 178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 52.6 mt -84.36 82.43 8.39 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 118.414 -1.314 . . . . 0.0 108.844 174.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.61 ' OG ' ' HB ' ' A' ' 186' ' ' THR . 10.9 m -76.91 130.85 38.12 Favored 'General case' 0 C--N 1.294 -1.824 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 179.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -50.02 -42.17 48.79 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.014 0.526 . . . . 0.0 111.822 -177.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.8 -48.29 81.27 Favored 'General case' 0 C--N 1.306 -1.309 0 C-N-CA 124.222 1.009 . . . . 0.0 110.835 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.521 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 43.0 tt0 -69.82 -39.98 76.15 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.674 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 190' ' ' SER . 95.0 t -65.68 -42.9 93.67 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 122.66 0.384 . . . . 0.0 111.88 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.17 -27.38 40.58 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 CA-C-O 121.314 0.578 . . . . 0.0 110.34 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -83.88 -2.31 56.2 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.208 -0.451 . . . . 0.0 112.049 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.521 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 76.8 mt-30 -84.05 -2.55 56.9 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.044 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 58.6 m -150.5 161.31 42.78 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-O 120.854 0.359 . . . . 0.0 110.669 176.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 13.5 m -70.73 142.45 88.47 Favored Pre-proline 0 N--CA 1.424 -1.768 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 175.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -55.64 -12.01 5.78 Favored 'Trans proline' 0 N--CA 1.491 1.333 0 C-N-CA 124.017 3.145 . . . . 0.0 115.08 -176.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.83 45.97 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 122.088 -0.383 . . . . 0.0 111.104 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -78.61 123.21 26.87 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.314 -0.554 . . . . 0.0 109.85 177.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 76.5 m -119.75 10.58 11.7 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.072 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 17.0 m -98.2 131.81 44.24 Favored 'General case' 0 N--CA 1.44 -0.946 0 CA-C-O 121.452 0.644 . . . . 0.0 112.609 -175.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 88.8 t -104.73 136.39 38.54 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 C-N-CA 124.455 1.102 . . . . 0.0 109.031 176.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 46.4 t80 -96.97 110.32 22.88 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 44.7 t -109.04 117.95 35.52 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -127.36 149.2 17.78 Favored Glycine 0 C--N 1.307 -1.072 0 C-N-CA 120.042 -1.075 . . . . 0.0 111.641 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 142.18 -34.85 1.8 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.703 -0.76 . . . . 0.0 113.146 178.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.474 ' HB ' HD13 ' A' ' 214' ' ' LEU . 21.4 t -89.51 102.81 13.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 O-C-N 122.311 -0.523 . . . . 0.0 110.509 -177.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 14.9 p -85.04 -22.35 29.05 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.684 0.754 . . . . 0.0 111.92 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.8 m -140.87 137.21 33.05 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.314 -0.866 . . . . 0.0 111.609 -178.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 88.06 5.38 76.94 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 121.08 -0.581 . . . . 0.0 111.824 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.474 HD13 ' HB ' ' A' ' 210' ' ' VAL . 52.1 tp -73.43 96.95 2.45 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.273 0.559 . . . . 0.0 110.147 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.8 p -108.61 169.58 8.56 Favored 'General case' 0 C--N 1.297 -1.7 0 CA-C-N 115.31 -0.859 . . . . 0.0 109.616 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.58 ' HA ' HG21 ' A' ' 232' ' ' ILE . 0.0 OUTLIER -67.83 -40.86 83.69 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-O 121.275 0.56 . . . . 0.0 111.267 178.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 7.1 pt20 -65.05 -38.75 91.88 Favored 'General case' 0 C--N 1.309 -1.155 0 C-N-CA 123.785 0.834 . . . . 0.0 112.266 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 42.7 tp -59.34 -45.81 90.33 Favored 'General case' 0 N--CA 1.449 -0.508 0 O-C-N 123.244 0.34 . . . . 0.0 110.8 179.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.451 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 30.3 mmt -72.97 -44.96 60.49 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.436 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 38.3 ttp-105 -56.06 -49.23 74.35 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.512 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -60.76 -41.27 95.12 Favored 'General case' 0 C--O 1.22 -0.483 0 O-C-N 123.439 0.462 . . . . 0.0 110.897 -179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.3 m -71.73 -47.6 52.74 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.995 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.451 ' HD1' ' O ' ' A' ' 219' ' ' MET 0.297 89.5 m-85 -69.49 -32.35 71.18 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 115.119 1.525 . . . . 0.0 115.119 -177.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.7 m -47.07 -48.1 54.11 Favored Pre-proline 0 CA--C 1.577 2.006 0 N-CA-C 115.596 1.702 . . . . 0.0 115.596 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.95 -13.86 39.89 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 121.611 1.541 . . . . 0.0 113.375 176.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -94.0 -32.24 13.92 Favored 'General case' 0 C--O 1.246 0.882 0 N-CA-C 110.075 -0.342 . . . . 0.0 110.075 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.531 ' HA3' ' HB2' ' A' ' 250' ' ' SER . . . -176.53 178.58 47.83 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.097 -1.049 . . . . 0.0 113.187 175.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -79.73 125.44 29.66 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 -177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 39.9 mm -91.65 132.04 37.17 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.693 -174.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 96.0 mmm -113.84 -38.91 4.11 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.201 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.518 ' OE2' ' HD3' ' A' ' 244' ' ' ARG . 48.8 mt-10 -138.64 144.92 39.91 Favored 'General case' 0 CA--C 1.498 -1.025 0 CA-C-O 120.673 0.273 . . . . 0.0 110.798 -176.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.58 HG21 ' HA ' ' A' ' 216' ' ' GLU . 34.5 mm -134.07 113.76 18.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.412 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 175.218 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.433 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 51.8 mtt180 -116.13 124.92 51.54 Favored 'General case' 0 CA--C 1.47 -2.112 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 177.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.52 143.8 37.79 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.23 0 C-N-CA 120.34 -0.544 . . . . 0.0 112.055 -175.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -141.89 82.94 13.19 Favored Pre-proline 0 N--CA 1.443 -0.818 0 N-CA-C 107.725 -1.213 . . . . 0.0 107.725 177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.55 -27.18 69.74 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.662 2.241 . . . . 0.0 112.606 -176.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 15.7 p-10 -72.08 -21.43 61.51 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.717 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.415 ' HB2' ' CD1' ' A' ' 240' ' ' TYR . 11.0 mptt -106.75 -7.05 17.4 Favored 'General case' 0 N--CA 1.464 0.265 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 172.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.61 32.78 57.04 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.349 -0.841 . . . . 0.0 114.642 178.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.435 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 14.6 p90 -144.24 164.85 29.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 118.002 0.901 . . . . 0.0 111.152 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.1 p -146.79 158.44 43.91 Favored 'General case' 0 N--CA 1.42 -1.952 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.535 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.435 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 76.1 m-85 -115.35 118.38 33.09 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 173.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 88.5 t -109.36 117.3 54.19 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.532 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.518 ' HD3' ' OE2' ' A' ' 231' ' ' GLU . 11.1 ttp180 -102.08 136.68 41.49 Favored 'General case' 0 N--CA 1.419 -1.976 0 C-N-CA 118.739 -1.185 . . . . 0.0 108.907 -179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -101.61 169.75 8.64 Favored 'General case' 0 N--CA 1.405 -2.697 0 CA-C-N 114.886 -1.052 . . . . 0.0 108.418 178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -74.54 -43.96 53.3 Favored 'General case' 0 C--N 1.275 -2.661 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.537 178.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.506 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 16.2 m -123.16 164.57 18.42 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.072 -174.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 78.1 t60 -76.26 -37.63 57.33 Favored 'General case' 0 C--N 1.317 -0.814 0 C-N-CA 123.622 0.769 . . . . 0.0 112.581 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.506 ' OE2' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -65.67 -45.6 82.32 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.193 0.52 . . . . 0.0 111.4 -173.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB2' ' HA3' ' A' ' 227' ' ' GLY . 3.8 p -65.46 -30.33 71.11 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.536 0.735 . . . . 0.0 111.715 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -69.26 -42.07 76.06 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.892 178.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.45 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.39 -39.87 89.32 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -45.58 87.93 Favored 'General case' 0 C--O 1.24 0.572 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.792 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.54 -48.39 81.85 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.586 -178.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 96.7 mt -56.28 -49.65 75.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.03 -179.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 252' ' ' ALA . 62.6 t -61.41 -43.51 96.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.834 -176.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 25.8 t -84.55 -35.93 22.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 71.3 t -77.22 -18.22 14.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 120.938 0.399 . . . . 0.0 111.08 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -61.23 98.11 0.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.168 0.508 . . . . 0.0 111.76 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.44 15.28 23.54 Favored Glycine 0 C--N 1.301 -1.377 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.414 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 40.4 p -90.38 -179.85 5.71 Favored 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.894 -0.722 . . . . 0.0 110.136 178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.4 m -132.87 116.95 17.13 Favored 'General case' 0 N--CA 1.425 -1.689 0 O-C-N 121.606 -0.684 . . . . 0.0 110.045 -178.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 65.4 mt -109.38 122.27 63.74 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 46.72 37.84 5.14 Favored 'General case' 0 C--N 1.3 -1.552 0 C-N-CA 125.396 1.479 . . . . 0.0 113.028 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 92.29 -12.0 70.72 Favored Glycine 0 C--O 1.223 -0.569 0 C-N-CA 120.884 -0.674 . . . . 0.0 112.927 178.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -96.14 122.64 39.21 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 57.9 t -72.06 120.32 20.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.1 m -110.71 142.24 23.71 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-O 121.919 0.866 . . . . 0.0 112.203 -175.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 54.7 tttm -130.27 146.8 51.92 Favored 'General case' 0 C--N 1.288 -2.085 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 91.2 m -121.06 155.94 33.29 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -145.97 -173.72 4.23 Favored 'General case' 0 C--N 1.314 -0.953 0 C-N-CA 126.89 2.076 . . . . 0.0 106.758 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 93.8 m95 -81.08 148.11 29.8 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -123.07 -163.28 11.75 Favored Glycine 0 N--CA 1.426 -1.969 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 119.046 -0.502 . . . . 0.0 110.7 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.436 ' HA3' ' C ' ' A' ' 94' ' ' HIS . . . . . . . . 0 CA--C 1.492 -1.372 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -101.19 101.27 11.94 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 17.3 tpt 72.67 -53.48 0.7 Allowed 'General case' 0 N--CA 1.486 1.359 0 C-N-CA 124.95 1.3 . . . . 0.0 110.604 -177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -87.53 -170.33 2.97 Favored 'General case' 0 C--O 1.257 1.489 0 CA-C-O 121.443 0.639 . . . . 0.0 109.677 178.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 28.7 p-10 -77.84 -18.69 56.02 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 122.068 -0.395 . . . . 0.0 110.15 -176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.436 ' C ' ' HA3' ' A' ' 89' ' ' GLY . 53.0 p-80 -125.52 169.59 12.28 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.053 -177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -115.11 131.79 56.81 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 104.107 -2.553 . . . . 0.0 104.107 172.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -102.84 117.5 34.76 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-O 120.958 0.409 . . . . 0.0 110.226 -173.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 85.1 t -114.05 138.14 44.91 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.442 ' HD1' ' CE1' ' A' ' 140' ' ' PHE . 67.5 t80 -96.82 126.02 41.68 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 46.5 t -111.49 129.12 67.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -138.62 177.26 20.28 Favored Glycine 0 N--CA 1.428 -1.853 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.3 t0 65.84 34.3 7.42 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 122.966 1.365 . . . . 0.0 107.651 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.415 HD23 HG21 ' A' ' 166' ' ' ILE . 98.3 mt -79.15 131.28 36.16 Favored 'General case' 0 CA--C 1.493 -1.222 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.544 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.447 ' HB2' ' HB3' ' A' ' 164' ' ' ARG . 7.3 t -98.17 150.76 37.07 Favored Pre-proline 0 C--N 1.283 -2.298 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 -178.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -52.99 -18.34 9.37 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 124.106 3.204 . . . . 0.0 115.64 -176.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -69.32 -20.82 63.87 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.418 ' CD1' ' HG ' ' A' ' 161' ' ' LEU . 44.3 mm -107.81 140.86 24.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.412 -174.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.645 HG22 ' OD2' ' A' ' 110' ' ' ASP . 6.0 t -138.6 176.99 8.21 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 124.374 1.07 . . . . 0.0 109.584 176.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.455 HG23 ' HA ' ' A' ' 125' ' ' ARG . 30.2 m -52.93 -44.86 67.36 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 124.6 1.16 . . . . 0.0 111.275 -176.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.445 ' CD ' ' HZ1' ' A' ' 128' ' ' LYS . 16.1 mp0 -67.33 -36.65 81.88 Favored 'General case' 0 C--N 1.286 -2.155 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.31 -177.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.645 ' OD2' HG22 ' A' ' 107' ' ' THR . 32.8 m-20 -67.13 -42.3 84.65 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 177.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.51 HD12 ' CG2' ' A' ' 126' ' ' VAL . 14.1 mt -58.34 -45.62 89.39 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.167 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -57.54 -45.61 84.87 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 123.475 0.484 . . . . 0.0 111.527 -178.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.73 -43.67 68.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 116.147 -0.479 . . . . 0.0 112.06 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -69.69 -37.0 76.47 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 -174.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 33.5 m-85 -86.76 -18.64 30.61 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -177.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.43 ' N ' ' HD2' ' A' ' 117' ' ' PRO . . . -54.7 -39.95 79.89 Favored Pre-proline 0 CA--C 1.57 1.719 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 116' ' ' ALA . 18.8 Cg_endo -64.0 -26.68 66.15 Favored 'Trans proline' 0 C--N 1.376 1.977 0 C-N-CA 121.502 1.468 . . . . 0.0 112.527 174.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -86.45 -42.78 13.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.603 0.239 . . . . 0.0 110.448 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -152.34 148.82 20.2 Favored Glycine 0 N--CA 1.428 -1.898 0 N-CA-C 111.341 -0.704 . . . . 0.0 111.341 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.567 ' HD2' ' OD2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -71.15 121.61 18.63 Favored 'General case' 0 N--CA 1.43 -1.455 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 177.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.8 mm -93.57 123.28 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.696 0 N-CA-C 107.234 -1.395 . . . . 0.0 107.234 -175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.4 t -82.41 -39.2 22.98 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 106.311 -1.737 . . . . 0.0 106.311 174.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -166.88 161.88 15.5 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 114.233 -1.349 . . . . 0.0 108.785 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -152.53 147.71 26.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.734 -1.95 . . . . 0.0 105.734 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.455 ' HA ' HG23 ' A' ' 108' ' ' THR . 4.2 ptp85 -153.22 136.06 15.38 Favored 'General case' 0 C--N 1.297 -1.677 0 C-N-CA 119.884 -0.726 . . . . 0.0 110.666 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.51 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -122.53 145.46 29.27 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.98 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 57.4 t -71.57 112.03 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.818 0 N-CA-C 103.738 -2.689 . . . . 0.0 103.738 169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.445 ' HZ1' ' CD ' ' A' ' 109' ' ' GLU . 1.6 ptpp? -123.55 166.1 16.02 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.528 -171.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -89.0 119.88 29.92 Favored 'General case' 0 C--N 1.282 -2.366 0 C-N-CA 123.944 0.897 . . . . 0.0 109.164 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 95.8 mmm -63.19 -17.42 62.39 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -91.09 -41.14 11.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 118.114 0.415 . . . . 0.0 111.376 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 18.7 p -95.09 -24.3 16.93 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.26 0.552 . . . . 0.0 111.464 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 79.48 11.17 85.14 Favored Glycine 0 N--CA 1.429 -1.768 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 -177.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.464 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 31.4 mmmt -105.57 169.31 8.54 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-N 116.761 0.28 . . . . 0.0 110.602 -177.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 78.3 p -69.4 161.47 29.33 Favored 'General case' 0 C--N 1.315 -0.924 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -172.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -100.88 -4.22 28.2 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.328 169.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 124.73 -12.64 7.78 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 119.616 -1.278 . . . . 0.0 115.722 176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 37.5 p90 -154.59 158.29 39.53 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 118.99 1.395 . . . . 0.0 112.477 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.11 -163.76 22.62 Favored Glycine 0 N--CA 1.434 -1.474 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.699 -178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.442 ' CE1' ' HD1' ' A' ' 98' ' ' PHE . 90.7 m-85 -142.76 151.06 40.85 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.036 0.934 . . . . 0.0 108.864 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 44.8 t -130.31 137.62 55.86 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 174.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -113.47 116.47 29.65 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 92.1 m-85 -101.04 150.81 22.52 Favored 'General case' 0 C--N 1.307 -1.263 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -69.69 -38.88 77.18 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 121.465 0.65 . . . . 0.0 111.254 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -121.37 154.93 35.82 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.539 ' HG2' ' OE1' ' A' ' 150' ' ' GLU . 59.1 tttm -58.76 -52.56 65.18 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.56 -1.2 . . . . 0.0 112.61 -175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 78.4 m95 -65.93 -27.85 68.48 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.789 -174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.567 ' OD2' ' HD2' ' A' ' 120' ' ' ARG . 2.0 m-20 -63.65 -44.04 95.0 Favored 'General case' 0 CA--C 1.503 -0.828 0 CA-C-O 121.69 0.757 . . . . 0.0 109.481 177.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.421 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.07 -46.49 67.7 Favored 'General case' 0 N--CA 1.438 -1.05 0 CA-C-N 114.634 -1.166 . . . . 0.0 111.158 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . 0.539 ' OE1' ' HG2' ' A' ' 146' ' ' LYS . 46.9 mt-10 -62.82 -40.48 97.55 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.67 -0.696 . . . . 0.0 111.122 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -61.35 -42.97 99.56 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 121.158 0.504 . . . . 0.0 109.68 178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -65.62 -40.36 92.5 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.111 178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.489 ' O ' ' HA3' ' A' ' 157' ' ' GLY . 76.9 mt -65.17 -45.44 93.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.685 0 C-N-CA 121.054 -0.258 . . . . 0.0 110.615 177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -68.62 -53.38 22.91 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 54.5 tp60 -87.19 -39.35 15.56 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -169.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.433 ' SD ' ' HB3' ' A' ' 159' ' ' GLN . 10.3 tpt -97.42 7.42 46.56 Favored 'General case' 0 N--CA 1.427 -1.605 0 CA-C-O 122.925 1.345 . . . . 0.0 109.09 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 153' ' ' ILE . . . -79.75 68.31 3.23 Favored Glycine 0 N--CA 1.428 -1.851 0 CA-C-N 114.802 -1.09 . . . . 0.0 113.499 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 122.37 31.52 1.06 Allowed Glycine 0 N--CA 1.427 -1.949 0 CA-C-N 115.483 -0.358 . . . . 0.0 112.245 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 165' ' ' GLN . 6.5 tp-100 -96.74 146.89 24.47 Favored 'General case' 0 N--CA 1.422 -1.846 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -74.05 89.85 1.97 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 123.807 0.692 . . . . 0.0 111.253 -177.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.418 ' HG ' ' CD1' ' A' ' 106' ' ' ILE . 46.5 tp -99.03 108.94 21.74 Favored 'General case' 0 N--CA 1.424 -1.764 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 175.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 91.15 -127.81 9.03 Favored Glycine 0 N--CA 1.435 -1.392 0 N-CA-C 108.246 -1.942 . . . . 0.0 108.246 -174.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -110.31 11.28 31.1 Favored Glycine 0 C--N 1.303 -1.257 0 C-N-CA 120.475 -0.869 . . . . 0.0 111.141 175.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.447 ' HB3' ' HB2' ' A' ' 103' ' ' SER . 26.8 tpt180 -141.67 144.01 33.89 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-O 121.221 0.534 . . . . 0.0 111.129 -176.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 159' ' ' GLN . 4.5 pt20 -85.98 121.05 28.05 Favored 'General case' 0 N--CA 1.433 -1.325 0 N-CA-C 107.853 -1.165 . . . . 0.0 107.853 174.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.415 HG21 HD23 ' A' ' 102' ' ' LEU . 2.3 pp -88.88 164.6 2.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.977 -173.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.44 ' NE ' ' H ' ' A' ' 168' ' ' THR . 6.3 tpm_? -115.07 147.58 40.0 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.44 ' H ' ' NE ' ' A' ' 167' ' ' ARG . 18.6 p -131.84 150.06 52.27 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -162.13 163.25 28.61 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 30.3 p-90 -71.09 132.32 44.91 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.44 83.4 5.45 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -172.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 8.0 t -72.37 -28.42 63.01 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 41.8 ttm180 69.9 -53.8 0.62 Allowed 'General case' 0 C--N 1.357 0.903 0 C-N-CA 125.746 1.619 . . . . 0.0 111.98 177.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -110.61 140.21 22.36 Favored Pre-proline 0 C--N 1.297 -1.704 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.683 178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.8 160.6 24.54 Favored 'Trans proline' 0 C--O 1.256 1.416 0 C-N-CA 122.614 2.209 . . . . 0.0 111.667 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -78.4 149.4 24.44 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 122.303 2.002 . . . . 0.0 110.573 172.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.43 ' HA ' ' HD3' ' A' ' 178' ' ' PRO . . . -101.34 123.47 44.55 Favored Pre-proline 0 C--N 1.315 -0.912 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 177' ' ' ALA . 46.7 Cg_endo -96.24 109.1 0.11 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 C-N-CA 122.484 2.122 . . . . 0.0 112.667 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -137.36 150.93 48.06 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-O 121.729 0.775 . . . . 0.0 112.368 176.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 30.1 t -113.87 -175.44 2.68 Favored 'General case' 0 N--CA 1.411 -2.393 0 N-CA-C 102.841 -3.022 . . . . 0.0 102.841 166.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 16.7 m -130.95 95.09 3.74 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 119.128 0.876 . . . . 0.0 109.506 179.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -135.27 -13.09 2.09 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-N 114.344 -1.298 . . . . 0.0 109.554 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 183' ' ' GLU . 1.4 pm0 -93.38 -41.08 10.03 Favored 'General case' 0 C--N 1.279 -2.485 0 CA-C-N 113.81 -1.541 . . . . 0.0 111.462 -177.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 17.9 m -83.82 -20.33 33.4 Favored 'General case' 0 C--N 1.284 -2.248 0 CA-C-N 114.852 -1.067 . . . . 0.0 109.879 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -94.79 143.19 26.65 Favored 'General case' 0 C--N 1.309 -1.159 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.912 -179.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 30.8 m 42.98 81.22 0.03 OUTLIER 'General case' 0 C--O 1.251 1.178 0 C-N-CA 126.549 1.939 . . . . 0.0 115.313 176.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -131.65 6.42 4.38 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -174.14 -172.75 0.73 Allowed 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 102.767 -3.049 . . . . 0.0 102.767 -177.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 74.2 mt -112.34 93.56 4.5 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 171.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.47 ' O ' HG23 ' A' ' 194' ' ' VAL . 4.3 m -73.48 144.84 46.06 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.522 -1.288 . . . . 0.0 107.522 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -53.15 -41.8 65.5 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.569 0.348 . . . . 0.0 110.271 -178.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.32 -49.6 66.71 Favored 'General case' 0 C--N 1.307 -1.239 0 C-N-CA 125.797 1.639 . . . . 0.0 110.244 177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -66.39 -45.43 80.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.001 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 190' ' ' SER . 58.6 t -63.21 -47.58 91.59 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.988 -177.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.401 HG23 ' CD2' ' A' ' 248' ' ' HIS . 9.8 p -68.49 -29.65 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.985 0 CA-C-O 121.239 0.542 . . . . 0.0 111.337 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 36.0 m-80 -86.85 -2.62 58.73 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.228 0.537 . . . . 0.0 111.699 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -93.87 5.02 53.01 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 57.6 m -152.19 163.32 39.63 Favored 'General case' 0 C--N 1.294 -1.804 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.647 174.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.4 m -74.3 142.27 78.26 Favored Pre-proline 0 N--CA 1.429 -1.508 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 176.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.11 -12.01 6.76 Favored 'Trans proline' 0 N--CA 1.493 1.462 0 C-N-CA 124.056 3.17 . . . . 0.0 115.014 -176.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.0 p -90.01 -14.56 33.7 Favored 'General case' 0 N--CA 1.428 -1.527 0 O-C-N 122.005 -0.434 . . . . 0.0 111.55 178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -78.7 123.61 27.33 Favored 'General case' 0 CA--C 1.516 -0.338 0 C-N-CA 120.839 -0.345 . . . . 0.0 111.229 179.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 78.7 m -120.19 24.21 10.55 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.172 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.5 m -94.19 120.62 34.69 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 121.074 0.464 . . . . 0.0 112.037 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 70.8 t -113.1 136.67 48.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 C-N-CA 122.83 0.452 . . . . 0.0 110.661 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -117.8 118.81 33.06 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 123.288 0.635 . . . . 0.0 109.942 179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.579 ' SG ' ' HB2' ' A' ' 241' ' ' SER . 22.0 p -118.98 131.6 56.02 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.37 150.74 19.92 Favored Glycine 0 C--N 1.306 -1.089 0 C-N-CA 120.495 -0.86 . . . . 0.0 111.636 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 147.39 -40.74 0.97 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.842 -0.694 . . . . 0.0 113.3 177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.526 ' HB ' HD13 ' A' ' 214' ' ' LEU . 18.0 t -91.75 103.54 14.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 O-C-N 122.509 -0.406 . . . . 0.0 110.492 -175.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 22.1 p -84.83 -25.79 27.86 Favored 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 121.704 0.764 . . . . 0.0 111.292 178.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 38.7 m -128.66 129.32 45.67 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.728 -0.607 . . . . 0.0 111.023 -176.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 92.27 4.26 66.59 Favored Glycine 0 CA--C 1.51 -0.231 0 N-CA-C 111.115 -0.794 . . . . 0.0 111.115 -178.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.544 HD12 ' SD ' ' A' ' 219' ' ' MET . 21.1 tp -72.25 106.31 4.37 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 15.0 p -127.93 155.3 44.44 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 -177.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.83 -34.06 75.26 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 120.649 -0.421 . . . . 0.0 111.351 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 221' ' ' GLN . 5.3 tp-100 -65.19 -49.43 69.79 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 123.799 0.84 . . . . 0.0 111.246 177.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 32.2 tp -62.13 -41.46 98.27 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.07 -176.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.544 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -67.47 -41.54 84.48 Favored 'General case' 0 C--N 1.31 -1.112 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.021 178.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.449 HH21 ' CD ' ' A' ' 217' ' ' GLN . 30.7 ttp180 -58.08 -47.35 83.48 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.726 177.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . 0.512 ' HG2' ' O ' ' A' ' 217' ' ' GLN . 15.2 mm100 -58.89 -36.19 74.27 Favored 'General case' 0 C--N 1.322 -0.6 0 O-C-N 123.403 0.439 . . . . 0.0 111.349 178.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 28.2 m -77.16 -49.71 14.6 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.463 -177.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -68.82 -33.63 74.17 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 58.6 m -47.87 -52.14 41.7 Favored Pre-proline 0 CA--C 1.565 1.538 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.27 -13.36 37.65 Favored 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 121.745 1.63 . . . . 0.0 113.563 176.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 22.8 m-85 -95.86 -36.95 10.93 Favored 'General case' 0 C--O 1.242 0.693 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.426 -177.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -165.08 177.14 40.66 Favored Glycine 0 N--CA 1.437 -1.275 0 C-N-CA 118.771 -1.681 . . . . 0.0 113.977 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 246' ' ' ASN . 43.0 mt-30 -84.13 115.56 22.46 Favored 'General case' 0 N--CA 1.433 -1.278 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 -178.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 61.1 mt -90.31 136.01 24.99 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.002 0 O-C-N 123.64 0.588 . . . . 0.0 112.054 -174.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 22.6 mtt -99.6 -39.15 8.44 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.613 173.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.497 ' CG ' ' HB3' ' A' ' 244' ' ' ARG . 11.5 pt-20 -160.95 156.43 24.84 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.678 -178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 19.0 mm -125.5 120.88 58.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -119.47 126.07 50.42 Favored 'General case' 0 CA--C 1.488 -1.408 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 174.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 19.6 m -125.78 144.4 35.99 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.212 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -139.83 89.35 11.52 Favored Pre-proline 0 C--N 1.317 -0.846 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.24 -15.11 42.07 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.944 2.429 . . . . 0.0 113.087 -176.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.438 ' C ' ' HD2' ' A' ' 238' ' ' LYS . 4.1 t70 -64.19 -38.2 90.21 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.951 -176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.438 ' HD2' ' C ' ' A' ' 237' ' ' ASP . 12.9 mptt -111.74 -4.34 14.7 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.135 0.493 . . . . 0.0 111.71 172.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.77 44.33 25.65 Favored Glycine 0 N--CA 1.44 -1.042 0 CA-C-N 115.393 -0.821 . . . . 0.0 114.385 177.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 20.7 p90 -137.17 163.45 30.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 117.067 0.434 . . . . 0.0 110.973 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.579 ' HB2' ' SG ' ' A' ' 207' ' ' CYS . 15.3 m -143.3 155.27 44.42 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 116.475 -0.329 . . . . 0.0 110.233 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -122.55 118.41 28.18 Favored 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 92.9 t -115.81 127.02 73.53 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.378 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.497 ' HB3' ' CG ' ' A' ' 231' ' ' GLU . 44.7 ttt180 -102.14 132.22 48.16 Favored 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -103.08 169.31 8.64 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.611 -179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 228' ' ' GLN . 34.1 t30 -75.88 -38.37 57.91 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.224 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -137.16 165.05 27.01 Favored 'General case' 0 N--CA 1.419 -1.978 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.13 -175.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . 0.401 ' CD2' HG23 ' A' ' 195' ' ' VAL . 72.3 t60 -71.48 -37.15 71.34 Favored 'General case' 0 C--N 1.313 -0.985 0 C-N-CA 123.324 0.649 . . . . 0.0 110.498 -173.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.524 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -60.59 -44.9 95.72 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 52.1 m -59.53 -42.36 92.13 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.312 -1.313 . . . . 0.0 110.28 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -71.3 -43.13 67.71 Favored 'General case' 0 N--CA 1.445 -0.708 0 CA-C-N 115.657 -0.702 . . . . 0.0 111.59 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -67.06 -41.22 86.83 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.948 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -63.24 -38.57 91.68 Favored 'General case' 0 C--O 1.239 0.552 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.074 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.76 -49.46 77.62 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.161 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.578 ' HA ' ' SG ' ' A' ' 270' ' ' CYS . 93.7 mt -57.71 -49.55 80.39 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.163 -179.12 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 252' ' ' ALA . 87.1 t -55.47 -43.07 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 O-C-N 123.843 0.714 . . . . 0.0 111.188 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 21.0 m -80.24 -39.81 28.28 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 115.306 -0.861 . . . . 0.0 112.311 -174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.7 t -76.29 -22.52 15.52 Favored 'Isoleucine or valine' 0 C--O 1.243 0.712 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 -177.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -65.83 99.53 0.48 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.476 0.655 . . . . 0.0 111.861 179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.65 14.42 25.41 Favored Glycine 0 C--N 1.303 -1.287 0 CA-C-N 115.061 -0.972 . . . . 0.0 112.544 176.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 21.5 p -94.37 178.39 5.63 Favored 'General case' 0 C--N 1.31 -1.113 0 C-N-CA 119.49 -0.884 . . . . 0.0 110.714 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 28.0 m -134.12 120.59 20.33 Favored 'General case' 0 N--CA 1.424 -1.753 0 O-C-N 121.911 -0.493 . . . . 0.0 109.83 -178.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 69.9 mt -113.37 123.66 69.23 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 46.28 37.03 3.69 Favored 'General case' 0 C--N 1.302 -1.494 0 C-N-CA 125.895 1.678 . . . . 0.0 113.414 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 95.39 -16.56 61.02 Favored Glycine 0 C--O 1.226 -0.397 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.759 178.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . 0.431 ' HB2' HG22 ' A' ' 210' ' ' VAL . 44.4 m-70 -93.28 119.09 32.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 110.11 -0.33 . . . . 0.0 110.11 -179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 58.2 t -70.03 126.76 30.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 30.3 m -108.42 142.76 20.2 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 122.573 1.178 . . . . 0.0 113.52 -175.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.546 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 15.3 tppt? -115.91 132.36 56.67 Favored 'General case' 0 C--N 1.289 -2.03 0 CA-C-N 113.806 -1.543 . . . . 0.0 108.233 177.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.578 ' SG ' ' HA ' ' A' ' 255' ' ' ILE . 16.5 t -123.75 144.78 49.47 Favored 'General case' 0 N--CA 1.431 -1.386 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.596 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.546 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 38.4 m-85 -152.07 -172.32 4.19 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.996 1.719 . . . . 0.0 107.395 175.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -77.19 145.61 37.54 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.624 ' O ' ' HG3' ' A' ' 274' ' ' LYS . . . -101.19 44.98 1.46 Allowed Glycine 0 C--N 1.305 -1.182 0 N-CA-C 110.299 -1.12 . . . . 0.0 110.299 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.624 ' HG3' ' O ' ' A' ' 273' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.315 -0.929 0 C-N-CA 127.592 2.357 . . . . 0.0 108.846 -174.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.389 0 N-CA-C 110.094 -1.202 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -60.56 -53.18 60.58 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 27.4 ptt? -78.33 158.85 28.69 Favored 'General case' 0 C--O 1.265 1.915 0 CA-C-N 115.337 -0.847 . . . . 0.0 108.917 174.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 72.59 171.71 0.31 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.111 1.364 . . . . 0.0 111.13 -177.084 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.2 t30 -82.4 -17.32 45.87 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.35 0.595 . . . . 0.0 110.327 -177.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -92.78 141.34 28.56 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.256 -172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -126.68 143.28 51.28 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 -177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 35.3 m-70 -109.15 133.53 52.89 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 -175.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 48.8 t -108.41 136.12 45.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.168 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -95.91 125.99 40.86 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 19.9 t -106.08 124.65 61.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -177.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -108.47 154.96 16.36 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.334 -176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . 0.284 28.4 t70 48.08 66.24 1.1 Allowed 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 126.156 1.782 . . . . 0.0 112.353 -175.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 102' ' ' LEU . 43.9 mt -87.71 108.73 19.25 Favored 'General case' 0 N--CA 1.401 -2.901 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.304 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.404 ' HA ' ' HD2' ' A' ' 104' ' ' PRO . 5.2 m -63.99 130.31 94.43 Favored Pre-proline 0 N--CA 1.396 -3.164 0 CA-C-N 113.26 -1.791 . . . . 0.0 109.47 -176.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.604 ' HD2' ' NH2' ' A' ' 164' ' ' ARG . 1.3 Cg_endo -52.11 -21.48 12.79 Favored 'Trans proline' 0 C--N 1.36 1.149 0 C-N-CA 122.684 2.256 . . . . 0.0 112.045 172.264 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -65.81 -21.07 66.46 Favored 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.546 HD11 ' HA3' ' A' ' 162' ' ' GLY . 35.0 mm -104.13 154.4 6.02 Favored 'Isoleucine or valine' 0 C--O 1.251 1.161 0 C-N-CA 125.738 1.615 . . . . 0.0 109.481 -176.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.8 t -129.22 172.65 11.24 Favored 'General case' 0 N--CA 1.426 -1.674 0 C-N-CA 123.166 0.587 . . . . 0.0 109.684 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.555 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 30.9 m -57.55 -32.67 67.34 Favored 'General case' 0 C--N 1.319 -0.744 0 C-N-CA 123.754 0.821 . . . . 0.0 111.39 -178.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.555 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.7 mp0 -65.21 -38.05 89.2 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.554 -1.203 . . . . 0.0 110.727 -177.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -62.04 -46.6 88.45 Favored 'General case' 0 CA--C 1.497 -1.088 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 176.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.487 HD12 ' CG2' ' A' ' 126' ' ' VAL . 13.8 mt -58.38 -45.34 89.65 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.342 179.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -57.77 -44.79 86.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.76 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.94 69.41 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 116.107 -0.497 . . . . 0.0 112.244 178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.5 -42.48 87.33 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.959 0.725 . . . . 0.0 112.959 -176.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.458 ' CD1' HG23 ' A' ' 111' ' ' ILE . 39.3 m-85 -83.57 -19.58 35.33 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -176.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.06 -49.28 88.33 Favored Pre-proline 0 CA--C 1.56 1.34 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -177.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -64.98 -11.33 29.25 Favored 'Trans proline' 0 C--N 1.376 2.025 0 C-N-CA 122.041 1.827 . . . . 0.0 113.693 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 34.1 m-85 -99.23 -28.07 13.5 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 120.635 -0.426 . . . . 0.0 111.566 -177.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -170.31 159.8 32.34 Favored Glycine 0 N--CA 1.43 -1.753 0 C-N-CA 120.14 -1.028 . . . . 0.0 111.774 -179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 82.1 mtm180 -78.25 120.72 23.43 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 61.2 mt -99.79 132.0 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.046 0 N-CA-C 107.821 -1.177 . . . . 0.0 107.821 -175.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.3 m -84.1 -39.35 19.62 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 175.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.413 ' OD2' ' HD2' ' A' ' 125' ' ' ARG . 23.4 t0 -166.27 159.02 14.58 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.377 -1.283 . . . . 0.0 109.498 177.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.19 140.24 24.06 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 104.952 -2.24 . . . . 0.0 104.952 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.413 ' HD2' ' OD2' ' A' ' 123' ' ' ASP . 8.1 ptm180 -154.5 140.45 18.27 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 123.638 0.586 . . . . 0.0 111.429 -175.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.487 ' CG2' HD12 ' A' ' 111' ' ' ILE . 59.1 t -121.08 146.57 25.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.832 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 -177.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 65.0 t -79.92 104.82 8.61 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.262 0 N-CA-C 104.221 -2.511 . . . . 0.0 104.221 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -128.41 165.82 19.9 Favored 'General case' 0 C--N 1.278 -2.504 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.334 -174.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.493 ' HA ' ' NZ ' ' A' ' 136' ' ' LYS . 29.7 t70 -69.65 131.21 44.26 Favored 'General case' 0 C--N 1.285 -2.236 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.589 177.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -62.52 -37.41 85.95 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 124.3 1.04 . . . . 0.0 113.198 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.51 -42.12 9.89 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -173.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 41.5 p -94.9 -14.11 24.81 Favored 'General case' 0 C--O 1.259 1.553 0 CA-C-O 121.23 0.538 . . . . 0.0 111.947 -176.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 69.06 20.75 75.07 Favored Glycine 0 C--O 1.214 -1.109 0 C-N-CA 120.951 -0.643 . . . . 0.0 111.768 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.516 ' HA ' ' HE3' ' A' ' 134' ' ' LYS . 0.0 OUTLIER -101.49 131.14 47.79 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -176.501 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 52.4 m -56.18 141.01 42.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -176.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.493 ' NZ ' ' HA ' ' A' ' 129' ' ' ASP . 55.8 mttp -97.04 8.15 45.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 128.53 -23.98 5.01 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 118.534 -1.793 . . . . 0.0 116.173 173.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . 0.412 ' C ' HD12 ' A' ' 102' ' ' LEU . 34.9 p90 -154.29 161.69 41.63 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 118.89 1.345 . . . . 0.0 112.086 -175.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -164.21 -176.64 36.24 Favored Glycine 0 N--CA 1.436 -1.33 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.71 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -141.71 147.1 36.89 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 123.501 0.72 . . . . 0.0 109.696 -177.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 39.3 t -127.23 130.47 70.97 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.169 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 174.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 47.4 m -111.49 117.03 31.91 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.506 -0.554 . . . . 0.0 109.506 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -94.6 160.18 14.75 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.915 -179.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -68.23 -32.71 73.11 Favored 'General case' 0 C--N 1.314 -0.968 0 O-C-N 124.435 1.085 . . . . 0.0 110.526 -179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.523 ' HB3' ' OD1' ' A' ' 148' ' ' ASP . 8.8 t-20 -139.53 153.71 47.52 Favored 'General case' 0 N--CA 1.431 -1.404 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.96 -177.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 63.9 mttm -57.86 -44.38 86.54 Favored 'General case' 0 C--O 1.216 -0.666 0 C-N-CA 124.297 1.039 . . . . 0.0 112.303 -179.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -70.73 -33.13 70.52 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.315 -0.254 . . . . 0.0 110.315 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.523 ' OD1' ' HB3' ' A' ' 145' ' ' ASN . 1.6 m-20 -60.02 -43.04 95.53 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 174.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.537 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.82 -46.17 72.64 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.96 -1.018 . . . . 0.0 111.275 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -61.49 -42.61 99.06 Favored 'General case' 0 C--N 1.323 -0.585 0 O-C-N 123.615 0.572 . . . . 0.0 111.069 -176.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -61.36 -41.94 97.89 Favored 'General case' 0 C--O 1.245 0.837 0 CA-C-O 121.583 0.706 . . . . 0.0 109.621 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.2 -41.18 86.26 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.298 -0.864 . . . . 0.0 111.475 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 149' ' ' ALA . 78.8 mt -58.8 -45.41 91.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 C-N-CA 122.485 0.314 . . . . 0.0 110.66 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -66.58 -51.08 60.4 Favored 'General case' 0 C--N 1.315 -0.902 0 O-C-N 123.613 0.571 . . . . 0.0 112.448 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -74.28 -28.89 61.41 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -176.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.35 15.55 24.31 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.266 175.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . 0.408 ' HA2' ' OG1' ' A' ' 168' ' ' THR . . . -75.08 55.08 2.7 Favored Glycine 0 CA--C 1.505 -0.546 0 CA-C-N 115.932 -0.576 . . . . 0.0 113.155 -177.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 103.68 68.08 0.76 Allowed Glycine 0 N--CA 1.407 -3.273 0 CA-C-O 121.648 0.582 . . . . 0.0 112.271 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -118.06 141.43 48.48 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 178.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 84.2 m95 -75.56 92.55 2.92 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.281 0.562 . . . . 0.0 109.662 -178.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 50.9 tp -101.67 109.54 21.35 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.589 -179.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 106' ' ' ILE . . . 80.17 -64.81 3.9 Favored Glycine 0 C--N 1.316 -0.543 0 CA-C-N 115.503 -0.771 . . . . 0.0 113.15 177.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -138.6 -58.01 0.05 OUTLIER Glycine 0 N--CA 1.437 -1.29 0 C-N-CA 120.978 -0.63 . . . . 0.0 111.903 -177.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.604 ' NH2' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -104.31 -178.65 3.72 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-O 121.927 0.87 . . . . 0.0 112.936 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -98.65 108.32 20.99 Favored 'General case' 0 N--CA 1.412 -2.352 0 CA-C-N 114.412 -1.267 . . . . 0.0 107.614 -178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 2.1 pp -82.73 148.33 5.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -176.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.405 ' HD3' ' HA ' ' A' ' 167' ' ' ARG . 25.5 mmt180 -116.52 158.78 23.08 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 112.852 0.686 . . . . 0.0 112.852 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . 0.408 ' OG1' ' HA2' ' A' ' 157' ' ' GLY . 9.2 p -121.4 150.24 41.8 Favored 'General case' 0 C--N 1.279 -2.467 0 CA-C-N 114.137 -1.392 . . . . 0.0 109.216 -179.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -153.16 150.58 29.21 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 25.0 m-90 -79.9 131.31 35.82 Favored 'General case' 0 C--N 1.306 -1.297 0 C-N-CA 123.717 0.807 . . . . 0.0 110.378 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.72 81.84 6.94 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.497 0.665 . . . . 0.0 109.339 175.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 10.6 p -102.88 -51.21 3.33 Favored 'General case' 0 C--N 1.307 -1.272 0 CA-C-N 115.015 -0.993 . . . . 0.0 111.529 -178.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? 75.18 -50.84 0.66 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.933 1.293 . . . . 0.0 111.858 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.407 ' HA ' ' HD2' ' A' ' 175' ' ' PRO . 27.3 tptp -110.47 112.79 56.54 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.443 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 13.0 Cg_endo -60.19 144.85 99.48 Favored 'Trans proline' 0 C--O 1.266 1.916 0 C-N-CA 121.493 1.462 . . . . 0.0 109.911 175.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 175' ' ' PRO . 47.0 Cg_exo -58.88 140.75 96.56 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.621 2.214 . . . . 0.0 113.274 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -103.34 147.38 34.09 Favored Pre-proline 0 C--N 1.295 -1.788 0 CA-C-N 114.424 -1.262 . . . . 0.0 108.255 177.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -53.76 123.65 13.91 Favored 'Trans proline' 0 C--O 1.25 1.09 0 C-N-CA 121.798 1.665 . . . . 0.0 108.936 171.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.429 ' O ' ' HG3' ' A' ' 179' ' ' LYS . 15.0 tptp -84.84 15.87 3.68 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 112.824 0.676 . . . . 0.0 112.824 -171.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 2.7 m -51.47 -47.06 63.28 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 122.236 1.017 . . . . 0.0 108.278 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 14.9 m -138.84 -67.8 0.45 Allowed 'General case' 0 N--CA 1.417 -2.119 0 N-CA-C 105.61 -1.996 . . . . 0.0 105.61 168.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.543 ' CE1' ' HE2' ' A' ' 187' ' ' LYS . 0.1 OUTLIER 179.37 85.0 0.01 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 C-N-CA 126.891 2.076 . . . . 0.0 106.887 175.008 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -90.79 88.86 7.24 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-O 123.448 1.594 . . . . 0.0 114.054 -169.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 65.4 m -153.09 31.0 0.49 Allowed 'General case' 0 C--N 1.282 -2.366 0 N-CA-C 103.872 -2.64 . . . . 0.0 103.872 173.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -171.96 135.08 0.8 Allowed 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 112.785 -2.007 . . . . 0.0 106.143 -172.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 3.7 m -57.85 109.62 0.76 Allowed 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 114.531 1.308 . . . . 0.0 114.531 -174.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.543 ' HE2' ' CE1' ' A' ' 182' ' ' TYR . 3.7 mtmp? -151.19 -60.71 0.18 Allowed 'General case' 0 CA--C 1.488 -1.425 0 N-CA-C 103.61 -2.737 . . . . 0.0 103.61 171.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . 0.629 ' HA ' ' ND2' ' A' ' 259' ' ' ASN . 80.8 mt-30 -99.41 -178.69 3.98 Favored 'General case' 0 N--CA 1.399 -3.017 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 159.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 84.7 mt -95.46 116.67 29.13 Favored 'General case' 0 C--N 1.265 -3.083 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 -179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.509 ' O ' HG23 ' A' ' 194' ' ' VAL . 9.0 m -65.46 142.38 58.18 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 -177.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -49.67 -45.25 48.46 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.185 0.439 . . . . 0.0 112.185 -178.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -65.36 -44.07 88.8 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.85 0.833 . . . . 0.0 110.359 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -60.21 -39.92 88.3 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 114.068 -1.424 . . . . 0.0 109.444 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 190' ' ' SER . 47.0 t -72.02 -49.66 42.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.414 HG23 ' CD2' ' A' ' 248' ' ' HIS . 6.7 p -66.03 -32.8 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-O 120.714 0.292 . . . . 0.0 111.775 -171.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 -74.29 -3.53 30.7 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.86 1.42 56.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 178.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.5 m -150.91 172.52 15.54 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-O 121.333 0.587 . . . . 0.0 112.113 177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 26.2 t -91.23 145.53 31.71 Favored Pre-proline 0 N--CA 1.425 -1.7 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 175.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.406 ' HA ' ' CG ' ' A' ' 248' ' ' HIS . 11.6 Cg_endo -53.9 -12.36 3.29 Favored 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 124.207 3.271 . . . . 0.0 115.394 -176.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 6.1 p -86.55 -13.86 44.61 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-O 121.008 0.432 . . . . 0.0 111.481 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -77.16 124.11 27.36 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.032 0.444 . . . . 0.0 111.609 -178.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 10.8 p -119.54 14.63 12.78 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.089 -178.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 11.3 m -102.03 120.8 41.01 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 120.205 -0.598 . . . . 0.0 112.456 -174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 76.4 t -113.33 137.34 46.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 C-N-CA 123.534 0.734 . . . . 0.0 110.257 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.583 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 65.6 t80 -98.34 123.22 42.33 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 122.933 0.493 . . . . 0.0 109.917 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.6 t -118.73 120.81 38.49 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 173.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -130.22 149.46 18.91 Favored Glycine 0 C--N 1.299 -1.477 0 C-N-CA 119.941 -1.124 . . . . 0.0 112.09 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.78 27.7 1.87 Allowed Glycine 0 C--O 1.215 -1.045 0 C-N-CA 120.814 -0.708 . . . . 0.0 113.932 177.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.535 ' HB ' HD13 ' A' ' 214' ' ' LEU . 14.2 t -138.31 113.85 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 27.0 p -85.71 -35.11 21.03 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 59.5 p -133.65 144.87 49.48 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-O 121.573 0.702 . . . . 0.0 111.697 -175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 80.61 3.75 90.19 Favored Glycine 0 C--N 1.319 -0.391 0 CA-C-N 115.337 -0.847 . . . . 0.0 112.061 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.724 HD12 ' SD ' ' A' ' 219' ' ' MET . 35.8 tp -71.64 98.44 1.91 Allowed 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 177.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 22.1 p -129.37 159.18 37.01 Favored 'General case' 0 N--CA 1.425 -1.703 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.692 -174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.477 ' O ' HG13 ' A' ' 232' ' ' ILE . 0.2 OUTLIER -54.2 -47.41 72.12 Favored 'General case' 0 C--N 1.317 -0.832 0 O-C-N 123.756 0.66 . . . . 0.0 110.013 176.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -63.89 -47.93 78.67 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -177.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 41.6 tp -62.31 -41.63 98.7 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 121.438 0.637 . . . . 0.0 111.182 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.724 ' SD ' HD12 ' A' ' 214' ' ' LEU . 0.0 OUTLIER -69.78 -44.84 69.29 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.812 -179.06 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 22.6 ttm-85 -60.58 -41.78 95.34 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 26.9 tt0 -58.79 -36.33 74.25 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.185 0.594 . . . . 0.0 110.859 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 30.4 m -79.9 -50.47 10.42 Favored 'General case' 0 CA--C 1.553 1.061 0 CA-C-O 121.129 0.49 . . . . 0.0 111.219 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 88.9 m-85 -69.17 -33.5 73.49 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 -178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 227' ' ' GLY . 9.8 t -52.84 -44.29 95.82 Favored Pre-proline 0 CA--C 1.566 1.572 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -175.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -63.83 -14.68 44.49 Favored 'Trans proline' 0 C--N 1.373 1.819 0 CA-C-N 121.104 1.43 . . . . 0.0 113.059 175.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -96.87 -32.81 11.89 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 110.108 -0.33 . . . . 0.0 110.108 178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.92 167.73 40.65 Favored Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.733 177.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -79.44 129.44 34.47 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.413 0.625 . . . . 0.0 111.182 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 37.2 mm -98.29 135.93 31.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 CA-C-N 114.556 -1.202 . . . . 0.0 111.245 -173.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 61.6 mtp -98.56 -40.8 8.05 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 174.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.439 ' CD ' HH21 ' A' ' 233' ' ' ARG . 14.5 tt0 -160.65 147.48 15.48 Favored 'General case' 0 C--O 1.253 1.279 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 -170.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.659 HG22 HG13 ' A' ' 234' ' ' VAL . 24.0 mm -118.32 121.74 67.88 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.81 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 170.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.439 HH21 ' CD ' ' A' ' 231' ' ' GLU . 4.0 tpp180 -105.27 119.51 39.23 Favored 'General case' 0 C--N 1.283 -2.288 0 N-CA-C 105.58 -2.007 . . . . 0.0 105.58 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . 0.659 HG13 HG22 ' A' ' 232' ' ' ILE . 6.7 m -124.42 144.47 34.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -137.44 83.19 26.48 Favored Pre-proline 0 C--N 1.315 -0.914 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -66.42 -23.64 50.66 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.567 2.178 . . . . 0.0 112.101 -177.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -71.36 -26.2 62.7 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.511 -177.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 45.5 mttp -108.36 -6.24 16.34 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-O 121.668 0.747 . . . . 0.0 109.011 178.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 74.96 31.71 57.61 Favored Glycine 0 C--O 1.248 1.024 0 CA-C-N 114.841 -1.072 . . . . 0.0 115.646 175.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 27.2 p90 -147.48 164.49 33.2 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 118.092 0.946 . . . . 0.0 111.363 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.448 ' HB3' HG12 ' A' ' 234' ' ' VAL . 33.6 p -146.57 160.47 42.11 Favored 'General case' 0 N--CA 1.426 -1.644 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.142 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -121.5 124.39 44.31 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 50.1 t -107.44 128.89 62.14 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.348 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . . . . . . . . . 72.9 mtp180 -104.18 126.01 50.95 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.922 179.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -103.42 165.19 11.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.08 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.428 HD22 ' N ' ' A' ' 246' ' ' ASN . 0.7 OUTLIER -87.58 -23.63 24.26 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.303 -0.629 . . . . 0.0 109.303 179.626 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.527 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 16.0 m -132.77 150.4 52.16 Favored 'General case' 0 N--CA 1.425 -1.679 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.482 -172.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . 0.414 ' CD2' HG23 ' A' ' 195' ' ' VAL . 76.5 t60 -76.3 -44.41 37.13 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 122.696 0.398 . . . . 0.0 111.389 -174.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.527 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.37 -45.45 91.39 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.579 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.471 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 44.5 m -59.12 -38.46 79.65 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.913 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.38 -42.34 71.86 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.521 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.583 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -64.92 -43.09 93.92 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.1 178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.2 t-160 -58.36 -43.64 88.5 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 123.533 0.733 . . . . 0.0 111.28 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.42 -47.93 83.57 Favored 'General case' 0 C--O 1.213 -0.851 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.306 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.0 mt -56.66 -48.2 81.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.584 178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.583 HG23 ' O ' ' A' ' 252' ' ' ALA . 89.9 t -51.69 -50.41 31.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 O-C-N 124.125 0.891 . . . . 0.0 111.496 178.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 26.9 t -84.42 -36.45 22.39 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 115.572 -0.74 . . . . 0.0 112.305 -172.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.98 -17.87 16.23 Favored 'Isoleucine or valine' 0 C--O 1.244 0.766 0 CA-C-O 120.934 0.397 . . . . 0.0 110.633 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . 0.629 ' ND2' ' HA ' ' A' ' 188' ' ' GLN . 7.2 t30 -61.61 95.27 0.05 Allowed 'General case' 0 C--O 1.235 0.335 0 CA-C-O 121.276 0.56 . . . . 0.0 110.621 176.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.27 26.47 6.94 Favored Glycine 0 N--CA 1.435 -1.371 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.182 178.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 22.1 p -98.7 -176.54 3.39 Favored 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 119.78 -0.768 . . . . 0.0 110.288 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 24.7 m -134.38 124.62 26.03 Favored 'General case' 0 N--CA 1.431 -1.423 0 O-C-N 121.618 -0.676 . . . . 0.0 111.937 -175.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 74.2 mt -134.24 141.73 42.88 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.843 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 175.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 29.9 tt0 55.57 34.15 22.57 Favored 'General case' 0 CA--C 1.565 1.523 0 CA-C-O 122.58 1.181 . . . . 0.0 110.081 -176.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 70.16 -6.61 5.33 Favored Glycine 0 CA--C 1.54 1.622 0 O-C-N 121.092 -1.005 . . . . 0.0 113.286 -178.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -99.68 145.67 27.36 Favored 'General case' 0 N--CA 1.434 -1.265 0 C-N-CA 122.98 0.512 . . . . 0.0 109.838 -178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.6 t -75.66 123.55 31.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.72 150.6 4.61 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 CA-C-O 122.512 1.149 . . . . 0.0 111.707 -176.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -123.91 129.23 50.64 Favored 'General case' 0 C--N 1.284 -2.265 0 CA-C-N 113.84 -1.527 . . . . 0.0 110.009 -171.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 58.3 m -124.96 147.93 48.66 Favored 'General case' 0 N--CA 1.44 -0.938 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 175.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -155.59 -171.78 3.9 Favored 'General case' 0 CA--C 1.509 -0.623 0 C-N-CA 127.164 2.186 . . . . 0.0 105.406 174.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -75.0 147.92 40.36 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -84.8 -41.07 7.84 Favored Glycine 0 C--N 1.302 -1.331 0 C-N-CA 120.029 -1.082 . . . . 0.0 113.257 -176.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.268 2.076 0 N-CA-C 101.048 -3.686 . . . . 0.0 101.048 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.485 -1.838 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -118.02 148.61 42.08 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.2 109.17 3.89 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 106.512 -1.662 . . . . 0.0 106.512 178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -159.2 -90.06 0.03 OUTLIER 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -89.72 -37.67 14.39 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 174.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.0 m80 -94.77 163.91 13.16 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 113.445 -1.707 . . . . 0.0 109.513 -176.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 26.5 t80 -125.49 127.63 46.76 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 58.8 t60 -102.21 123.63 46.38 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.978 -174.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 52.3 t -119.76 137.35 53.92 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 C-N-CA 123.678 0.791 . . . . 0.0 109.949 -177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.559 ' HB2' ' HB2' ' A' ' 171' ' ' ALA . 88.3 t80 -97.76 126.86 43.33 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 178.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 14.7 t -106.37 128.38 60.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -127.78 175.53 18.31 Favored Glycine 0 N--CA 1.433 -1.566 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -178.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 64.31 24.74 13.36 Favored 'General case' 0 N--CA 1.484 1.239 0 C-N-CA 124.046 0.938 . . . . 0.0 110.896 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 88.9 mt -70.04 103.93 2.42 Favored 'General case' 0 N--CA 1.432 -1.35 0 CA-C-N 114.914 -1.039 . . . . 0.0 110.824 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.3 m -65.09 146.35 98.94 Favored Pre-proline 0 N--CA 1.415 -2.221 0 CA-C-N 114.106 -1.406 . . . . 0.0 110.105 -178.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.558 ' O ' ' HB3' ' A' ' 134' ' ' LYS . 13.9 Cg_endo -59.27 -18.09 43.16 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 123.146 2.564 . . . . 0.0 111.04 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -69.38 -22.31 63.73 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 114.495 -1.23 . . . . 0.0 109.229 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 45.7 mm -100.0 152.57 4.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.847 0 C-N-CA 124.756 1.222 . . . . 0.0 109.069 -177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 8.9 t -134.72 172.97 12.2 Favored 'General case' 0 C--N 1.289 -2.057 0 C-N-CA 124.335 1.054 . . . . 0.0 108.88 173.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.572 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 33.0 m -57.23 -36.33 70.78 Favored 'General case' 0 C--O 1.244 0.78 0 CA-C-O 121.701 0.762 . . . . 0.0 111.1 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.572 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 1.9 mp0 -62.88 -38.39 90.68 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 114.346 -1.297 . . . . 0.0 110.748 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -61.99 -46.96 86.94 Favored 'General case' 0 CA--C 1.496 -1.129 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.427 HD12 ' CG2' ' A' ' 126' ' ' VAL . 27.9 mt -59.74 -45.71 94.27 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.157 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -57.74 -47.08 83.46 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.969 -178.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.95 -42.95 69.1 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 179.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.72 -42.3 77.86 Favored 'General case' 0 CA--C 1.509 -0.596 0 N-CA-C 112.587 0.588 . . . . 0.0 112.587 -175.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.506 ' HB2' HD11 ' A' ' 121' ' ' ILE . 37.7 m-85 -83.52 -19.6 35.4 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -175.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.18 -45.74 98.15 Favored Pre-proline 0 CA--C 1.567 1.626 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 -178.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -64.35 -32.37 61.23 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 121.555 1.503 . . . . 0.0 112.092 176.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -80.79 -42.32 21.91 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.902 -176.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -150.37 145.71 14.03 Favored Glycine 0 N--CA 1.42 -2.371 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.276 -178.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.73 121.18 21.32 Favored 'General case' 0 N--CA 1.423 -1.777 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.506 HD11 ' HB2' ' A' ' 115' ' ' PHE . 64.1 mt -105.45 124.41 60.37 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.309 0 CA-C-N 114.911 -1.041 . . . . 0.0 108.722 -173.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 14.7 m -78.88 -38.93 36.49 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.322 -1.362 . . . . 0.0 107.322 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -165.4 155.81 13.48 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.674 175.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.11 140.71 23.45 Favored 'General case' 0 N--CA 1.427 -1.612 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.423 ' HA ' HG23 ' A' ' 108' ' ' THR . 19.8 ptp180 -154.16 143.2 21.18 Favored 'General case' 0 C--N 1.297 -1.716 0 O-C-N 123.515 0.509 . . . . 0.0 110.634 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.427 ' CG2' HD12 ' A' ' 111' ' ' ILE . 57.3 t -121.4 146.58 26.2 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.909 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 -177.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 62.0 t -78.16 105.86 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.097 0 N-CA-C 104.652 -2.351 . . . . 0.0 104.652 171.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.498 ' HD2' ' O ' ' A' ' 133' ' ' GLY . 59.4 pttt -120.57 164.63 16.18 Favored 'General case' 0 N--CA 1.404 -2.757 0 CA-C-N 115.19 -0.913 . . . . 0.0 110.47 -174.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -70.17 133.21 46.86 Favored 'General case' 0 C--N 1.289 -2.065 0 C-N-CA 124.208 1.003 . . . . 0.0 111.916 -174.081 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 ptp -62.72 -33.73 75.72 Favored 'General case' 0 C--N 1.309 -1.19 0 N-CA-C 113.982 1.104 . . . . 0.0 113.982 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -92.84 -43.41 9.01 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 112.445 0.535 . . . . 0.0 112.445 -174.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 26.6 p -95.3 -18.45 20.79 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 112.533 0.568 . . . . 0.0 112.533 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . 0.498 ' O ' ' HD2' ' A' ' 128' ' ' LYS . . . 74.17 11.66 81.77 Favored Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 116.255 -0.43 . . . . 0.0 113.083 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.558 ' HB3' ' O ' ' A' ' 104' ' ' PRO . 0.9 OUTLIER -105.96 154.18 20.95 Favored 'General case' 0 C--N 1.317 -0.827 0 O-C-N 122.409 -0.465 . . . . 0.0 110.293 -177.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.4 m -52.36 142.81 16.39 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 114.274 1.212 . . . . 0.0 114.274 -175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.48 ' HE2' ' HA ' ' A' ' 136' ' ' LYS . 6.3 mmpt? -92.4 -10.54 37.71 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.857 176.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 140.5 -19.52 2.8 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 119.363 -1.398 . . . . 0.0 114.568 177.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -154.4 160.79 41.85 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 117.888 0.844 . . . . 0.0 112.026 -175.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.6 -167.85 29.82 Favored Glycine 0 N--CA 1.436 -1.321 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 -179.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -153.82 155.29 35.52 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 117.467 0.634 . . . . 0.0 111.819 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 48.6 t -132.48 137.5 54.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 29.5 m -115.07 116.9 29.17 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -94.48 148.73 21.94 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.672 -177.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -75.41 -38.32 59.95 Favored 'General case' 0 C--N 1.312 -1.022 0 O-C-N 124.111 0.882 . . . . 0.0 109.795 179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 26.7 t-20 -110.16 140.82 43.85 Favored 'General case' 0 N--CA 1.427 -1.607 0 CA-C-O 121.558 0.694 . . . . 0.0 112.092 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . . . . . . . . . 62.3 mttp -62.04 -44.17 97.26 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 76.1 t-105 -70.91 -29.0 64.93 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.936 0.398 . . . . 0.0 109.948 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.425 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 56.1 m-20 -59.76 -40.78 89.31 Favored 'General case' 0 CA--C 1.506 -0.734 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.56 176.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.501 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -68.54 -46.71 68.77 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.59 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 24.4 mm-40 -61.56 -40.34 94.36 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 112.567 0.581 . . . . 0.0 112.567 178.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 43.1 t30 -60.91 -42.48 98.14 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -67.6 -47.22 70.33 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.603 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.501 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.3 mt -61.02 -45.11 99.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-O 120.78 0.324 . . . . 0.0 111.044 -179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -65.92 -42.35 90.22 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -87.02 -33.53 19.53 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 119.388 -0.925 . . . . 0.0 112.498 -178.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -102.8 16.15 27.36 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 -177.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -79.02 46.57 2.97 Favored Glycine 0 C--N 1.309 -0.929 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 175.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . . . . . . . . . . . 121.27 60.73 0.23 Allowed Glycine 0 N--CA 1.417 -2.623 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 -175.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 5.0 tp60 -122.11 148.98 44.21 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -177.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . 0.5 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 77.6 m95 -75.77 94.98 3.36 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.512 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 53.9 tp -110.34 136.13 50.0 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 76.93 -106.24 2.17 Favored Glycine 0 CA--C 1.486 -1.728 0 N-CA-C 107.792 -2.123 . . . . 0.0 107.792 -174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -135.4 5.29 4.17 Favored Glycine 0 N--CA 1.429 -1.778 0 C-N-CA 119.078 -1.534 . . . . 0.0 111.031 173.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 160' ' ' TRP . 5.2 mmt180 -131.03 -176.68 4.08 Favored 'General case' 0 CA--C 1.512 -0.506 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 34.6 tt0 -103.66 118.19 36.14 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.241 -178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . . . . . . . . . 19.3 pt -105.86 156.48 6.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 59.8 mtt85 -129.87 159.04 37.81 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 118.334 0.515 . . . . 0.0 111.332 -177.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 18.0 p -132.35 154.4 49.79 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 -179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -154.81 162.16 41.21 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 9.7 m0 -65.2 132.25 48.62 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 123.661 0.784 . . . . 0.0 110.525 177.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.559 ' HB2' ' HB2' ' A' ' 98' ' ' PHE . . . -134.55 21.88 3.65 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 121.408 0.623 . . . . 0.0 110.15 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 7.0 p -72.01 -73.67 0.18 Allowed 'General case' 0 N--CA 1.428 -1.552 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.45 -177.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -112.47 139.08 48.35 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.136 -0.691 . . . . 0.0 109.136 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.99 118.47 67.86 Favored Pre-proline 0 C--N 1.31 -1.144 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -61.27 152.03 75.09 Favored 'Trans proline' 0 CA--C 1.549 1.23 0 C-N-CA 123.782 2.988 . . . . 0.0 114.254 -175.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.56 149.08 30.13 Favored 'Trans proline' 0 CA--C 1.534 0.513 0 C-N-CA 122.816 2.344 . . . . 0.0 111.952 178.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -102.13 155.92 35.87 Favored Pre-proline 0 C--N 1.309 -1.157 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_exo -59.64 146.9 94.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.516 2.144 . . . . 0.0 110.931 175.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.572 ' HE3' ' O ' ' A' ' 185' ' ' ASN . 49.7 mmtm 59.89 3.83 0.52 Allowed 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.023 1.329 . . . . 0.0 113.593 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 22.3 m -102.7 11.77 37.22 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 120.659 0.266 . . . . 0.0 111.681 -175.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 8.2 t -151.49 -58.3 0.16 Allowed 'General case' 0 C--N 1.304 -1.39 0 C-N-CA 119.855 -0.738 . . . . 0.0 111.551 -179.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -177.96 147.22 0.45 Allowed 'General case' 0 C--N 1.29 -1.981 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.785 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -161.88 164.35 28.69 Favored 'General case' 0 CA--C 1.503 -0.861 0 C-N-CA 125.394 1.477 . . . . 0.0 108.264 176.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 15.1 m -90.4 -22.93 21.21 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 176.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.572 ' O ' ' HE3' ' A' ' 179' ' ' LYS . 24.5 t-20 -75.22 101.87 4.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.451 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 12.2 p -90.11 161.07 15.96 Favored 'General case' 0 C--N 1.299 -1.592 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.387 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . 0.282 14.5 tppt? -92.9 73.85 4.84 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 123.146 1.45 . . . . 0.0 111.712 177.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -150.77 -169.23 3.33 Favored 'General case' 0 C--N 1.277 -2.551 0 N-CA-C 102.757 -3.053 . . . . 0.0 102.757 173.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . . . . . . . . . 55.5 mt -82.88 78.57 9.45 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 118.381 -1.328 . . . . 0.0 110.062 176.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.44 ' O ' HG23 ' A' ' 194' ' ' VAL . 18.0 m -70.61 135.79 48.7 Favored 'General case' 0 N--CA 1.429 -1.486 0 CA-C-N 114.82 -1.082 . . . . 0.0 108.278 178.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -49.92 -42.59 48.62 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.887 0.475 . . . . 0.0 111.598 -177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -59.39 -47.67 84.56 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.752 0.821 . . . . 0.0 110.716 178.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 35.1 tt0 -70.54 -39.68 73.86 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.506 -178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 190' ' ' SER . 88.8 t -66.79 -46.36 85.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 4.7 p -65.03 -27.4 42.27 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 CA-C-O 121.259 0.552 . . . . 0.0 110.842 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 32.8 m-80 -83.51 -2.25 55.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.255 178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 77.2 mt-30 -83.24 -2.23 55.06 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.061 0.458 . . . . 0.0 112.205 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 42.7 m -150.48 163.92 37.21 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.07 0.462 . . . . 0.0 111.022 176.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 45.5 t -72.15 143.33 85.93 Favored Pre-proline 0 N--CA 1.425 -1.697 0 N-CA-C 106.38 -1.711 . . . . 0.0 106.38 173.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.44 -12.31 5.76 Favored 'Trans proline' 0 N--CA 1.487 1.105 0 C-N-CA 123.943 3.095 . . . . 0.0 114.66 -177.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 14.8 m -87.87 -14.64 38.87 Favored 'General case' 0 N--CA 1.435 -1.192 0 O-C-N 122.069 -0.394 . . . . 0.0 111.134 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -79.29 121.8 25.54 Favored 'General case' 0 C--O 1.213 -0.853 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 83.7 m -120.77 16.38 11.86 Favored 'General case' 0 C--N 1.293 -1.879 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.398 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.516 ' HA ' ' HA ' ' A' ' 244' ' ' ARG . 8.2 m -97.99 128.37 44.51 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 120.237 -0.585 . . . . 0.0 112.226 -174.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 92.2 t -103.39 137.3 32.33 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.224 0 C-N-CA 124.231 1.013 . . . . 0.0 109.204 178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 270' ' ' CYS . 63.0 t80 -102.55 120.05 39.87 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 241' ' ' SER . 4.7 p -117.62 131.59 56.63 Favored 'General case' 0 C--N 1.297 -1.696 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 176.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -134.38 151.09 20.21 Favored Glycine 0 C--N 1.301 -1.413 0 C-N-CA 120.45 -0.881 . . . . 0.0 111.248 178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 136.57 -27.77 2.93 Favored Glycine 0 C--O 1.239 0.457 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.741 178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.427 ' HB ' HD13 ' A' ' 214' ' ' LEU . 13.2 t -92.05 95.25 5.31 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 O-C-N 122.442 -0.446 . . . . 0.0 110.156 -177.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 24.8 p -85.16 -17.87 35.87 Favored 'General case' 0 C--N 1.306 -1.303 0 CA-C-O 121.773 0.796 . . . . 0.0 111.718 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 48.1 m -141.95 139.5 32.5 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.544 -0.722 . . . . 0.0 110.52 -178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.39 5.19 87.32 Favored Glycine 0 C--O 1.227 -0.297 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.796 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.427 HD13 ' HB ' ' A' ' 210' ' ' VAL . 56.6 tp -75.78 96.11 3.59 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-O 121.302 0.572 . . . . 0.0 110.438 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 25.7 p -108.7 167.24 10.21 Favored 'General case' 0 N--CA 1.418 -2.064 0 CA-C-N 115.238 -0.892 . . . . 0.0 108.741 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -71.11 -34.35 71.0 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-O 121.291 0.567 . . . . 0.0 110.929 178.429 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -64.64 -38.31 90.57 Favored 'General case' 0 N--CA 1.442 -0.875 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.353 175.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 23.0 tp -58.1 -45.83 86.57 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-O 121.233 0.54 . . . . 0.0 110.413 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . . . . . . . . . 29.0 mmt -66.3 -35.09 79.5 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.626 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 216' ' ' GLU . 57.7 mtt85 -66.34 -38.04 86.73 Favored 'General case' 0 C--N 1.314 -0.948 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.125 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.76 -48.25 80.2 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 4.0 m -76.72 -50.52 13.41 Favored 'General case' 0 N--CA 1.421 -1.881 0 CA-C-N 115.836 -0.62 . . . . 0.0 112.221 -177.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . . . . . . . . 0.349 97.4 m-85 -70.0 -33.43 72.03 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 117.023 2.231 . . . . 0.0 117.023 -173.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 21.7 t -55.33 -45.67 99.82 Favored Pre-proline 0 CA--C 1.564 1.502 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -175.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -64.07 -13.74 39.4 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.448 1.432 . . . . 0.0 113.425 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -95.93 -27.92 14.93 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 120.835 -0.346 . . . . 0.0 110.901 179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.452 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -178.0 179.92 48.26 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.014 -1.089 . . . . 0.0 113.09 176.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -80.2 128.88 34.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -177.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 49.2 mm -81.9 135.83 24.21 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.704 -177.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.43 -38.03 4.79 Favored 'General case' 0 C--N 1.313 -0.994 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.204 179.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -160.05 151.84 20.13 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.403 HD13 HG13 ' A' ' 243' ' ' VAL . 19.4 mm -133.92 117.11 25.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . . . . . . . . . 36.1 mtm-85 -121.63 130.2 53.32 Favored 'General case' 0 CA--C 1.481 -1.69 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 174.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 20.8 m -125.22 144.34 35.6 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.44 0 CA-C-O 120.849 0.357 . . . . 0.0 111.677 -174.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -140.08 84.39 14.97 Favored Pre-proline 0 C--N 1.314 -0.94 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 178.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.48 -18.4 43.51 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.67 2.246 . . . . 0.0 112.581 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.3 -27.18 62.29 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.444 -175.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 240' ' ' TYR . 9.4 mptt -109.21 -8.61 15.09 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 172.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.51 43.12 25.32 Favored Glycine 0 N--CA 1.442 -0.932 0 CA-C-N 115.167 -0.924 . . . . 0.0 114.705 179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.491 ' CD2' ' HB2' ' A' ' 238' ' ' LYS . 46.0 p90 -142.12 162.88 34.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 117.473 0.636 . . . . 0.0 110.906 177.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . 0.614 ' HB3' ' SG ' ' A' ' 207' ' ' CYS . 46.7 t -145.44 156.06 43.51 Favored 'General case' 0 N--CA 1.418 -2.043 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.407 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -117.34 118.38 32.09 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 173.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.403 HG13 HD13 ' A' ' 232' ' ' ILE . 85.5 t -114.68 113.9 45.02 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.365 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.516 ' HA ' ' HA ' ' A' ' 204' ' ' THR . 42.7 ttp-105 -99.03 137.28 37.79 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 119.562 -0.855 . . . . 0.0 109.027 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -102.7 168.24 9.38 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.757 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -82.23 -35.53 28.09 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.4 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.503 ' HB2' ' OE1' ' A' ' 249' ' ' GLU . 2.0 p -113.81 144.15 43.48 Favored 'General case' 0 N--CA 1.408 -2.56 0 CA-C-N 114.877 -1.056 . . . . 0.0 111.601 -173.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -75.51 -42.82 51.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.466 0.707 . . . . 0.0 110.847 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.503 ' OE1' ' HB2' ' A' ' 247' ' ' SER . 0.0 OUTLIER -60.48 -45.53 93.43 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.751 178.202 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.452 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 18.1 m -63.97 -33.23 75.24 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.702 179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.48 -42.24 71.67 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.233 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -65.81 -39.17 90.63 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 9.1 t-160 -58.42 -45.15 89.02 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.62 176.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.52 -47.94 83.57 Favored 'General case' 0 C--O 1.207 -1.153 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.248 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.4 mt -57.17 -49.05 80.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.956 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.48 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.0 t -62.47 -44.42 99.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 O-C-N 123.652 0.595 . . . . 0.0 111.414 -178.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 24.9 t -79.26 -36.22 40.18 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-N 116.18 -0.463 . . . . 0.0 112.021 -173.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 92.6 t -77.53 -17.1 14.27 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -56.7 95.94 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 123.535 0.734 . . . . 0.0 112.47 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 97.38 18.32 28.85 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.426 -0.806 . . . . 0.0 112.436 175.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 47.1 p -95.02 -174.27 3.2 Favored 'General case' 0 C--N 1.312 -1.056 0 C-N-CA 120.019 -0.673 . . . . 0.0 110.729 179.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 27.3 m -134.53 119.18 18.14 Favored 'General case' 0 N--CA 1.418 -2.075 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 -178.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 64.7 mt -100.84 111.15 29.62 Favored 'Isoleucine or valine' 0 CA--C 1.484 -1.587 0 CA-C-O 121.242 0.544 . . . . 0.0 109.788 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 44.51 36.55 1.73 Allowed 'General case' 0 C--N 1.291 -1.94 0 CA-C-N 112.924 -1.944 . . . . 0.0 114.541 179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 116.58 -27.88 7.74 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.925 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -98.89 124.32 43.73 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 122.385 -0.479 . . . . 0.0 111.934 -178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 54.2 t -69.59 129.24 33.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 27.5 m -117.46 153.07 19.33 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.135 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.464 ' HE2' ' HA ' ' A' ' 269' ' ' LYS . 0.1 OUTLIER -127.45 130.78 49.89 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 113.637 -1.62 . . . . 0.0 108.41 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 99.4 m -120.24 154.59 34.68 Favored 'General case' 0 C--O 1.25 1.085 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 175.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -156.77 -170.3 3.27 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 128.109 2.564 . . . . 0.0 106.035 174.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 97.8 m95 -81.41 151.85 27.7 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 118.178 0.444 . . . . 0.0 110.981 177.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . . . . . . . . . . . -130.93 -172.01 13.03 Favored Glycine 0 N--CA 1.431 -1.68 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.433 ' HA ' ' NZ ' ' A' ' 274' ' ' LYS . 1.5 tpmp? . . . . . 0 N--CA 1.414 -2.251 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.624 -179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.487 -1.678 0 N-CA-C 108.451 -1.86 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -76.85 95.64 4.12 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 174.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 68.6 mmm -81.6 86.52 6.36 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.48 -174.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 65.15 179.68 0.19 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.19 1.396 . . . . 0.0 112.399 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 145' ' ' ASN . 52.5 t30 -93.32 -13.8 27.7 Favored 'General case' 0 C--N 1.309 -1.17 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.4 ' ND1' ' HA ' ' A' ' 144' ' ' PHE . 47.0 m-70 -92.64 153.98 18.65 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.356 -170.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.48 ' HB2' ' HG2' ' A' ' 146' ' ' LYS . 33.8 t80 -132.37 140.12 48.38 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 178.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.444 ' O ' ' HB3' ' A' ' 171' ' ' ALA . 79.0 m-70 -106.88 135.32 48.64 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.45 HG22 HD11 ' A' ' 153' ' ' ILE . 52.0 t -119.14 137.61 52.52 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 -179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -99.56 126.19 45.49 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.18 137.6 35.66 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 -177.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -141.14 174.88 22.56 Favored Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 110.672 -0.971 . . . . 0.0 110.672 -177.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.481 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 48.3 t0 60.27 40.74 17.46 Favored 'General case' 0 N--CA 1.485 1.294 0 CA-C-O 122.641 1.21 . . . . 0.0 107.927 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.436 ' O ' ' HA2' ' A' ' 137' ' ' GLY . 88.6 mt -84.09 128.53 34.62 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.58 179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 m -72.02 149.43 92.25 Favored Pre-proline 0 C--N 1.292 -1.932 0 CA-C-N 115.162 -0.926 . . . . 0.0 108.773 177.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -58.63 -26.08 77.67 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.232 2.621 . . . . 0.0 114.516 -175.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.3 pm0 -79.57 -15.21 58.07 Favored 'General case' 0 N--CA 1.447 -0.612 0 CA-C-O 120.936 0.398 . . . . 0.0 110.913 -179.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.505 ' O ' ' HB2' ' A' ' 135' ' ' SER . 50.4 mm -82.88 139.24 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 9.2 t -137.88 172.3 13.14 Favored 'General case' 0 N--CA 1.41 -2.466 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.235 -174.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.575 ' HB ' ' OE2' ' A' ' 109' ' ' GLU . 56.0 m -54.79 -44.42 73.71 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 124.258 1.023 . . . . 0.0 110.199 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.575 ' OE2' ' HB ' ' A' ' 108' ' ' THR . 2.2 mp0 -61.42 -37.55 83.92 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.525 -1.216 . . . . 0.0 110.352 179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -69.83 -47.65 61.92 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.544 -178.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.504 HG23 ' CD1' ' A' ' 115' ' ' PHE . 14.8 mt -61.81 -39.27 82.81 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.489 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 67.8 mttm -55.87 -48.42 75.58 Favored 'General case' 0 C--O 1.223 -0.296 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.403 177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.48 -45.39 65.79 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.19 179.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.03 -41.3 97.46 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 -176.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.504 ' CD1' HG23 ' A' ' 111' ' ' ILE . 17.2 m-85 -87.52 -15.48 37.42 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -176.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.64 -42.18 91.0 Favored Pre-proline 0 CA--C 1.569 1.674 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -63.96 -28.84 66.6 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 121.609 1.539 . . . . 0.0 112.53 176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -86.81 -43.28 12.62 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.698 0.285 . . . . 0.0 110.758 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.445 ' HA2' ' NH1' ' A' ' 120' ' ' ARG . . . -147.12 147.92 19.12 Favored Glycine 0 N--CA 1.426 -2.02 0 C-N-CA 119.435 -1.364 . . . . 0.0 113.176 -176.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.585 ' HD2' ' OD1' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -72.86 120.79 18.96 Favored 'General case' 0 N--CA 1.424 -1.76 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 174.86 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.404 HG21 ' HB2' ' A' ' 124' ' ' ALA . 63.6 mt -104.67 129.5 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.959 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.744 -171.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 m -80.78 -39.19 27.22 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 174.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -165.36 148.97 8.25 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.225 176.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.442 ' HA ' ' HA ' ' A' ' 141' ' ' VAL . . . -140.87 141.18 34.66 Favored 'General case' 0 CA--C 1.465 -2.298 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.563 ' HA ' HG23 ' A' ' 108' ' ' THR . 17.7 ttm180 -153.28 145.84 24.16 Favored 'General case' 0 N--CA 1.402 -2.869 0 C-N-CA 119.971 -0.692 . . . . 0.0 111.293 -173.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 81.0 t -121.41 133.12 68.96 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.434 HG12 ' NZ ' ' A' ' 136' ' ' LYS . 17.5 t -91.99 103.27 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.408 -2.525 0 C-N-CA 117.147 -1.821 . . . . 0.0 106.622 176.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 49.0 pttt -105.82 166.16 10.67 Favored 'General case' 0 C--N 1.278 -2.517 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.828 -173.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.553 ' OD2' HG22 ' A' ' 132' ' ' THR . 9.5 t70 -75.52 137.14 40.68 Favored 'General case' 0 C--N 1.292 -1.896 0 O-C-N 123.582 0.551 . . . . 0.0 111.261 177.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.3 ptp -63.32 -33.2 75.0 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -81.87 -51.19 8.35 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -172.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.553 HG22 ' OD2' ' A' ' 129' ' ' ASP . 12.2 t -97.71 -10.97 24.01 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.927 -176.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 70.08 19.89 75.93 Favored Glycine 0 C--N 1.335 0.527 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.083 179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . . . . . . . . . 35.5 mttp -106.0 145.86 30.82 Favored 'General case' 0 CA--C 1.499 -0.982 0 N-CA-C 111.579 0.215 . . . . 0.0 111.579 -173.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 106' ' ' ILE . 36.3 t -56.26 143.02 35.4 Favored 'General case' 0 C--N 1.317 -0.825 0 O-C-N 123.795 0.685 . . . . 0.0 111.221 -179.524 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.434 ' NZ ' HG12 ' A' ' 127' ' ' VAL . 30.4 mtmm -99.6 11.39 39.32 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 176.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . 0.436 ' HA2' ' O ' ' A' ' 102' ' ' LEU . . . 105.99 0.86 38.98 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 115.616 1.006 . . . . 0.0 115.616 171.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -148.54 159.8 43.72 Favored 'General case' 0 C--O 1.25 1.127 0 CA-C-N 118.015 0.908 . . . . 0.0 111.252 -175.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -173.92 -169.41 36.11 Favored Glycine 0 N--CA 1.438 -1.204 0 N-CA-C 110.235 -1.146 . . . . 0.0 110.235 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -153.95 155.82 36.33 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 117.545 0.673 . . . . 0.0 110.469 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 124' ' ' ALA . 46.2 t -134.65 137.26 51.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.935 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 25.2 m -116.25 118.48 32.9 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 176.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -98.28 158.65 15.44 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.291 -178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . 0.4 ' HA ' ' ND1' ' A' ' 94' ' ' HIS . 71.0 m-85 -70.52 -38.65 74.28 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 123.748 0.655 . . . . 0.0 111.026 179.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.476 ' HB3' ' OD2' ' A' ' 148' ' ' ASP . 7.2 t-20 -125.04 149.53 47.69 Favored 'General case' 0 N--CA 1.421 -1.878 0 CA-C-O 121.653 0.74 . . . . 0.0 112.213 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.48 ' HG2' ' HB2' ' A' ' 95' ' ' PHE . 52.2 mttp -60.42 -38.34 83.72 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.09 -0.959 . . . . 0.0 113.525 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 86.9 m95 -70.38 -28.45 65.11 Favored 'General case' 0 C--N 1.312 -1.027 0 O-C-N 122.95 0.156 . . . . 0.0 110.723 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.585 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 33.8 m-20 -60.6 -45.14 95.08 Favored 'General case' 0 N--CA 1.488 1.461 0 CA-C-O 122.164 0.983 . . . . 0.0 108.739 174.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.447 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -69.72 -39.7 76.7 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-N 114.439 -1.255 . . . . 0.0 111.421 -179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -59.81 -45.99 90.64 Favored 'General case' 0 C--N 1.316 -0.863 0 C-N-CA 124.073 0.949 . . . . 0.0 108.762 -177.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -63.97 -46.29 85.31 Favored 'General case' 0 C--O 1.243 0.725 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.381 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.92 89.82 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -176.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.45 HD11 HG22 ' A' ' 97' ' ' VAL . 73.9 mt -61.93 -45.0 99.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-N 117.82 0.282 . . . . 0.0 110.754 -178.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -64.54 -41.77 96.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 113.142 0.793 . . . . 0.0 113.142 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -86.18 -40.29 15.77 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.458 0.911 . . . . 0.0 113.458 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.402 ' CE ' ' HB2' ' A' ' 159' ' ' GLN . 66.2 mmm -85.04 15.66 3.95 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 113.037 0.754 . . . . 0.0 113.037 -176.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -72.27 5.35 14.99 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 121.159 0.311 . . . . 0.0 112.779 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.464 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 165.9 46.84 0.02 OUTLIER Glycine 0 N--CA 1.418 -2.503 0 C-N-CA 120.345 -0.931 . . . . 0.0 113.643 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . 0.402 ' HB2' ' CE ' ' A' ' 156' ' ' MET . 23.4 mt-30 -93.06 154.99 17.79 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -75.75 90.37 2.87 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 123.876 0.735 . . . . 0.0 110.091 -179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.55 110.18 20.8 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 107.207 -1.405 . . . . 0.0 107.207 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 96.19 -138.86 14.17 Favored Glycine 0 N--CA 1.427 -1.918 0 N-CA-C 109.199 -1.561 . . . . 0.0 109.199 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -96.26 2.88 63.63 Favored Glycine 0 C--N 1.303 -1.279 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.22 177.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 30.0 mtm180 -147.59 -164.19 1.95 Allowed 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.877 -0.786 . . . . 0.0 108.877 -179.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -102.27 159.73 15.15 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 176.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.464 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 38.8 pt -121.75 169.85 12.59 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.377 0 N-CA-C 107.332 -1.358 . . . . 0.0 107.332 174.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.481 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 12.0 mmt180 -127.1 171.06 11.71 Favored 'General case' 0 CA--C 1.499 -1.006 0 CA-C-O 121.63 0.729 . . . . 0.0 110.091 178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 16.6 p -133.66 150.53 51.56 Favored 'General case' 0 C--N 1.281 -2.392 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.171 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -141.21 147.62 38.61 Favored 'General case' 0 C--N 1.312 -1.023 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 19.7 m95 -80.7 130.87 35.34 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -175.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.444 ' HB3' ' O ' ' A' ' 96' ' ' HIS . . . -107.07 -50.98 2.99 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 120.029 -0.669 . . . . 0.0 111.355 179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.412 ' HB ' ' CD2' ' A' ' 95' ' ' PHE . 4.0 m -83.28 22.83 0.96 Allowed 'General case' 0 CA--C 1.565 1.54 0 CA-C-O 121.885 0.85 . . . . 0.0 110.903 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -162.32 118.08 1.94 Allowed 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -111.37 144.46 30.55 Favored Pre-proline 0 C--N 1.293 -1.879 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 177.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' HA ' ' HD3' ' A' ' 176' ' ' PRO . 52.1 Cg_endo -71.64 148.57 53.46 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 121.908 1.739 . . . . 0.0 111.351 177.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 175' ' ' PRO . 39.8 Cg_exo -63.62 148.67 92.17 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 122.403 2.068 . . . . 0.0 112.081 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -67.59 124.45 89.28 Favored Pre-proline 0 C--O 1.256 1.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.004 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -74.1 -165.97 0.29 Allowed 'Trans proline' 0 C--O 1.244 0.805 0 C-N-CA 123.079 2.52 . . . . 0.0 111.981 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -133.4 22.39 4.03 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 46.8 m 63.16 -166.46 0.23 Allowed 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.455 -176.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 2.8 t -100.96 86.83 3.14 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-O 122.106 0.955 . . . . 0.0 112.816 -178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 45.9 p90 -176.1 166.93 2.96 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.082 -1.872 . . . . 0.0 108.429 176.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -90.43 142.4 27.77 Favored 'General case' 0 N--CA 1.426 -1.64 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 16.0 m -83.57 21.09 1.26 Allowed 'General case' 0 C--N 1.312 -1.06 0 CA-C-O 121.229 0.538 . . . . 0.0 111.785 -176.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 -149.89 145.79 26.73 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . . . . . . . . . 1.4 p -79.54 94.27 5.59 Favored 'General case' 0 N--CA 1.406 -2.664 0 CA-C-O 121.713 0.768 . . . . 0.0 111.29 177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . 0.561 ' HB2' ' HZ3' ' A' ' 187' ' ' LYS . 0.3 OUTLIER -54.49 -41.63 69.8 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.426 175.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -112.68 143.97 42.99 Favored 'General case' 0 N--CA 1.427 -1.621 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 176.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 194' ' ' VAL . 85.1 mt -113.01 136.23 52.91 Favored 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -177.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.477 ' O ' HG23 ' A' ' 194' ' ' VAL . 21.2 t -111.49 147.41 35.39 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 179.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . 0.408 ' HA ' HG21 ' A' ' 256' ' ' VAL . 85.3 t80 -54.05 -43.06 69.91 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -175.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.417 ' O ' HG12 ' A' ' 195' ' ' VAL . 10.4 p-10 -65.97 -40.42 91.26 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.227 179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 197' ' ' GLN . 9.3 tm-20 -69.32 -43.76 73.09 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.007 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 190' ' ' SER . 87.1 t -64.41 -45.61 95.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 123.451 0.7 . . . . 0.0 112.196 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 192' ' ' ASP . 4.0 p -63.84 -25.6 38.59 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.25 0 CA-C-O 121.59 0.71 . . . . 0.0 110.219 -177.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -87.62 -1.98 58.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.471 -0.786 . . . . 0.0 112.118 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.481 ' HG3' ' O ' ' A' ' 193' ' ' GLU . 92.8 mt-30 -81.49 -12.1 58.97 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 120.825 0.345 . . . . 0.0 111.533 -177.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 72.2 m -153.88 174.14 14.99 Favored 'General case' 0 C--N 1.314 -0.952 0 O-C-N 122.067 -0.396 . . . . 0.0 110.736 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 14.1 m -73.95 142.91 80.26 Favored Pre-proline 0 N--CA 1.428 -1.534 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . 0.432 ' HA ' ' CE1' ' A' ' 248' ' ' HIS . 16.0 Cg_endo -57.07 -12.04 8.92 Favored 'Trans proline' 0 N--CA 1.49 1.279 0 C-N-CA 124.102 3.201 . . . . 0.0 114.623 -177.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.3 p -85.93 -15.51 41.42 Favored 'General case' 0 N--CA 1.426 -1.628 0 O-C-N 121.972 -0.455 . . . . 0.0 111.649 179.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -79.13 123.48 27.4 Favored 'General case' 0 C--O 1.216 -0.682 0 C-N-CA 120.405 -0.518 . . . . 0.0 110.015 176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 22.1 p -119.58 21.22 12.17 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-O 121.001 0.429 . . . . 0.0 110.727 177.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.424 ' HB ' ' O ' ' A' ' 273' ' ' GLY . 1.7 m -101.09 125.34 47.71 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.038 -174.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . 0.439 HG13 HG12 ' A' ' 255' ' ' ILE . 84.4 t -104.2 135.56 41.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 C-N-CA 123.725 0.81 . . . . 0.0 110.537 178.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -103.43 119.48 38.96 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 53.9 t -113.42 129.01 56.64 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -133.8 149.03 19.62 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 119.408 -1.377 . . . . 0.0 112.364 177.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 125.95 8.82 4.98 Favored Glycine 0 C--O 1.218 -0.906 0 C-N-CA 120.977 -0.63 . . . . 0.0 114.187 177.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.468 ' O ' ' HA2' ' A' ' 239' ' ' GLY . 9.8 t -122.33 106.25 17.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 67.0 p -85.92 -34.07 21.03 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -176.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 18.2 m -131.74 137.15 48.1 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 121.762 0.791 . . . . 0.0 112.343 -168.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 78.89 5.98 88.7 Favored Glycine 0 CA--C 1.507 -0.457 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.721 178.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.439 HD13 ' HB ' ' A' ' 210' ' ' VAL . 45.0 tp -68.81 99.43 1.03 Allowed 'General case' 0 N--CA 1.43 -1.445 0 CA-C-O 121.48 0.657 . . . . 0.0 109.639 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 20.5 p -111.47 166.04 11.47 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.548 -179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.74 -36.09 83.19 Favored 'General case' 0 N--CA 1.426 -1.632 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.735 177.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -65.23 -47.48 76.68 Favored 'General case' 0 N--CA 1.422 -1.848 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.069 178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 43.3 tp -54.5 -45.7 73.32 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 123.506 0.503 . . . . 0.0 111.408 -178.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.465 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.0 mmt -72.77 -38.36 67.32 Favored 'General case' 0 C--N 1.321 -0.669 0 C-N-CA 120.15 -0.62 . . . . 0.0 110.373 -179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 45.5 ttm180 -58.55 -47.24 84.88 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.607 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -62.1 -35.21 78.02 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 123.023 0.529 . . . . 0.0 111.19 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 34.5 m -76.85 -50.78 12.6 Favored 'General case' 0 CA--C 1.554 1.098 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.906 -177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.465 ' HD1' ' O ' ' A' ' 219' ' ' MET . 89.6 m-85 -69.7 -33.33 72.37 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 115.621 1.712 . . . . 0.0 115.621 -177.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 23.0 t -50.89 -48.05 84.99 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 114.632 1.345 . . . . 0.0 114.632 -175.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.19 -13.59 38.83 Favored 'Trans proline' 0 C--N 1.37 1.67 0 C-N-CA 121.599 1.533 . . . . 0.0 113.429 176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -96.43 -32.76 12.17 Favored 'General case' 0 C--O 1.242 0.663 0 C-N-CA 120.521 -0.472 . . . . 0.0 111.05 -177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 250' ' ' SER . . . -168.58 174.31 43.26 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 119.26 -1.448 . . . . 0.0 113.28 176.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -80.77 120.13 24.25 Favored 'General case' 0 CA--C 1.505 -0.773 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . 0.411 HG21 HD11 ' A' ' 232' ' ' ILE . 61.1 mt -94.73 135.73 28.02 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.994 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.109 -177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 95.7 mmm -112.25 -24.91 9.55 Favored 'General case' 0 C--N 1.31 -1.111 0 O-C-N 123.39 0.431 . . . . 0.0 111.02 179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 12.7 tt0 -151.22 143.23 23.94 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . 0.411 HD11 HG21 ' A' ' 229' ' ' ILE . 24.9 mm -133.41 123.07 45.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 C-N-CA 123.354 0.662 . . . . 0.0 109.396 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.405 ' HB2' ' HB2' ' A' ' 242' ' ' PHE . 55.8 mtm180 -124.87 127.45 47.14 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 173.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 23.3 m -125.81 144.16 36.87 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.456 -178.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -140.84 86.35 11.88 Favored Pre-proline 0 C--N 1.313 -1.004 0 N-CA-C 109.46 -0.571 . . . . 0.0 109.46 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -64.81 -21.17 64.8 Favored 'Trans proline' 0 C--O 1.213 -0.759 0 C-N-CA 122.643 2.229 . . . . 0.0 111.927 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . 0.437 ' OD2' ' HG2' ' A' ' 238' ' ' LYS . 2.0 t70 -61.79 -37.39 84.19 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.621 -177.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . 0.448 ' HB2' ' CE2' ' A' ' 240' ' ' TYR . 40.2 mmtm -112.07 -0.38 15.68 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 115.941 -0.572 . . . . 0.0 112.18 175.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 210' ' ' VAL . . . 74.62 39.53 40.72 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.486 -0.779 . . . . 0.0 114.86 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 238' ' ' LYS . 42.4 p90 -143.9 167.06 23.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.746 0.773 . . . . 0.0 111.638 179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 27.7 m -146.74 158.8 43.99 Favored 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.054 0.541 . . . . 0.0 110.61 177.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 233' ' ' ARG . 89.5 m-85 -118.28 118.64 32.36 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 173.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 58.5 t -113.87 115.8 50.73 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.14 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 179.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.617 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 33.8 ttm180 -106.75 129.74 54.58 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 121.67 0.748 . . . . 0.0 110.546 -177.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -102.54 169.88 8.38 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 114.584 -1.189 . . . . 0.0 112.212 -173.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -73.14 -33.91 65.78 Favored 'General case' 0 C--N 1.308 -1.212 0 CA-C-N 114.155 -1.384 . . . . 0.0 110.494 178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.4 ' HB2' ' OE2' ' A' ' 249' ' ' GLU . 88.1 p -140.05 165.15 28.12 Favored 'General case' 0 N--CA 1.421 -1.915 0 C-N-CA 119.516 -0.874 . . . . 0.0 111.736 -178.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . 0.432 ' CE1' ' HA ' ' A' ' 200' ' ' PRO . 71.1 t60 -72.68 -37.75 67.78 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 123.57 0.748 . . . . 0.0 110.123 -174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 249' ' ' GLU . 1.5 mp0 -61.22 -47.21 87.15 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB3' ' HA3' ' A' ' 227' ' ' GLY . 50.2 m -59.24 -41.71 89.39 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.495 -1.23 . . . . 0.0 110.609 178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.92 -42.66 69.6 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.111 -177.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.569 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.29 -41.29 89.99 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 109.991 -0.374 . . . . 0.0 109.991 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -58.66 -45.28 89.72 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.717 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -59.4 -48.72 80.55 Favored 'General case' 0 N--CA 1.443 -0.817 0 O-C-N 123.416 0.447 . . . . 0.0 110.349 -179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.439 HG12 HG13 ' A' ' 205' ' ' VAL . 97.9 mt -56.41 -49.38 77.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.691 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 252' ' ' ALA . 59.3 t -59.91 -44.77 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 O-C-N 123.629 0.58 . . . . 0.0 111.398 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 23.8 t -76.96 -36.27 56.63 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.732 -173.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 85.5 t -77.79 -18.15 13.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-O 121.072 0.463 . . . . 0.0 110.683 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -62.12 100.25 0.16 Allowed 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.269 0.557 . . . . 0.0 111.582 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 103.18 11.16 34.72 Favored Glycine 0 C--N 1.292 -1.881 0 CA-C-N 115.285 -0.87 . . . . 0.0 112.052 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 38.9 p -83.01 174.77 10.59 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 119.506 -0.877 . . . . 0.0 109.837 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 23.0 m -127.23 117.03 21.51 Favored 'General case' 0 C--N 1.29 -2.016 0 C-N-CA 119.966 -0.694 . . . . 0.0 111.212 -176.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 78.5 mt -128.04 141.33 46.74 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.214 0 N-CA-C 106.069 -1.826 . . . . 0.0 106.069 177.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 264' ' ' GLU . 33.1 tt0 56.21 34.19 23.49 Favored 'General case' 0 CA--C 1.561 1.371 0 CA-C-O 122.344 1.069 . . . . 0.0 110.241 -177.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 69.58 -6.05 5.08 Favored Glycine 0 CA--C 1.54 1.626 0 O-C-N 121.357 -0.84 . . . . 0.0 113.185 -178.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 36.7 m80 -100.98 144.0 30.45 Favored 'General case' 0 N--CA 1.432 -1.361 0 C-N-CA 123.14 0.576 . . . . 0.0 109.821 -178.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 61.0 t -78.13 115.29 19.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 34.1 m -98.79 145.24 10.44 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 CA-C-O 121.571 0.7 . . . . 0.0 110.622 -176.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -130.15 146.83 51.82 Favored 'General case' 0 C--N 1.296 -1.731 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . . . . . . . . . 84.1 m -115.86 158.66 22.62 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 176.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -153.1 -172.68 4.32 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 126.448 1.899 . . . . 0.0 107.338 175.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . 0.443 ' CD1' ' HB2' ' A' ' 197' ' ' GLN . 97.7 m95 -81.87 146.09 30.03 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 110.067 -0.346 . . . . 0.0 110.067 176.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.424 ' O ' ' HB ' ' A' ' 204' ' ' THR . . . -124.77 -171.03 13.25 Favored Glycine 0 C--N 1.297 -1.628 0 N-CA-C 111.37 -0.692 . . . . 0.0 111.37 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . 0.429 ' NZ ' ' HB3' ' A' ' 274' ' ' LYS . 1.0 OUTLIER . . . . . 0 C--O 1.265 1.891 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.486 -1.729 0 N-CA-C 108.89 -1.684 . . . . 0.0 108.89 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.407 ' O ' ' HD2' ' A' ' 176' ' ' PRO . . . 64.21 -175.26 0.16 Allowed 'General case' 0 N--CA 1.473 0.696 0 O-C-N 124.81 0.947 . . . . 0.0 110.834 -178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 50.2 ttm -163.15 78.35 0.44 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.438 -0.208 . . . . 0.0 110.438 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . 43.45 -169.71 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.149 1.78 . . . . 0.0 115.684 173.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -109.32 -35.44 6.27 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 171.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -95.03 152.67 18.13 Favored 'General case' 0 C--N 1.308 -1.218 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.306 -177.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.506 ' HB2' ' HA ' ' A' ' 146' ' ' LYS . 32.8 t80 -131.97 142.77 49.71 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -175.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -104.35 130.21 52.22 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG22 HD11 ' A' ' 153' ' ' ILE . 88.5 t -113.03 138.53 42.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 C-N-CA 123.403 0.681 . . . . 0.0 110.145 -177.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . 0.401 ' HD1' ' CE2' ' A' ' 140' ' ' PHE . 75.9 t80 -98.4 125.46 43.57 Favored 'General case' 0 C--O 1.244 0.796 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.76 137.31 47.35 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -143.95 178.04 22.25 Favored Glycine 0 C--N 1.304 -1.212 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.423 ' CB ' ' HG2' ' A' ' 167' ' ' ARG . 45.9 t0 63.76 27.52 14.68 Favored 'General case' 0 N--CA 1.496 1.836 0 CA-C-O 122.889 1.328 . . . . 0.0 108.887 178.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 86.5 mt -68.8 124.42 23.63 Favored 'General case' 0 CA--C 1.49 -1.334 0 CA-C-N 114.185 -1.371 . . . . 0.0 111.29 -178.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.478 ' OG ' ' HB2' ' A' ' 164' ' ' ARG . 15.6 m -66.64 136.8 94.86 Favored Pre-proline 0 N--CA 1.419 -1.996 0 CA-C-N 114.703 -1.135 . . . . 0.0 108.47 177.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.06 -17.6 39.04 Favored 'Trans proline' 0 N--CA 1.483 0.899 0 C-N-CA 123.295 2.663 . . . . 0.0 113.621 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.446 ' CD ' ' HZ1' ' A' ' 134' ' ' LYS . 15.5 mm-40 -85.02 -10.44 56.97 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.245 0.545 . . . . 0.0 110.517 -179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 41.6 mm -89.96 152.59 3.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 12.2 t -137.2 172.88 12.34 Favored 'General case' 0 N--CA 1.417 -2.081 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.418 HG22 ' HE3' ' A' ' 112' ' ' LYS . 63.1 m -56.36 -46.28 80.07 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 123.98 0.912 . . . . 0.0 111.955 -177.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -66.32 -34.3 77.68 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 115.449 -0.796 . . . . 0.0 112.047 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.54 -45.73 92.95 Favored 'General case' 0 C--O 1.217 -0.629 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ILE . . . . . 0.503 HD12 ' CG2' ' A' ' 126' ' ' VAL . 18.8 mt -57.96 -43.14 84.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.891 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.466 ' HE2' ' H ' ' A' ' 124' ' ' ALA . 95.6 mttt -59.72 -44.25 93.82 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.506 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.66 -42.54 70.66 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.82 178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -65.9 -44.45 85.2 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.487 ' HB2' HD11 ' A' ' 121' ' ' ILE . 35.6 m-85 -83.62 -16.66 44.36 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -53.44 -47.14 97.33 Favored Pre-proline 0 CA--C 1.56 1.341 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -178.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.92 -14.89 47.63 Favored 'Trans proline' 0 C--N 1.376 1.993 0 C-N-CA 121.848 1.699 . . . . 0.0 113.163 178.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -99.89 -16.68 17.93 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.712 -177.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 179.12 154.19 12.67 Favored Glycine 0 N--CA 1.431 -1.634 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.113 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -77.25 121.2 23.35 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-O 120.987 0.422 . . . . 0.0 110.188 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.487 HD11 ' HB2' ' A' ' 115' ' ' PHE . 52.1 mt -108.83 135.23 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.759 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -176.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.5 p -87.65 -38.9 15.48 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 174.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -166.44 157.61 12.93 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-N 114.784 -1.098 . . . . 0.0 110.011 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.466 ' H ' ' HE2' ' A' ' 112' ' ' LYS . . . -140.11 152.05 45.82 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.4 ptp85 -152.81 138.03 17.43 Favored 'General case' 0 C--N 1.302 -1.495 0 C-N-CA 119.673 -0.811 . . . . 0.0 111.059 -176.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.503 ' CG2' HD12 ' A' ' 111' ' ' ILE . 47.9 t -121.67 147.84 25.44 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.569 -175.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . . . . . . . . . 64.0 t -75.28 105.71 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.964 0 N-CA-C 103.258 -2.868 . . . . 0.0 103.258 167.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 13.8 ptmm? -132.73 165.36 24.69 Favored 'General case' 0 C--N 1.28 -2.448 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.53 -169.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.21 121.6 23.89 Favored 'General case' 0 C--N 1.272 -2.761 0 N-CA-C 106.919 -1.511 . . . . 0.0 106.919 173.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' MET . . . . . . . . . . . . . 21.0 mmt -63.31 -34.09 76.94 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 114.481 1.289 . . . . 0.0 114.481 -178.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -82.94 -45.63 13.92 Favored 'General case' 0 C--N 1.319 -0.728 0 O-C-N 123.491 0.494 . . . . 0.0 111.973 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 40.3 p -94.85 -16.71 22.7 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 -176.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . 84.61 -2.21 88.21 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.186 -1.007 . . . . 0.0 112.815 178.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 105' ' ' GLU . 28.7 mtpp -80.57 130.19 34.97 Favored 'General case' 0 C--N 1.307 -1.248 0 C-N-CA 122.991 0.517 . . . . 0.0 111.186 -174.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.6 m -61.11 144.74 52.99 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 122.82 0.448 . . . . 0.0 111.689 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -89.67 -3.94 57.99 Favored 'General case' 0 C--O 1.221 -0.426 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.091 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLY . . . . . . . . . . . . . . . 129.14 -16.16 5.77 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 119.578 -1.296 . . . . 0.0 115.108 175.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -154.4 162.17 41.31 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 118.498 1.149 . . . . 0.0 112.132 -177.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -168.98 -166.51 28.15 Favored Glycine 0 N--CA 1.434 -1.453 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.256 -177.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.401 ' CE2' ' HD1' ' A' ' 98' ' ' PHE . 96.6 m-85 -141.46 150.48 42.31 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 124.0 0.92 . . . . 0.0 109.367 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 42.8 t -128.17 137.41 57.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.437 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 175.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 22.7 m -112.51 116.6 30.52 Favored 'General case' 0 N--CA 1.428 -1.533 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 149' ' ' ALA . 71.9 m-85 -96.88 153.18 18.04 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.295 -179.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -66.6 -34.09 77.11 Favored 'General case' 0 C--N 1.317 -0.83 0 O-C-N 124.366 1.041 . . . . 0.0 109.812 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 15.6 t-20 -134.75 143.76 47.32 Favored 'General case' 0 N--CA 1.425 -1.699 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.725 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' LYS . . . . . 0.506 ' HA ' ' HB2' ' A' ' 95' ' ' PHE . 48.2 pttt -61.21 -35.14 76.37 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 115.816 1.784 . . . . 0.0 115.816 -179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TRP . . . . . . . . . . . . . 65.7 t-105 -70.6 -34.96 72.71 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 179.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.414 ' HB2' ' O ' ' A' ' 145' ' ' ASN . 1.2 m-20 -60.03 -43.98 94.94 Favored 'General case' 0 N--CA 1.484 1.271 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.802 177.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.538 ' O ' HG13 ' A' ' 153' ' ' ILE . . . -67.18 -45.94 75.42 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 114.69 -1.141 . . . . 0.0 112.012 -178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -61.73 -47.78 83.68 Favored 'General case' 0 C--N 1.319 -0.743 0 O-C-N 123.896 0.748 . . . . 0.0 109.435 -174.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.78 -35.09 78.05 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.336 -177.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ALA . . . . . . . . . . . . . . . -63.95 -40.19 95.86 Favored 'General case' 0 N--CA 1.445 -0.699 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.611 176.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 149' ' ' ALA . 82.1 mt -59.5 -46.32 93.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.693 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -66.63 -44.96 80.62 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -69.74 -33.86 73.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 113.172 0.804 . . . . 0.0 113.172 -177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 70.8 mmm -96.83 15.84 20.93 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.58 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLY . . . . . . . . . . . . . . . -69.79 57.32 0.74 Allowed Glycine 0 CA--C 1.531 1.078 0 O-C-N 123.989 0.805 . . . . 0.0 113.694 -179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLY . . . . . 0.444 ' HA2' ' O ' ' A' ' 166' ' ' ILE . . . 102.84 44.85 1.71 Allowed Glycine 0 N--CA 1.423 -2.196 0 N-CA-C 112.299 -0.321 . . . . 0.0 112.299 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -95.77 145.5 25.28 Favored 'General case' 0 N--CA 1.423 -1.791 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TRP . . . . . . . . . . . . . 82.8 m95 -70.42 91.29 0.75 Allowed 'General case' 0 C--N 1.309 -1.175 0 O-C-N 123.894 0.746 . . . . 0.0 110.854 -179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 47.4 tp -99.12 121.89 41.61 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.097 175.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLY . . . . . . . . . . . . . . . 80.52 -72.59 2.64 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.498 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLY . . . . . . . . . . . . . . . -165.42 9.72 0.07 OUTLIER Glycine 0 C--N 1.313 -0.739 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.255 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.478 ' HB2' ' OG ' ' A' ' 103' ' ' SER . 31.2 mtp-105 -149.56 172.63 14.7 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -89.68 149.16 22.9 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.444 ' O ' ' HA2' ' A' ' 158' ' ' GLY . 42.6 pt -119.46 163.39 16.82 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 173.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 101' ' ' ASP . 10.7 mmt180 -117.81 166.46 12.44 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 119.374 -0.931 . . . . 0.0 110.265 -179.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 5.1 p -147.32 153.91 40.29 Favored 'General case' 0 C--N 1.275 -2.642 0 CA-C-N 114.059 -1.428 . . . . 0.0 109.429 -175.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -161.92 159.82 27.14 Favored 'General case' 0 C--O 1.248 0.996 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . . . . . . . . . 8.8 m-90 -71.83 128.83 37.01 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 -178.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.18 -43.56 6.59 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.101 0.477 . . . . 0.0 109.922 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.487 ' HB ' ' CE1' ' A' ' 95' ' ' PHE . 16.8 m -72.08 121.84 19.92 Favored 'General case' 0 N--CA 1.43 -1.426 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 174.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -149.01 -46.89 0.14 Allowed 'General case' 0 C--N 1.304 -1.37 0 C-N-CA 120.196 -0.602 . . . . 0.0 110.357 -169.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -80.08 110.45 16.27 Favored Pre-proline 0 C--N 1.307 -1.266 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.411 176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.21 147.96 67.56 Favored 'Trans proline' 0 C--O 1.264 1.799 0 C-N-CA 122.356 2.037 . . . . 0.0 112.441 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 90' ' ' ALA . 37.7 Cg_endo -66.25 156.46 64.85 Favored 'Trans proline' 0 C--O 1.252 1.198 0 C-N-CA 123.721 2.947 . . . . 0.0 113.467 -179.543 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -77.71 152.66 80.61 Favored Pre-proline 0 C--O 1.246 0.902 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.566 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PRO . . . . . 0.45 ' C ' ' HD2' ' A' ' 179' ' ' LYS . 57.5 Cg_endo -68.76 -171.32 0.38 Allowed 'Trans proline' 0 C--N 1.36 1.167 0 C-N-CA 123.007 2.471 . . . . 0.0 112.378 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.45 ' HD2' ' C ' ' A' ' 178' ' ' PRO . 2.1 mptp? -125.63 93.93 3.99 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.955 0.407 . . . . 0.0 111.256 179.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 54.5 m -157.98 40.91 0.28 Allowed 'General case' 0 C--N 1.311 -1.096 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' THR . . . . . . . . . . . . . 3.4 m -144.59 20.36 1.68 Allowed 'General case' 0 C--N 1.312 -1.041 0 CA-C-O 121.46 0.648 . . . . 0.0 109.924 -174.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -125.85 -17.85 5.28 Favored 'General case' 0 CA--C 1.483 -1.633 0 C-N-CA 119.765 -0.774 . . . . 0.0 110.284 -176.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -60.52 112.02 1.82 Allowed 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.097 -1.41 . . . . 0.0 111.029 -173.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' SER . . . . . . . . . . . . . 13.5 m -89.99 17.93 6.33 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 121.833 0.825 . . . . 0.0 110.054 -177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -100.52 -156.58 0.56 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' THR . . . . . 0.485 ' HB ' ' HA ' ' A' ' 190' ' ' SER . 4.3 m -86.01 25.62 1.11 Allowed 'General case' 0 CA--C 1.578 2.052 0 CA-C-O 122.411 1.101 . . . . 0.0 110.143 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' LYS . . . . . . . . . . . . . 15.9 tptp 68.62 -49.39 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 126.462 1.905 . . . . 0.0 113.962 179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLN . . . . . . . . . . . . . 7.1 mm-40 -100.99 -147.17 0.35 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LEU . . . . . 0.543 HD22 HG13 ' A' ' 256' ' ' VAL . 0.0 OUTLIER -63.03 125.65 24.73 Favored 'General case' 0 N--CA 1.403 -2.792 0 N-CA-C 105.569 -2.011 . . . . 0.0 105.569 171.679 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.557 ' HB3' ' OD1' ' A' ' 192' ' ' ASP . 67.5 m -106.18 139.55 40.52 Favored 'General case' 0 C--N 1.27 -2.865 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 -160.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -58.29 -41.16 83.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.842 178.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.557 ' OD1' ' HB3' ' A' ' 190' ' ' SER . 4.5 p-10 -64.02 -39.8 94.91 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.289 177.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 190' ' ' SER . 1.3 tm-20 -69.12 -45.94 68.91 Favored 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 123.765 0.826 . . . . 0.0 111.108 177.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 190' ' ' SER . 62.3 t -67.7 -45.71 84.15 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.007 -179.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' VAL . . . . . . . . . . . . . 5.4 p -64.57 -33.88 65.99 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.746 0 CA-C-O 121.146 0.498 . . . . 0.0 111.033 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -76.71 -2.6 33.74 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -89.54 0.99 56.52 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' SER . . . . . . . . . . . . . 43.3 m -148.12 161.58 41.13 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-O 121.086 0.469 . . . . 0.0 111.67 175.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' SER . . . . . . . . . . . . . 15.6 m -76.49 146.55 77.45 Favored Pre-proline 0 N--CA 1.427 -1.615 0 N-CA-C 107.713 -1.217 . . . . 0.0 107.713 174.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -53.39 -12.05 2.35 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 124.395 3.397 . . . . 0.0 115.544 -176.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' SER . . . . . . . . . . . . . 5.6 p -90.0 -14.51 33.81 Favored 'General case' 0 N--CA 1.425 -1.68 0 O-C-N 121.801 -0.562 . . . . 0.0 111.787 179.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASN . . . . . . . . . . . . . 61.3 t30 -77.61 121.28 23.73 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 119.965 -0.694 . . . . 0.0 110.075 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' CYS . . . . . . . . . . . . . 62.6 m -121.67 19.85 11.07 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.82 -179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 15.6 m -103.69 124.47 48.91 Favored 'General case' 0 C--N 1.319 -0.737 0 O-C-N 121.925 -0.484 . . . . 0.0 111.637 -175.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' VAL . . . . . . . . . . . . . 85.6 t -114.04 137.37 47.5 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 C-N-CA 123.445 0.698 . . . . 0.0 110.539 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.566 ' HB2' ' HA2' ' A' ' 273' ' ' GLY . 62.7 t80 -98.24 127.03 43.97 Favored 'General case' 0 C--N 1.315 -0.912 0 C-N-CA 123.354 0.662 . . . . 0.0 109.26 176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 49.3 t -117.64 132.37 56.51 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 176.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -142.75 156.74 26.48 Favored Glycine 0 C--N 1.3 -1.454 0 C-N-CA 119.962 -1.113 . . . . 0.0 112.426 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . 120.26 -12.96 10.39 Favored Glycine 0 C--O 1.241 0.561 0 C-N-CA 121.094 -0.574 . . . . 0.0 113.669 176.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . 0.489 ' HB ' HD13 ' A' ' 214' ' ' LEU . 11.9 t -104.94 96.28 4.47 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 O-C-N 122.116 -0.637 . . . . 0.0 110.857 -175.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' THR . . . . . . . . . . . . . 20.9 p -85.92 -21.85 27.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.552 0.692 . . . . 0.0 111.915 178.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' SER . . . . . . . . . . . . . 32.4 t -131.66 146.73 52.34 Favored 'General case' 0 C--N 1.305 -1.348 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.455 -176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.02 5.74 71.48 Favored Glycine 0 C--N 1.32 -0.312 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.544 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.489 HD13 ' HB ' ' A' ' 210' ' ' VAL . 43.5 tp -75.0 102.0 4.67 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.389 0.614 . . . . 0.0 111.19 -176.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 31.2 p -115.82 162.95 16.57 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.8 -26.87 63.51 Favored 'General case' 0 N--CA 1.424 -1.743 0 CA-C-O 120.894 0.378 . . . . 0.0 111.192 177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' GLN . . . . . . . . . . . . . 31.5 mm-40 -65.41 -50.53 65.12 Favored 'General case' 0 C--O 1.221 -0.409 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 175.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 33.9 tp -55.1 -43.82 74.36 Favored 'General case' 0 CA--C 1.509 -0.613 0 O-C-N 124.048 0.843 . . . . 0.0 111.425 -173.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' MET . . . . . 0.541 ' O ' ' HD1' ' A' ' 223' ' ' PHE . 31.6 mmt -69.06 -47.28 65.7 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 120.036 -0.666 . . . . 0.0 110.401 -178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.9 ptt-85 -64.83 -40.64 95.52 Favored 'General case' 0 C--O 1.203 -1.358 0 C-N-CA 119.458 -0.897 . . . . 0.0 111.921 -176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -58.69 -34.91 71.81 Favored 'General case' 0 C--N 1.315 -0.903 0 O-C-N 123.652 0.595 . . . . 0.0 110.867 178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.5 m -75.31 -49.97 17.49 Favored 'General case' 0 N--CA 1.438 -1.063 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.607 178.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PHE . . . . . 0.541 ' HD1' ' O ' ' A' ' 219' ' ' MET . 92.2 m-85 -69.79 -33.91 73.03 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 -175.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 57.9 m -47.5 -50.09 51.62 Favored Pre-proline 0 CA--C 1.561 1.379 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 -176.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -63.98 -15.57 49.94 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 121.399 1.399 . . . . 0.0 113.11 178.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -97.73 -34.72 10.8 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.141 -178.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -162.93 165.53 36.46 Favored Glycine 0 N--CA 1.441 -1.027 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.1 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLN . . . . . 0.608 ' HB2' ' OD1' ' A' ' 246' ' ' ASN . 1.3 mp0 -80.71 131.34 35.44 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 -176.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 33.9 mm -95.44 135.55 29.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.994 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' MET . . . . . . . . . . . . . 71.3 mtp -112.35 -37.88 4.85 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.434 175.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' GLU . . . . . 0.43 ' HB3' ' HB3' ' A' ' 244' ' ' ARG . 37.2 tt0 -148.84 148.18 29.6 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 -175.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ILE . . . . . . . . . . . . . 23.6 mm -134.02 126.82 50.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 178.257 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' ARG . . . . . 0.407 ' HE ' ' CD ' ' A' ' 231' ' ' GLU . 62.0 mtt-85 -124.58 125.51 44.29 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' VAL . . . . . . . . . . . . . 16.2 m -125.26 146.03 31.62 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 O-C-N 123.528 0.517 . . . . 0.0 111.07 -174.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -144.84 89.12 6.71 Favored Pre-proline 0 C--N 1.317 -0.812 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.49 -22.97 37.95 Favored 'Trans proline' 0 N--CA 1.48 0.701 0 C-N-CA 122.791 2.328 . . . . 0.0 113.217 -176.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -68.93 -34.17 74.94 Favored 'General case' 0 C--N 1.313 -1.014 0 CA-C-O 121.455 0.645 . . . . 0.0 110.516 -176.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -103.98 -16.15 15.41 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-O 122.09 0.948 . . . . 0.0 109.606 178.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' GLY . . . . . . . . . . . . . . . 75.9 48.45 10.03 Favored Glycine 0 C--N 1.295 -1.748 0 CA-C-N 113.621 -1.627 . . . . 0.0 114.884 173.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . 0.41 ' HE2' ' CE2' ' A' ' 242' ' ' PHE . 16.3 p90 -149.6 166.01 30.55 Favored 'General case' 0 C--N 1.314 -0.962 0 N-CA-C 109.782 -0.451 . . . . 0.0 109.782 178.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' SER . . . . . . . . . . . . . 19.5 m -146.76 160.42 42.27 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 123.191 0.597 . . . . 0.0 110.591 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PHE . . . . . 0.41 ' CE2' ' HE2' ' A' ' 240' ' ' TYR . 56.7 m-85 -121.11 128.67 52.79 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 173.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 47.9 t -116.34 128.93 73.52 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ARG . . . . . 0.43 ' HB3' ' HB3' ' A' ' 231' ' ' GLU . 13.3 ttm180 -107.08 127.32 53.38 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' PHE . . . . . . . . . . . . . 37.0 m-85 -103.45 169.66 8.41 Favored 'General case' 0 C--N 1.297 -1.712 0 O-C-N 123.884 0.74 . . . . 0.0 109.431 178.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.608 ' OD1' ' HB2' ' A' ' 228' ' ' GLN . 27.1 p-10 -97.2 -12.59 22.82 Favored 'General case' 0 C--N 1.307 -1.241 0 O-C-N 123.526 0.516 . . . . 0.0 110.658 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' SER . . . . . 0.577 ' HB3' ' OE2' ' A' ' 249' ' ' GLU . 37.4 m -141.74 152.31 43.7 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.16 -175.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -75.98 -45.38 35.08 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 123.441 0.696 . . . . 0.0 111.174 -172.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' GLU . . . . . 0.577 ' OE2' ' HB3' ' A' ' 247' ' ' SER . 0.0 OUTLIER -59.13 -45.44 90.93 Favored 'General case' 0 C--N 1.311 -1.091 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.139 178.681 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 39.7 m -59.12 -40.6 85.93 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.551 177.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ALA . . . . . . . . . . . . . . . -70.87 -42.75 69.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.242 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . 0.521 ' O ' HG23 ' A' ' 256' ' ' VAL . . . -66.45 -40.47 89.43 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.447 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -58.94 -46.51 87.82 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.753 178.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ALA . . . . . . . . . . . . . . . -61.48 -41.7 97.66 Favored 'General case' 0 N--CA 1.444 -0.729 0 O-C-N 123.618 0.574 . . . . 0.0 111.167 -178.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 97.2 mt -59.37 -50.82 78.45 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.139 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.135 177.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' VAL . . . . . 0.543 HG13 HD22 ' A' ' 189' ' ' LEU . 44.4 t -57.31 -40.44 74.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -176.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' SER . . . . . . . . . . . . . 6.2 p -83.02 -40.03 20.49 Favored 'General case' 0 N--CA 1.421 -1.91 0 N-CA-C 112.646 0.61 . . . . 0.0 112.646 -175.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' VAL . . . . . . . . . . . . . 90.1 t -77.52 -23.14 14.27 Favored 'Isoleucine or valine' 0 C--O 1.245 0.822 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -63.88 94.07 0.09 Allowed 'General case' 0 N--CA 1.471 0.618 0 CA-C-O 121.448 0.642 . . . . 0.0 112.483 -176.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . 104.29 17.06 16.58 Favored Glycine 0 N--CA 1.44 -1.051 0 CA-C-N 115.112 -0.949 . . . . 0.0 113.268 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' THR . . . . . . . . . . . . . 32.6 p -95.13 177.72 5.78 Favored 'General case' 0 C--N 1.317 -0.822 0 C-N-CA 120.017 -0.673 . . . . 0.0 110.508 176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' THR . . . . . . . . . . . . . 33.4 m -135.15 130.1 34.87 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.469 -0.769 . . . . 0.0 111.267 -177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ILE . . . . . . . . . . . . . 3.5 mp -110.98 111.18 35.06 Favored 'Isoleucine or valine' 0 C--O 1.243 0.724 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 173.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 46.06 37.28 3.67 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 125.779 1.632 . . . . 0.0 115.202 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . 114.57 -27.25 8.96 Favored Glycine 0 N--CA 1.442 -0.959 0 C-N-CA 120.216 -0.992 . . . . 0.0 112.517 177.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' HIS . . . . . . . . . . . . . 84.3 m-70 -93.36 118.27 31.09 Favored 'General case' 0 C--N 1.308 -1.199 0 C-N-CA 120.296 -0.562 . . . . 0.0 111.015 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 53.3 t -77.41 124.31 35.58 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' VAL . . . . . . . . . . . . . 31.2 m -100.13 139.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-O 122.632 1.206 . . . . 0.0 112.028 -176.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.668 ' HD2' ' CE2' ' A' ' 271' ' ' TYR . 17.5 tppt? -120.96 128.92 53.18 Favored 'General case' 0 C--N 1.276 -2.606 0 CA-C-N 113.941 -1.481 . . . . 0.0 108.2 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 206' ' ' TYR . 95.8 m -132.08 142.6 49.58 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 112.455 0.539 . . . . 0.0 112.455 178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' TYR . . . . . 0.668 ' CE2' ' HD2' ' A' ' 269' ' ' LYS . 35.7 m-85 -152.08 -169.75 3.45 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 105.304 -2.11 . . . . 0.0 105.304 175.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' TRP . . . . . . . . . . . . . 98.6 m95 -72.26 146.85 46.96 Favored 'General case' 0 C--N 1.302 -1.482 0 C-N-CA 120.609 -0.436 . . . . 0.0 109.921 176.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 206' ' ' TYR . . . -71.02 -42.75 58.77 Favored Glycine 0 CA--C 1.5 -0.894 0 O-C-N 123.646 0.591 . . . . 0.0 112.523 -178.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.451 0 N-CA-C 100.942 -3.725 . . . . 0.0 100.942 179.0 . . . . . . . . 1 1 . 1 stop_ save_